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Cystic fibrosis diabetes (CFD) is the most common co-morbidity affecting nearly half of 
adults with cystic fibrosis over 30 years. Its presence has a significant impact on 
nutritional status, respiratory function, morbidity and mortality. Contrary to UK clinical 
guidelines there are currently no self-management education programmes for people 
with CFD. It is unclear what the barriers and facilitators are to help patients manage 
the additional demands of CFD, and specifically what people with CFD require to help 
them manage the potentially competing demands of blood glucose, nutritional status 
and lung function simultaneously. This study answers the research question “how can 
we best meet the self-management education requirements of people with CFD?” 
Methods 
This study, informed by the MRC Framework for developing and evaluating complex 
intervention, was conducted in two stages. 
Stage 1a - a systematic search of four electronic bibliographic data bases was carried 
out to identify qualitative studies exploring the experience of living with and managing 
CFD. Meta-ethnography was used to synthesise the findings. 
Stage 1b - a qualitative single occasion interview design, guided by the principles of IPA 
was conducted to provide insight into the self-management experiences of people 
with CFD and help identify skills and knowledge people with CFD require to self-
manage their condition. Eight adults, from one CF centre participated.  
Stage two developed and reviewed the MAGIC – Managing Abnormal Glucose in Cystic 
Fibrosis) programme. A stakeholder development group, consisting of 9 healthcare 
professional and 7 people with CFD, was established to co-design the MAGIC 
programme. Over 11 months, 4 workshops focusing on the content, structure and 
design of the MAGIC programme took place. Cognitive interviews were conducted with 
ten people, not previously involved in its development, to review the face validity of 
the MAGIC programme.  
Results 
The meta-ethnography demonstrated that individual perception of CFD directly affects 
its management. Many challenges in self-managing CFD were identified in the IPA 
study, these included: trying to balance CF and CFD, not having sufficient knowledge to 
inform appropriate self-management decisions and being inadequately supported by 
healthcare professionals. These evidences, from stage one, and expertise from the 
stakeholder development group informed the development of the MAGIC programme. 
This was developed as an on-line self-management education programme, designed 
for 1:1 delivery at home. It consisted of a staged approach to learning built around four 
modules. Its theoretical underpinnings were informed by self-efficacy theory, the self-
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management framework for chronic illness and adult learning styles. The cognitive 
interviews identified technological problems, omissions, errors and comprehension 
difficulties in the MAGIC programme which were addressed before face validity was 
established. 
Conclusions 
This study developed the MAGIC programme, a unique self-management education 
programme for people with CFD. It is grounded in evidence generated from a 
qualitative systematic review, qualitative interviews and shared experiences of people 
with CFD and healthcare professional expert in the management of CFD. 
Recommendations for further research to assess the efficacy of the MAGIC programme 
include a feasibility study, a rare disease trial and the development of a core outcome 
set for CFD. 
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To provide the background to this study this chapter will give: a brief review of cystic 
fibrosis (CF), an in-depth exploration of cystic fibrosis diabetes (CFD) and an overview 
of diabetes self-management education (DSME) programmes. This will be followed by 
an overview of my interest within this field and the outline of this thesis.  
1.1 Background to cystic fibrosis 
CF is the most common life-limiting genetic disease in the Caucasian population. It is a 
complex multisystem disease characterised by abnormal transport of sodium and 
chloride; this results in thick viscous secretions in the lungs, gastrointestinal tract, liver, 
pancreas and reproductive tract and elevated sodium and chloride concentrations in 
sweat. 
1.2 Prevalence and survival 
CF is an autosomal recessive disorder. One in 25 people in the UK carry a CF gene 
mutation (Cystic Fibrosis Trust 2019). CF occurs in approximately one in every 2500 live 
births (Dodge et al. 2007) and currently affects 10,461 people in the UK (Cystic Fibrosis 
Trust 2018a). In the 1930’s, when CF was first described, 70% of babies died within the 
first year of life (Andersen 1938). Of those born in the 1970’s over half died before 
they reached mid-late teens (Dodge et al. 2007). The median predicted age of survival, 
for a child born today with CF, is 47 years (Cystic Fibrosis Trust 2018a). Improved 
survival is attributed to many factors which include: specialist CF centre 
multidisciplinary care, improved nutritional management, routine airway clearance 
techniques, improved antibiotic therapy (Plant et al. 2013) and newborn screening 
(Dijk et al. 2011). Improvements in survival has resulted in the development of co-
morbidities which increase the complexities of treating and managing CF.  
1.3 The underlying genetic defect 
The CF gene was first identified in 1989 (Kerem et al. 1989); it codes for a protein 
called the cystic fibrosis transmembrane conductance regulator (CFTR). This protein 
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acts as a chloride channel and is responsible for the movement of chloride ions across 
the apical membrane of epithelial cells (Ratjen 2009). Chloride ions affect the amount 
of water moved in and out of cells. CFTR is widely found in epithelial cells of the 
airways, salivary glands, sweat glands, pancreas, intestines and reproductive tract and 
this is where the major clinical manifestations are exhibited (Davis 2006). CF causing 
gene mutations lead to defective or absent CFTR, which in turn results in elevated 
concentrations of sodium and chloride in sweat and viscous secretions in organs such 
as the lungs, gastrointestinal tract and the male reproductive system.  
More than 2000 CFTR variants have been identified. Six classes of CFTR mutations have 
been recognised (table 1); classification is based upon the impact on CFTR protein 
function. F508del, a class II mutation, is the most common CFTR mutation; 
approximately 90.9% of the UK CF population have at least one copy of the F508del 
mutation (Cystic Fibrosis Trust 2018a). Class II mutations result in CFTR protein that is 
not folded or processed correctly. The relationship between different gene mutations 
and clinical phenotype is complex and often result in variable levels of disease severity, 
this is even seen between siblings with the same genotype (O'Sullivan & Freedman 
2009). Environmental factors and other genetic components such as CF modifiers have 
also been proposed in playing a role in the clinical outcome of people with CF 
(Zielenski 2000).  
Table 1 Classes of CFTR mutation 
Class CFTR defect 
I No functional CFTR protein 
II CFTR trafficking defect 
III Defective channel regulation 
IV Decreased channel conductance 
V Reduced synthesis of CFTR 
VI Decreased CFTR stability 
 
1.4 Diagnosis 
Since 2007 all babies born in the UK are screened for CF as part of the Newborn 
Screening Programme. This leads to earlier diagnosis which has been shown to have a 
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positive effect on nutritional status (Farrell et al. 1997, Leung et al. 2017), respiratory 
outcomes (Cystic Fibrosis Foundation et al. 2009) and survival (Dijk et al. 2011). The 
majority of people with CF are therefore now diagnosed in infancy but those born 
before the introduction of newborn screening may be diagnosed in later life. 
Symptoms of CF include; faltering growth/ undernutrition, protracted diarrhoea, 
recurrent respiratory infections, pancreatitis and male infertility. The diagnosis of CF 
later in life as a result of clinical manifestations is confirmed by sweat testing, CF 
genotyping and measures of CFTR function such as the nasal potential difference test 
(Farrell et al. 2008).  
1.5 Clinical manifestations 
1.5.1 Respiratory tract 
In the CF respiratory tract mucus secretions contain less water and are therefore 
viscous and more difficult to clear. The presence of viscous mucus in the lungs 
increases the risk of colonisation by pathogens and leaves the lungs susceptible to 
infections and inflammation. Recurrent respiratory infections lead to progressive lung 
damage and loss of lung function which can ultimately result in death from respiratory 
failure.  
1.5.2 Gastrointestinal tract 
CF has a major effect on the gastrointestinal system and gastrointestinal complications 
include: pancreatic exocrine insufficiency, gastro-oesophageal reflux disease and distal 
intestinal obstructive syndrome.  
Pancreatic exocrine insufficiency is the most common gastrointestinal complication, 
affecting between 80 to 90% of people with CF (Somaraju & Solis-Moya 2016). Damage 
to the pancreas begins in utero and is progressive; pancreatic cells are replaced with 
fibrous scar tissue as a result of tissue damage caused by the deposits of dried up 
secretions. This inhibits pancreatic function causing a reduction in the production of 
pancreatic enzymes. Pancreatic enzymes play an important role in the digestion of 
macronutrients, predominately proteins, fats and carbohydrates. When the quantity of 
pancreatic enzymes secreted in response to a meal is insufficient to maintain normal 
20 
 
digestive processes pancreatic exocrine insufficiency occurs. Fat maldigestion and 
malabsorption are the major clinical manifestation of pancreatic exocrine insufficiency, 
if left untreated they will result in sub-optimal nutritional status and deficiency of fat 
soluble vitamins (Cystic Fibrosis Trust 2016).  
Pancreatic enzyme replacement therapy is used to treat pancreatic exocrine 
insufficiency; it is prescribed with all fat and protein containing meals and snacks. The 
aims of treatment are to achieve adequate digestion of all nutrients thereby 
controlling the signs and symptoms of malabsorption. This is essential in order to 
achieve sufficient growth and development, preserve normal nutritional status and 
obtain adequate fat-soluble vitamin levels.  
1.5.3 Liver disease 
The majority of hepatobiliary complications seen in people with CF present in 
childhood or early adolescence. The clinical presentation of CF liver disease is variable 
and ranges from asymptomatic elevation in serum liver enzymes to cirrhosis. Liver 
steatosis, which has been shown to have little clinical impact, is the most common 
finding, affecting 23-75 percent of people with CF (Lewindon & Ramm 2011, Parisi et 
al. 2013). Cirrhosis is irreversible; in 5-15 percent of cases focal biliary cirrhosis leads to 
multilobular biliary cirrhosis and portal hypertension (Parisi et al. 2013). Liver failure is 
uncommon, mainly affecting older children and adults (Debray et al. 2011). 
The aim of treatment of cystic fibrosis liver disease is to prevent liver damage and 
complications associated with portal hypertension and cirrhosis. Ursodeoxycholic acid 
is widely used to treat people with cystic fibrosis liver disease (Moyer & Balistreri 
2009). Liver transplantation is an option for some people with end-stage cystic fibrosis 
liver disease. 
1.5.4 Reproductive system 
Approximately 98% of men with CF are infertile due to the blockage or absence of the 
vas deferens. Advances in fertility treatments involving sperm aspiration and intra-
cytoplasmic sperm injection (ICSI) has led to many men with CF fathering children 
(Lyon & Bilton 2002). Women with CF may well have normal fertility, however the risks 
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of pregnancy upon maternal health including the unpredictable impact of pregnancy 
upon lung function and challenges in maintaining adequate nutrition should be 
considered prior to conception (Edenborough et al. 2008).  
1.5.5 Bone disease 
Low bone mineral density is a common complication seen in children and adults with 
CF. Its aetiology is multifactorial and risk factors include; deficiencies of vitamin D, 
vitamin K and calcium, CFTR dysfunction, poor nutritional status, glucocorticoid use, 
hypogonadism, respiratory exacerbations and low physical activity levels (Sermet-
Gaudelus et al. 2011). Prevention and detection of low bone mineral density are an 
important part of routine CF care because of the associated risk of fragility fractures.   
1.6 Management of cystic fibrosis 
1.6.1 Multidisciplinary approach to care 
All people with CF receive their care from a Specialist CF Centre, this care should be 
delivered by a specialist multidisciplinary team of trained and experienced healthcare 
professionals (UK Cystic Fibrosis Trust Standards of Care Working Group 2011, NICE 
2017). The multidisciplinary team should contain specialist consultants, clinical nurse 
specialists, dietitians, physiotherapists, clinical psychologists, social workers, 
pharmacists and administrative support. 
1.6.2 Medical therapy 
There is no cure for CF; medical management aims to maintain health by helping to 
control symptoms of the disease. Medical management of respiratory disease 
includes: the use of oral, inhaled and intravenous antibiotics to help to treat or control 
persistent infections, bronchodilators to open up the airways, corticosteroids to 
reduce inflammation in the airways and mucolytics such as rhDNASe which decreases 
the viscosity of airway secretions and assists sputum clearance. 
1.6.3 Physiotherapy 
A CF specialist physiotherapist will provide individualised advice, this includes 
appropriate airway clearance techniques and exercise. Daily airway clearance is 
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required to aid the removal of bronchial secretions; this is often in conjunction with 
the use of mucolytic agents. Keeping the airways clear of secretions helps reduce lung 
inflammation and infections and improves lung function (Association of Chartered 
Physiotherapists in Cystic Fibrosis 2017).  
1.6.4 Nutrition 
Progressive respiratory disease is the major cause of mortality in people with CF 
however, good nutritional status has been associated with improved survival (Corey et 
al. 1988, Stallings et al. 2008). Intensive nutritional management involving a high-
energy, high-fat diet and pancreatic enzymes has been the mainstay of treatment for 
people with CF over the past 35 years and nutritional failure is no longer accepted as a 
consequence of CF (Collins 2018).  
There is a wide variation in energy requirements between people with CF, however 
requirements are generally quoted as being 110-200 percent of those required by 
healthy individuals of the same age and gender (Stallings et al. 2008). Energy 
requirement will vary according to nutritional and clinical status, age, gender, presence 
of infections and control of malabsorption. People with CF who are pancreatic 
sufficient tend to have lower energy requirements and fewer nutritional problems 
than those who are pancreatic insufficient. For some people with CF, despite following 
a high-fat, high-energy diet, nutrition will be a problem and supplementary nutritional 
support may be required. This will usually follow a staged approach of first trying oral 
nutritional supplements, only progressing to enteral tube feeding if nutritional 
requirements are not achieved (Cystic Fibrosis Trust 2016). 
Improvements in survival and nutritional status in people with CF have contributed to 
overweight and obesity becoming a more frequent problem (Panagopoulou et al. 
2014, Hanna & Weiner 2015). In the UK approximately 17% of adults are overweight 
and 4% are obese (Cystic Fibrosis Trust 2016). Obesity is not just seen in people with CF 
who are older and pancreatic sufficient (Stephenson et al. 2013) it is now an emerging 
problem in children and people with CF who are pancreatic insufficient (Hanna & 
Weiner 2015).  
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A CF specialist dietitian is an integral part of the multi-disciplinary team providing on-
going nutritional assessment and appropriate dietary advice. This will facilitate normal 
growth/ development, optimise nutritional status and support long-term health and 
well-being. 
1.6.5 Psychosocial care 
CF is a progressive life-limiting disease, which impacts on all aspects of day-to-day life. 
Treatment regimens for people with CF are complex, with a high burden of treatment; 
routine CF care can take two-three hours per day (Sawicki et al. 2009). People with CF 
and their carers can often experience difficulties managing this chronic disease, its 
treatment demands and the impact it has upon their lives. People with CF should have 
access to psychosocial support from clinical psychologists and social workers as part of 
their routine CF management (UK Cystic Fibrosis Trust Standards of Care Working 
Group 2011, NICE 2017).  
1.6.6 Cross infection 
Cross-infection with different respiratory pathogens between people with CF can be 
detrimental (Whiteford et al. 1995). For this reason, people with CF are advised not to 
meet face to face. Group-based based activities involving direct contact are therefore 
prohibited. CF centres are advised to follow infection control guidelines to segregate 
patients in wards and outpatient clinics (UK Cystic Fibrosis Trust Standards of Care 
Working Group 2011, NICE 2017). The loss of peer support between people with CF is a 
negative consequence of segregation (Quittner et al. 2016b). Social media and online 
forums are used amongst people with CF to offer peer support, however a recent 
study highlighted that despite the use of electronic communications adolescents with 
CF were still meeting in person (Helms et al. 2015). This implies the need for 
heightened education amongst this vulnerable age-group of the CF population 
regarding the risks of cross-infection. 
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1.7 Future CF care 
1.7.1 Ageing CF population 
Predictions indicate that the number of people with CF in the United Kingdom will 
increase by 54% from 2010 to 2025 due to improvements in survival. There will be a 
79% increase in the adult population and 25% increase in the paediatric population 
(Burgel et al. 2015). This will have a significant impact on the provision of CF care, with 
the need to develop more CF centres, particularly for adults, to be able to continue to 
provide high-standard CF care.  
1.7.2 Correcting the Underlying CFTR Protein Dysfunction 
Treating the basic defect underlying the CF phenotype is an approach to address many 
of the on-going treatment challenges people with CF experience. The first drugs 
developed to treat the underlying causes of CF are CFTR potentiators, these work by 
improving CFTR channel function, and correctors that work by improving the number 
of CFTR channels (Burgener & Moss 2018). As different mutations cause different 
defects in CFTR protein, the medications developed only are effective in people with 
specific mutations. Therefore, these recent advancements have made addressing the 
basic CF defect realistic for the first time, for some. 
Recently a study with Ivacaftor (a CFTR potentiator), highlighted that there may be a 
period in early life where some repair of pancreatic exocrine function may be possible 
(Davies et al. 2015). Further research is needed with regards to this and to also 
ascertain the potential impact of CFTR potentiators on pancreatic endocrine function.  
1.7.3 Co-morbidities 
With improved life expectancy, people with CF are at increased risk for co-morbid 
conditions that may have an impact upon mortality and quality of life. Cystic fibrosis 
diabetes (CFD) is the most common co-morbidity in people with CF. UK CF registry data 
demonstrates a much higher prevalence of CFD (33.8%) in adults compared to other 
co-morbidities such as: gastro-oesophageal reflux disease (19.7%), osteopenia (18.2%), 
liver disease (16.2%), osteoporosis (7.3%) and distal intestinal obstructive syndrome 
(7.3%) (Cystic Fibrosis Trust 2018a).  
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1.8 Background to cystic fibrosis diabetes 
Since the late 1990s the term cystic fibrosis related diabetes has been used to describe 
diabetes in people with CF. Prior to this it was referred to as diabetes of cystic fibrosis 
or cystic fibrosis diabetes mellitus. To reflect the findings and recommendations of this 
study the term cystic fibrosis diabetes will be used throughout this thesis. The reasons 
for this will be explored in chapter three. 
People with CF and pancreatic insufficiency experience a gradual reduction in insulin 
production over time and, this causes the higher prevalence of CFD seen in the adult 
CF population. CFD is a serious co-morbidity with significant impact on morbidity and 
mortality.  
1.8.1 Prevalence 
The prevalence of CFD increases with age. Data from the USA shows it affects 2% of 
children, 19% of adolescents, 40% of adults in their 20s and 45-50% of adults >30 years 
(Moran 2009). In the UK data from the CF Trust’s Registry Report shows 10.2% of 
children aged 10-15 years and 33.8% of the adults 16, or older, are on CFD treatment 
(Cystic Fibrosis Trust 2018a). The CF Trust Registry only records people diagnosed with 
CFD who are on CFD treatment. Therefore, anyone diagnosed with CFD but not on 
treatment, such as those on dietary modifications, are not included in this registry 
data.  
CF genotype has an association with the prevalence of CFD. Lewis et al. (2015) found 
several associations between CF genetic and CFD. In people with CF and severe 
genotypes (no functional CFTR protein expressed, pancreatic insufficiency) prevalence 
of CFD is higher than those with mild genotype (mild CFTR dysfunction, pancreatic 
sufficiency) - 60% vs 14% p<0.0001). A gender variation was also seen with 66% 
females with a severe genotype compared to 54% males developing CFD. There was a 
significant increase in the prevalence of CFD with age - 19 of 23 women (83%) 
compared to 18 of 28 men (64%), aged 40-49 with severe genotype had CFD. While 
these numbers are small, they are an important consideration with increased 
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predictions of survival in the CF population and thus growing numbers of adults in this 
older age group. 
1.8.2 Pathophysiology  
CFD has a complex pathophysiology. CFD shows features of both type 1 and type 2 
diabetes (table 2) but it is a distinct clinical entity with important pathological 
differences (Moran et al. 2018). The primary cause of CFD is insulin deficiency, but 
factors distinctive to CF such as undernutrition, malabsorption, increased energy 
expenditure, glucagon deficiency, liver dysfunction, chronic and acute infections 
influence glucose metabolism (Dyce et al. 2015, Moran et al. 2018). Glucose tolerance 






Table 2 Comparison of features of different types of diabetes 
 * Type 1 diabetes used to be regarded as a disease of children and adolescents however approximately fifty percent of newly diagnoses cases of type 1 diabetes are now 
in people greater than 18 years old (JDRF 2018). 
+More cases of type 2 diabetes are being seen in young people, currently in the UK 1.9% of those < 19 years with diabetes have type 2 (Diabetes UK 2016a)
 Type 1 Type 2 CFD 
Cause Autoimmune destruction of β cells & near 
complete insulin deficiency 
Insulin resistance and effect of glucose on 
pancreatic function 
Severe, not complete insulin deficiency 
Insulin sensitivity reduced during acute illness 
Onset Usually acute Insidious Insidious 
Peak age of onset Children- late 30s * Adult+ 18-24 years 
Usual nutritional status Generally normal weight Obese Generally normal- underweight 
Diagnosis and screening Clinical features 
Elevated random glucose levels 
Clinical features 
Oral glucose tolerance test, elevated fasting 
plasma glucose 
Clinical features are rare 
Oral glucose tolerance test & continuous 
glucose monitoring 
Fasting plasma glucose unhelpful  
Usual treatment Insulin Diet, oral agents, insulin Insulin 
Treatment rationale Reduction in osmotic effects of high 
glucose. 
 
Reduction in long-term complication risks 
Reduction in osmotic effects of high glucose 
 
 
Reduction in long-term complication risks 
Reduction in the impact on high glucose on 
lung function, infection risk and nutritional 
status 
Reduction in long-term complication risks 
Dietary management Healthy balanced diet 
 
 
Reduction simple carbohydrates 
Healthy balanced diet 
 
Weight reduction 
Reduction simple carbohydrates 
Usual energy intake to meet requirements 
(100-200% of normal) 
Optimisation of nutritional status 
Modification of simple carbohydrates 
Complications  
 




Risk of micro- and macrovascular complications 
Significant effects of hyperglycaemia on 
nutritional and respiratory status  
Risk of microvascular complications 
Macrovascular complications are rare 
Ketosis risk Yes Unusual Rare 




1.8.2.1 Insulin deficiency 
The primary cause of CFD is insulin deficiency. There is destruction of the pancreatic 
tissue, caused by thick mucus secretions and obstructive damage, with accompanying 
fibrosis and disorganisation of the islet cells, which gradually result in a reduction in 
insulin production (Moran et al. 2010a). The reduction in β cell numbers in CFD is not 
related to autoimmune disease as is the case in type 1 diabetes (Bridges et al. 2018). 
People with CFD do not have complete insulin deficiency as seen in type 1 diabetes, 
they maintain some residual insulin production (Moran et al. 2018). Initially a delay 
and reduction in peak insulin production is seen and the secretion of basal insulin is 
often preserved (Perano et al. 2014). 
Pancreatic destruction is not the only reason for glycaemic abnormalities in CF. Animal 
models of CFD suggest a functional deficiency in islet cells plays a part (Moheet & 
Moran 2017). Newborn CF pigs have been shown to have abnormal insulin secretion 
and reduced responsiveness to hyperglycaemia, which was not caused by reduced islet 
cell mass (Uc et al. 2015). Similar observations have been seen in the CF ferret which 
from birth demonstrated abnormal glucose tolerance (Olivier et al. 2012). Glycaemic 
abnormalities have also been seen in infants and children with CF, where insufficient 
insulin secretion has been proposed as the cause (Yi et al. 2016).  
1.8.2.2 Insulin resistance 
In people with CF, insulin sensitivity is usually normal (Moran et al. 1994). Where there 
is another reason for insulin resistance such as acute respiratory infection, 
corticosteroid treatment or immunosuppressive therapy reduced insulin sensitivity 
may cause hyperglycaemia (Bridges et al. 2018). Insulin resistance is not as important 
as insulin deficiency in the pathogenesis of CFD, but it will vary throughout the clinical 
course of CF and therefore needs consideration. 
1.8.2.3 Impairment in glucagon secretion 
Glycaemic abnormalities in people with CF can also be attributed to impairment of 
glucagon secretion due to total islet destruction (Moran et al. 2018). Like insulin, 





In people with CFD, unlike those with type 1 diabetes, the risk of ketoacidosis is rare. 
This is because of the impairment in glucagon secretion and/or maintenance of some 
residual insulin secretion (Moran et al. 2018). 
1.8.2.4 CFTR protein 
CFD mainly occurs in people with CFTR mutations associated with more severe disease 
including pancreatic exocrine insufficiency (Moran et al. 2018). The CFTR protein may 
have a role in glycaemic abnormalities in CF (Prentice et al. 2016) because CFTR has a 
role in insulin secretion and β cell function (Osorio 2014). From birth, CF ferrets have 
demonstrated abnormal insulin secretion signifying, that CFTR might play a role in 
insulin secretion (Olivier et al. 2012).  
1.8.3 Clinical manifestations 
In people with CF, a decline in body weight and lung function has been seen in the 
early stages of abnormal glucose metabolism, prior to the diagnosis of CFD (Lanng et 
al. 1992, Brodsky et al. 2011, Hameed et al. 2015). Insulin deficiency is associated with 
a catabolic state, which may be a potential mechanism for decline in both respiratory 
and nutritional status (Moheet & Moran 2017). It is less clear whether hyperglycaemia 
or insulin deficiency have a causal relationship with poor outcomes, such as lower lung 
function, sub-optimal nutritional status or reduced survival, or are simply markers of 
more advanced or complicated disease (Jones & Sainsbury 2016). Due to the 
complexities in the clinical manifestation of CFD it is not clear if sicker people with CF 
get diabetes or if diabetes makes people with CF sicker. 
1.8.3.1 Impact on survival  
CFD is associated with increased mortality (Finkelstein et al. 1988, Chamnan et al. 
2010, Lewis et al. 2015). Lewis et al. (2015) recently demonstrated that despite earlier 
identification and treatment of CFD aged-adjusted mortality remains 3.5 times greater 
in people with CFD compared to those without (Lewis et al. 2015). Being female is 
typically associated with worse survival in CF (Corriveau et al. 2018). However, CFD 
increased the risk of death in both men and women, the protective effects of the male 
sex seen in CF men without diabetes was no longer apparent (Lewis et al. 2015). It is 




been shown to have a variable impact on survival (Adler et al. 2011, Lewis et al. 2015). 
Hyperglycaemia, as defined as HbA1c >6.5%, has been associated with a threefold 
increase risk of death in people with CFD (Adler et al. 2011). Conversely HbA1c and 
duration of CFD were found to be similar between aged-matched survivors and those 
who died during their 30s and 40s (Lewis et al. 2015). This suggests that even well-
controlled diabetes adds an additional inflammatory burden that together with CF-
related respiratory inflammation creates a greater risk of death for these individuals 
(Lewis et al. 2015). 
1.8.3.2 Impact on lung disease  
In a cross-sectional study of >7500 people with CF a lower forced expiratory volume in 
1 second (FEV1) was observed in all age groups with CFD (Koch et al. 2001). The mean 
FEV1 was 72%, at all ages, in those without diabetes compared to 52% in those with 
CFD. Moran et al. (2009a) also demonstrated that lung function remains lowered in 
people with CFD, this was despite earlier diagnosis and initiation of insulin. 
People with CFD also experience a higher rate in decline in lung function (FEV1) 
compared to those with normal glucose tolerance (Milla et al. 2000). Lung function 
decline has been reported as being nearly twice as high, with an average yearly rate in 
FEV1 decline of 3.2% in those with CFD compared to 1.8% in those without (Mohan et 
al. 2008). Despite earlier diagnosis and insulin treatment this effect is only partially 
reversed with CFD treatment (Rolon et al. 2001, Dobson et al. 2002). Mohan et al. 
(2008) demonstrated significant improvement in lung function at 3 months and one 
year following insulin initiation however, this was not sustained. At 2 and 3 years post-
insulin initiation the rate of lung function decline observed was similar to that of pre-
treatment ( -3.2% FEV1 per year).  
The mechanism that links CFD with inflammation and infection is not fully understood; 
in vitro studies have demonstrated that increased airways surface liquid glucose 
concentration is associated with an increased growth of Staphylococcus aureus and 
Pseudomonas aeruginosa in the airways (Brennan et al. 2007, Bradbury et al. 2009). 
Blood glucose levels of > 8mmol/l are associated with elevated airways glucose 




airways bacteria (Brennan et al. 2007). This is a serious concern for people with CF. 
Lung damage is a result of the vicious cycle between infection and inflammation. 
Mucus blocks the airways, allowing bacteria to grow and cause infections. An increase 
production of mucus is the result of infection, this causes inflammation which damage 
cilia in the airways and leads to difficulties clearing mucus secretions from the lungs.  
Therefore, hyperglycaemia causes elevated glucose in the airways, which in turn 
promotes the growth of airway bacteria and contributes to respiratory infections and 
lung function decline (Hameed et al. 2015).  
1.8.3.3 Impact on nutritional status 
Insulin is an anabolic hormone essential to the body for the metabolism of protein, fats 
and carbohydrates. Its primary role is to promote the absorption of carbohydrates 
(particularly glucose) from the blood into fat, skeletal muscle and the liver. Hence a 
deficiency of insulin would lead to a worsening of nutritional status because: the body 
would not be able to turn ingested glucose into energy, glucose released by the liver 
through the process of glycogenolysis would not be converted to energy and the body 
would start breaking down its stores of protein and fat as an alternative source of 
energy. Insulin deficiency in CF is insidious, therefore the slow gradual loss of insulin 
over time causes weight and lean body mass loss (Bridges et al. 2018). It is not unusual 
to observe a decline in BMI for several years prior to the diagnosis of CFD (Finkelstein 
et al. 1988, Lanng et al. 1992, Hameed et al. 2010). Unintentional weight loss is not 
uncommon in type 1 diabetes presentation (Diabetes UK 2019) however in CFD it 
presents much more slowly. 
Hyperglycaemia will also promote glycosuria and hence the loss of energy in urine. This 
can also contribute to difficulties in maintaining weight and/or weight loss.  
1.8.3.4 Microvascular and macrovascular complications 
With improvements in survival, the risk of diabetic complications in people with CFD 
requires attention. Duration of diabetes and glycaemic control are two influential 
factors in the risk of developing microvascular complications (Andersen et al. 2006, 
Schwarzenberg et al. 2007). A study of people who had CFD and fasting 




complications to be less than that seen in people with type 1 or type 2 diabetes, with 
microalbuminuria, retinopathy, neuropathy and autonomic gastropathy affecting 14% 
16%, 55% and 50% respectively (Moran et al. 2010b). The presence of some residual 
insulin secretion in people with CFD and absence of metabolic abnormalities seen in 
type 2 diabetes may contribute to this lower prevalence (Moheet & Moran 2017). In 
another study nephropathy and neuropathy rates were reported as similar to those 
with type 1 diabetes, however a lower rate of retinopathy was seen (van den Berg et 
al. 2008). Other risk factors associated with retinopathy in this type 1 population such 
as smoking, higher HbA1c, cholesterol and BMI may have been additional contributory 
factors to developing retinopathy. Retinopathy has also been seen in three individuals 
with abnormal glucose tolerance who do not meet the criteria for CFD (Gilchrist et al. 
2015). 
Routine annual examination for neuropathy and retinopathy along with urine 
screening for microalbuminuria are recommended for people with CFD (Cystic Fibrosis 
Trust 2004, Moran et al. 2010b, Middleton et al. 2014), however this guidance needs 
revision in light of cases of retinopathy developing in abnormal glucose tolerance 
(Gilchrist et al. 2015). Macrovascular complications are rare in people with CFD due to 
low cardiovascular risks factors seen in this population (Moheet & Moran 2017).  
1.8.4 Diagnosis 
The development of CFD tends to be insidious due to slow and progressive deficiency 
of insulin and hence gradual deterioration in glucose tolerance. Few people with CF 
have completely ‘normal’ glucose tolerance and CFD is viewed as part of a continuum 
of glucose tolerance abnormalities (Figure 1) (Moran et al. 2010a). Glucose tolerance 
can vary due to the clinical variability in CF e.g. respiratory exacerbations, transient use 
of corticosteroid treatment, periods of increased glucose loads such as the use of 
enteral tube feeding (Moran et al. 2018). In clinical practice it is not unusual for people 
with CF to only require insulin treatment during periods of illness, corticosteroid use or 





Figure 1 The clinical spectrum of glucose tolerance in CF 
The diagnosis of CFD can be difficult to make because the majority of people with CFD 
do not show any obvious symptoms (table 3) at the time of diagnosis (Moran et al. 
2018). The median age (interquartile range) of diagnosis of CFD is 18.7 years (15.5-25) 
(Konrad et al. 2013). Early intervention can protect against a decline in lung function 
and weight loss therefore CFD screening programmes are recommended as standard 
practice (Cystic Fibrosis Trust 2004, Middleton et al. 2014, Moran et al. 2018). 
Table 3 Symptoms of CFD 
Symptoms of CFD 
 
Unexplained polyuria or polydipsia 
Blurred vision 
Inability to maintain or gain weight despite nutritional 
intervention 
Inadequate growth velocity 
Unexplained decline in lung function 
Increased frequency of respiratory exacerbations 
Delayed puberty 
 
1.8.5 Screening for CFD 
The importance of monitoring blood glucose levels due to the clinical effects of CFD is 
well recognised, with annual screening for CFD recommended from 10 years of age 




1.8.5.1 Oral glucose tolerance test  
The oral glucose tolerance test (OGTT) is used to diagnose diabetes by measuring the 
body’s response to glucose. Following an overnight fast (8-14 hours) a fasting blood 
glucose sample is taken. Patients are then required to drink a glucose solution 
containing up to 75g of glucose. A further blood sample is taken two hours after the 
test load. Table 4 identifies the WHO criteria for the diagnosis of diabetes (WHO 2018). 
Table 4 WHO Criteria for the diagnosis of diabetes (WHO 2018) 










Impaired fasting glucose 
 
 
Fasting plasma glucose ≥7.0mmol/l  
or 
2–h plasma glucose   ≥11.1mmol/l 
 
Fasting plasma glucose <7.0mmol/l  
and 
2–h plasma glucose   ≥7.8 and <11.1mmol 
 
Fasting plasma glucose 6.1 to 6.9mmol/l 
and (if measured) 
2-h plasma glucose <7.8mmol/l 
 
The use of OGTT as a screening tool for CFD has received much criticism for many 
reasons. Firstly, the OGTT is designed to diagnose diabetes. It may not identify the 
early stages of dysglycaemia seen in CFD, which start to impact weight and lung 
function before the diagnostic criteria for diabetes are met. This highlights important 
questions about early dysglycaemia in CF and the methods used to detect this (Dobson 
et al. 2004, Hameed et al. 2011, Schmid et al. 2014). Secondly, the relevance of the 2-
hour OGTT has been questioned. The 60- minute OGTT has been associated with 
indicators of clinical deterioration in adults with CF and may therefore be a more 
appropriate measure to use (Coriati et al. 2016). Similarly sampling blood at 30 or 60 
minutes has been shown to identify earlier glucose abnormalities to alert insulin 
deficiency before the onset of CFD (Dobson et al. 2004, Hameed et al. 2011). Thirdly, 
the cut-off values from OGTT determining CFD were taken from type 2 diabetes (table 




treatment is initiated to prevent respiratory and nutritional decline (Bridges et al. 
2018). Finally, wide variations in glucose tolerance are observed in people with CF, 
particularly due to the effects of insulin resistance during infections therefore OGTT 
results will be subjected to wide variability throughout the clinical course of CF (Dyce 
et al. 2015). 
Due to low sensitivity random glucose, urinary glucose and HbA1c are not 
recommended as screening tools for CFD (Moran et al. 2010b). HbA1c is unreliable in 
people with CF because it can be artificially low due to increased red blood cell 
turnover (Moran et al. 2010a) or high in those with iron deficiency (Bridges et al. 
2018). High blood glucose levels may also be intermittent in the early stages of CFD 
and not significant enough to elevate HbA1c (Prentice et al. 2016). HbA1c > 5.8% 
(40mmol/mol/) has been proposed as a screening tool to predict the need for an OGTT 
in an adult CF clinic (Burgess et al. 2016) although this practice has been met with 
criticism for still not being sensitive enough to identify early glucose abnormalities 
(Widger et al. 2016).  
Following a positive OGTT a period of serial blood glucose monitoring or continuous 
glucose monitoring is needed to identify when elevations in blood glucose levels occur 
and to guide treatment decisions. The question when to initiate treatment for 
dysglycaemia is not clear cut. Bridges et al. (2018) suggest that people who meet the 
diagnostic criteria for diabetes should be treated and in those with impaired glucose 
tolerance on OGTT or post-prandial blood glucose >8mmol/l treatment should be 
considered if weight or lung function is declining. 
1.8.5.2 Continuous Glucose Monitoring Systems 
Continuous glucose monitoring systems (CGMS) are increasingly being used in CF 
centres, in addition to or instead of OGTT, to assist in the early identification of 
abnormal glucose metabolism and to inform treatment decisions (O'Riordan et al. 
2009, Dyce et al. 2015). It is however not licenced as a tool to diagnose any type of 
diabetes (Prentice et al. 2016). CGMS involves the insertion of a small probe (figure 2), 
into the subcutaneous tissue of the abdomen, which is attached to a transmitter 




levels approximately every five minutes and can be worn for up to ten days. It can be 
inserted quickly and easily in the clinical setting and has the additional benefit of 
allowing individuals to be at home following their usual routines and diet. CGMS has 
been shown to correlate with plasma glucose levels in people with CF (Dobson et al. 
2003, O'Riordan et al. 2009). Some CGMS may require blood glucose measurements 
(via finger-prinks) for calibration (Dexcom 2018, Medtronic 2018). A useful addition to 
CGMS are the visual reports obtained (figure 3); in clinical practice these can assist 
with treatment initiation decisions, dietary changes, treatment modifications and 
patient education.  
 
Figure 2 IPro2 sensor 
 





One of the significant factors for initiating treatment of dysglycaemia is the impact on 
nutrition. CGMS has been used to highlight children at risk of nutritional decline, 
where a CGMS value greater than 7.8mmol/l for over 4.5% of the test was predicative 
of a decline in weight standard deviation scores (Hameed et al. 2010). However, there 
are no definitive criteria when to start insulin based on CGMS. One paediatric CF 
centre has modified the findings from Hameed’s research to guide its treatment 
decisions- table 5 (RBHFT 2017). However, in clinical practice treatment decisions tend 
to be made by CFD teams on an individual basis (Cystic Fibrosis Trust 2004, Middleton 
et al. 2014, Moran et al. 2018).  
Table 5 CFD management strategy based on CGMS results  (RBHFT 2017)  
Diagnostic category CGM values Treatment 
CFD 2 x peaks >11.1mmol/l 
and 




No more than 1 peak >11.1mmol/l 
and/or 
>10% of time >7.8mmol/l 
Consider insulin 









Repeat CGMS in 12 
months 
Normal No peaks >11.1mmol/l 
and 
<4.5% of time >7.8mmol/l 
None 




In type 1 or type 2 diabetes the rationale for treating hyperglycaemia is to minimise 
osmotic symptoms and reduce the risk of long-term diabetic complications (Bridges et 
al. 2018). Treating CFD is not just about correcting hyperglycaemia, its primary focus 
is on preserving or improving clinical and nutritional status and hence influencing 
survival (Moheet & Moran 2017). The aims of management of CFD are therefore: to 
maintain optimal growth, nutritional status and respiratory function, to achieve good 
control of blood glucose levels and to avoid long-term diabetic complications (Cystic 




as to when and how to treat. This reflects the complexities of CFD and the uniqueness 
of the individual. What is clear, however, are the benefits of early treatment.  
1.8.6.1 Insulin 
All clinical guidelines recommend insulin therapy as first line treatment because 
the primary cause of CFD is insulin deficiency (Cystic Fibrosis Trust 2004, Middleton et 
al. 2014, Moran et al. 2018). There is no evidence to support the benefits of one insulin 
over another and choice is assessed on an individual basis taking into account lifestyle 
and clinical and nutritional status (Cystic Fibrosis Trust 2016, Bridges et al. 2018). 
Insulin has additional anabolic properties and it offers wider flexibility due to the 
variety of preparations available. In clinical practice within the author’s CF centre 
insulin analogues (aspart, lispro) are primarily used to treat post-prandial 
hyperglycaemia, they may be taken on their own or as part of a basal-bolus regimen. 
Basal insulin (detemir, glargine) may also be used on its own to treat insulin deficiency 
in the early stages of CFD. Insulin therapy is associated with improvements 
in glycaemic control, lung function and nutritional status (Moran et al. 2009, Hameed 
et al. 2012, Moheet & Moran 2017).   
1.8.6.2 Oral antidiabetic drugs 
Oral antidiabetic drugs are not widely used in the treatment of CFD and studies on 
their use are limited (Ballmann et al. 2014, Onady & Stolfi 2016). A recent study 
concluded that Repaglinide, a prandial blood glucose regulator, should be considered 
as an alternative treatment to insulin for patients with newly diagnosed CFD (Ballmann 
et al. 2018). This was a multi-centre, open-labelled, randomised trial involving 49 CF 
centres in Europe conducted over nine years. There was no control group to compare 
the effects of insulin with Repaglinide, so it’s uncertain if the small changes observed 
were due to the effects of the treatment or the natural course of the cohort. A short-
acting insulin was used as the comparative, not an insulin analogue, which is most 
commonly used in routine clinical practice; therefore, not an ideal comparator. 
The doses of insulin used were also low and this may not have therefore resulted in 
any significant change. More research is therefore needed before the wider use of 





Incretin modifiers, such as dipeptidyl peptidase-4 (DPP-4) inhibitors are used in the 
management of type 2 diabetes. DPP-4 is an enzyme which destroys the hormone 
incretin. Incretins help the body stimulate the release of insulin when it is 
required (after meals) and decreases the manufacture of glucagon by the liver 
when not required (during digestion) (Diabetes UK 2018). Therefore, DPP-4 
inhibitors help regulate blood glucose by protecting incretins from damage. DPP-
4 inhibitors only work if the pancreas has some functioning β cells (Pathak & 
Bridgeman 2010). There is limited experience of the use of these products in 
people with CF (Hellman et al. 2014, Sunsoa et al. 2017, Farrell et al. 2018). 
These small observational studies have demonstrated that DPP-4 inhibitors are 
safe, well tolerated and improve glycaemic control. DPP-4 inhibitors may be 
beneficial for those with CF who have a good nutritional status, early stages of 
dysglycaemia and demonstrate barriers to insulin therapy (Sunsoa et al. 2017, Farrell 
et al. 2018). DPP-4 inhibitors are a lower treatment burden than insulin because they 
are once daily oral agents and the risks of hypoglycaemia are low so routine blood 
glucose monitoring is reduced.  
With the ageing CF population and the improved nutritional status, including the 
emergence of overweight and obese people with CF, it may be time to start 
challenging if insulin is the most appropriate treatment for all people with CFD. Oral 
antidiabetic agents may be a more suitable choice for overweight and obese adults 
with glucose dysregulation. However more research within this area is required to 
provide evidence to support this. 
1.8.6.3 Nutritional management 
Conventional healthy dietary recommendations for the treatment of diabetes are not 
always appropriate for the management of CFD; diet alone is rarely used to treat CFD. 
Through the combination of CGMS or serial blood glucose monitoring and a food 
intake diary the cause of glucose excursions can often be identified. Where glucose 
excursions are attributed to specific dietary factors such as refined carbohydrate drinks 
and snacks, which offer very little nutritional benefit, individuals will be advised to 




changes have resulted in improved glycaemic control without the need for medication  
(Barrett et al. 2017). Dietary advice is therefore individualised but based around 
regular meals and snacks containing complex carbohydrates with modification to the 
quantity, distribution and timing of simple carbohydrates. 
The role of carbohydrate counting, where insulin doses are matched to the 
carbohydrate content of foods and drinks, is not formalised in the management of 
CFD. Some individuals may be taught it along with insulin dose adjustment, but the 
decision is usually based on individualised assessment. Carbohydrate counting and 
insulin dose adjustment has been shown to result in more dietary freedom in people 
with type 1 diabetes (DAFNE Study Group 2002), such work does not currently exist, to 
the same extent, in the CFD population with only a few conference abstracts exploring 
carbohydrate counting (Robb et al. 2009, Watson et al. 2012, Still & Philip 2017).  
One of the challenges to the management of CFD is in those individuals who require 
oral nutritional supplements or enteral tube feeding to meet their nutritional 
requirements (Wilson et al. 2000). Both oral nutritional supplements and enteral tube 
feeds are high in carbohydrates and will therefore increase blood glucose levels. 
Individuals are encouraged to take oral nutritional supplements as part of their meals, 
with additional insulin factored in. The introduction of enteral tube feeding requires 
regular blood glucose monitoring and adjustments to insulin (type and/or dose) to 
achieve optimal glycaemic control (Kelly & Moran 2013). Through clinical experience 
patients who require enteral tube feeding tend to be the sicker ones who spend more 
time in hospital experiencing recurrent respiratory exacerbations. This concurrent 
instability in health further adds to the complexities in trying to optimise glycaemic 
control.  
People with CFD should be treated at specialist CF centres which have expertise in 
both CF and CFD, and receive individualised dietary advice and appropriate medical 
treatment (Cystic Fibrosis Trust 2004, Middleton et al. 2014, Bridges et al. 2018, Moran 





The diagnosis and onset of diabetes in people with CF signifies the development of a 
second chronic illness, which comes with its own burden of treatment and monitoring 
in addition to the high treatment burden already associated with managing CF. Only 
one study was identified which explored health related quality of life specifically in 
people with CFD. Worse treatment burden domain scores on the Cystic Fibrosis 
Questionnaire -Revised (CFQ-R) were seen in people with CFD on insulin when 
compared to those with: CFD not on insulin, impaired glucose tolerance or normal 
glucose tolerance (Kwong et al. 2019). The score was adjusted for other medication 
including pancreatic enzymes, nebulised and oral medications. Thus, indicating a 
significantly greater treatment burden in people with CFD on insulin. It however did 
not explore the specific elements of the demands associated with increased treatment 
burden such as blood glucose monitoring, the type and mode of delivery of insulin or 
the impact of additional clinic attendance. These factors also need to be considered. A 
generic CF quality of life questionnaire such as the CFQ-R is not designed to identify 
CFD specific factors, a CFD specific quality of life measure is required. Currently such a 
patient reported outcome measure does not exist. 
A significant part of managing diabetes involves self-management; people with CFD 
must make decisions about how to manage their life, CF and CFD. In a large 
international, cross-sectional study, emotional or psychological problems such as 
anxiety, diabetes distress and depression have been shown to be experienced by at 
least forty percent of people with diabetes (Peyrot et al. 2005). Diabetes distress is an 
emotional distress related to the constant anxieties and burdens associated with 
managing diabetes over time (Fisher et al. 2014). Diabetes distress is associated with 
sub-optimal glycaemic control and self-management problems (Fisher et al. 2013, 
Hessler et al. 2014). Very limited research exploring how individuals manage CFD 
within their daily lives exists (Kelly & Moran 2013), this includes the emotional and 
psychological well-being of people with CFD. 
NICE has published recommendations for the identification, treatment and 




(NICE 2009). However, emotional and psychological support has been identified as one 
of the ‘15 healthcare essentials’ for people with diabetes indicating that emotional 
distress should be addressed as part of routine care for all people with diabetes rather 
than just being treated when identified (Diabetes UK 2016b). 
No recommendations exist for the psychosocial and emotional support of people with 
CFD. NICE CF guidelines recommend people with CF should have access to a clinical 
psychologist as part of routine CF care and they should conduct a general mental 
health and wellbeing assessment as part of the CF annual review (NICE 2017). The 
International Committee on Mental Health in CF recommend the General Anxiety 
Disorder (GAD-7) and Patient Health Questionnaire (PHQ-9) should be used as 
screening tools for anxiety and depression in people with CF (Quittner et al. 2016a). 
The Cystic Fibrosis Questionnaire -Revised (CFQ-R) is the best validated and most 
frequently used patient-reported outcome measure in CF research (Habib et al. 2015, 
Ronit et al. 2017). It measures health-related quality of life in adults and adolescents 
with CF and consist of 44 items across 12 domains (Quittner et al. 2005). The 
respiratory domain has been approved by the Food and Drug Administration (FDA) in 
the USA for use as the endpoint in clinical trials (Goss & Quittner 2007). No patient 
reported outcome measurements specifically for CFD exist. 
With earlier diagnosis and treatment of dysglycaemia it is imperative that people with 
CFD receive sufficient and appropriate support by healthcare professionals, so they can 
successfully manage their conditions. 
1.9 Background to diabetes self-management education 
programmes 
As with type 1 and type 2 diabetes a key part of CFD care involves changes in 
behaviour and lifestyle modifications. For people with CFD this also means the addition 
of more treatment and monitoring. The focus of care should include the provision of 




Diabetes self-management education (DSME) plays a vital role in enabling people with 
diabetes to manage their illness on a day-to-day basis (Diabetes UK 2015a). DSME 
programmes should aim to facilitate knowledge, skills and ability in order to improve 
self-management and clinical outcomes (Beck et al. 2017). People with diabetes need 
to have the skills, knowledge and confidence to manage their diabetes successfully.  
The provision of education of people with diabetes is considered on three levels 
(Diabetes UK 2015a): 
1. One-to-one advice and information 
2. Informal ongoing learning e.g. peer groups 
3. Structured education programmes meeting agreed criteria (NICE 2016) 
NICE (2015) suggest that structured education should form an integral part of type 1 
diabetes care and that all adults with type 1 diabetes should be offered a place on a 
DSME programme. DSME programmes should: be evidence-based, have specified aims 
and objectives, follow a structured written curriculum with theoretical underpinning, 
support the development of self-management of diabetes, be delivered by trained 
facilitators, be quality assured and audited regularly (NICE 2016). DSME programmes 
are regarded as complex interventions because they contain many interacting 
components with variable levels of complexity (Craig et al. 2008). 
In the UK, there are a wide variety of DSME programmes for people with type 1 and 
type 2 diabetes (Diabetes UK 2015b). There is not a ‘gold standard’ DSME programme, 
but incorporating psychosocial and behavioral strategies into programmes have shown 
improved outcomes (Funnell et al. 2012). DSME programmes differ in content, theory, 
format, presentation (individual, group or on-line) and duration. Some programmes 
are specific to individual hospital trusts and only available to patients who attend that 
trust while others are available nationally. Programmes which meet NICE criteria, 
available at a national level, include: Dose Adjustment For Normal Eating (DAFNE Study 
Group 2002), Diabetes Education and Self-management for On-going and Newly 
Diagnosed -DESMOND (Davies et al. 2008), X-PERT (Deakin et al. 2006), Diabetes 




Resources for Training in Insulin and Eating- BERTIE (Everett et al. 2003) and Healthy 
living for People with Diabetes - HeLP Diabetes (Murray et al. 2017). Table 6 highlights 
the key characteristics of these programmes.  
Table 6 Characteristics of National DSME programmes 
 
Both one-to-one and group education has been shown to be effective in improving 
diabetes self-management (Lawal & Lawal 2016). There is however some contrast 
between findings and the evidence is limited to a small number of studies. Group 
education has been shown to be more effective than individual education in improving 
HbA1c, diabetes knowledge and weight (Deakin et al. 2006, Merakou et al. 2015). In 
comparison, equal impact on HbA1c at 12-18 months has been seen when comparing 
group verses individual education (Duke et al. 2009). People often learn from one 








(DAFNE Study Group 
2002) 
Type 1  
 
Five days delivered 
over one week or 
one day a week over 
five weeks  
Group  yes 
X-PERT Diabetes, X-PERT 
insulin 
 
(Deakin et al. 2006) 
Type 1 or 
type 2  
Six weekly sessions 
of approximately 2½ 
hours 
Group  yes 
DESMOND 
 
(Davies et al. 2008) 





(Sturt et al. 2006b) 
Type 2 12-week interactive 









Type 1 One day per week 
for four weeks 
 
Online modular 












(Murray et al. 2017) 







Some people benefit from this interactive nature of groups, but this is not applicable 
to all. NICE (2015) recognise this and advise alternative education programmes of 
equal standard for people not able or unwilling to take part in a group. What is 
important is that, however delivered, DSME programmes need to be adaptable to 
meet specific learning needs of the participants (Lawal & Lawal 2016). For people with 
CFD DSME programmes will need to be delivered on a one-to-one basis. This is due to 
strict cross-infection policies that recommend against contact between individuals 
with CF (UK Cystic Fibrosis Trust Standards of Care Working Group 2011, NICE 2017). 
DSME programmes for adults with type 1 diabetes have shown improvements in 
HbA1c (DAFNE Study Group 2002, Everett et al. 2003), quality of life (DAFNE Study 
Group 2002), diabetes management skills and food knowledge (Everett et al. 2003). In 
adults, with type 2 diabetes, reduction in HbA1c (Deakin et al. 2006), greater weight 
loss and lower prevalence of depression (Davies et al. 2008) have been seen. The 
availability of DSME for delivery on a 1:1 basis, that have been formally evaluated, is 
very limited. The Diabetes Manual, a 1:1 intervention for type 2 diabetes, showed 
small statistically significant improvements in diabetes distress and diabetes 
management self-efficacy over 26 weeks and reduction in HbA1c maintained at 12 
months (Sturt et al. 2006a, Sturt et al. 2006b, Sturt et al. 2008). The first UK trial of  a 
web-based DSME programme for 1:1 delivery to people with type 2 diabetes (HeLP-
Diabetes), demonstrated a reduction in HbA1c at 12 months but no overall impact on 
diabetes distress (Murray et al. 2017). No validated programmes for 1:1 delivery for 
type 1 diabetes were identified. BERTIE is available as a web-based programme, for 
people with type 1 diabetes, however it has not been formally evaluated, and its 
delivery is not structured or facilitated (BERTIE 2019).  
DSME plays a vital role in enabling people with diabetes to manage their illness on a 
day-to-day basis, however no DSME programme that meet NICE criteria currently 
exists in routine practice for people with CFD. A pilot study of a structured education 
programme for people with CFD that met NICE criteria has been reported (Watson et 
al. 2012, Collins et al. 2015). This was based on a modified DAFNE programme and 




Positive non-significant changes in CF and diabetes quality of life and a trend towards 
improvement in HbA1c at 6 months were seen (Watson et al. 2012, Collins et al. 2015). 
However, this programme was very labour intensive for the educators, required a 
significant amount of participant’s time, did not result in many significant sustained 
outcomes and was difficult to recruit to (unpublished results, S Collins was one of the 
study educators). Post-programme evaluations (unpublished) were received from nine 
participants. All found the programme helpful, with learning how to carbohydrate 
count and adjust insulin to carbohydrate ratios viewed as the most beneficial. Three of 
the participants suggested that online resources would be helpful. For people with 
CFD, future DSME programmes need to be more flexible, accessible and adaptable, 
and more consideration to clinical and nutritional variability and method of 
programme delivery is required.   
1.10 My interest in the topic 
Prior to commencing this study, I had been working as a specialist dietitian with adults 
with CF for nearly twenty years. Through my work I developed a strong interest in CFD 
and its management. I learnt that managing CFD was a complex phenomenon. To 
support my management skills I developed extended clinical and educational roles 
such as insulin dose adjustment, carbohydrate counting, setting up CGMS, teaching 
insulin administration and blood glucose monitoring so that I could work at an 
advanced level of clinical practice. During this NIHR Clinical Doctoral Research 
Fellowship I have completed a comprehensive programme of training to develop 
personal, professional and research skills (appendix 1). This included a supplementary 
prescribing qualification which allows me, under a clinical management plan, to 
prescribe insulin for people with CFD. 
I learnt that advanced communication and counselling skills were necessary to help 
manage these patients with multiple co-morbid conditions. I therefore made the 
decision to complete a MSc in Counselling and Healthcare and Rehabilitation in 2005. 
My dissertation for this gave me my first exposure to qualitative research 




The chronic nature of CF and CFD leads to frequent patient contact with healthcare 
professionals. This helped me start to develop a greater insight into the management 
of CFD in the context of the lives it affects. I began to appreciate that not everyone 
with CF has the same relationship with CFD and for some it was a major obstacle and 
far worse than CF. How CFD impacted upon the lives of people with CFD appeared to 
affect self-management skills. I became more aware that the requirements of people 
with CFD need to be considered in the context of how they manage their CF and their 
lives. This started me questioning why do people experience CFD in different ways and 
what factors help them or inhibit them in their management and coping?   
In the challenging and changing healthcare environment the quality of patient care and 
support is not always optimal. Time is often very limited and because of this care can 
often be more reactive rather than proactive. Due to constraints in time and the 
prioritisation of clinical care needs, educational support often comes second. I found 
this frustrating as knowledge is the cornerstone for self-management. I began to ask 
questions about how to improve education of people with CFD without it increasing 
the time they are required to attend hospital or impacting on their current level of care 
and support? It also made me think about what are the essential skills needed to be 
able to effectively self-manage CFD so that time could be focussed upon these? 
Through my clinical practice I have worked with lots of different healthcare 
professionals but their understanding of CFD and its management were very variable. 
I’ve witnessed patients being informed of the consequences of sub-optimal glycaemic 
control with very little or no help being offered on how to improve the situation. I 
believe that part of this was because some healthcare professionals are not confident 
enough to give advice because they lack understanding of the complexities of CFD. This 
led me to question what support and education do people with CFD require and what 
is the best method to deliver it? It also made me think about the education and 
support needs of healthcare professionals so they can more effectively help optimise 
the management of CFD. In the organisation I worked in I felt that many healthcare 
professionals believed CFD should be managed by specialists in that field. This was of 




lives of approximately half of the adult CF population. These concerns led to a 
successful application for an NIHR Clinical Doctoral Research Fellowship to undertake 
this PhD. 
My experience in the management of people with CFD has given me the opportunity 
to present at a national and international levels. I am currently a professional member 
of the steering group updating the UK CF Trust’s guidelines for the management of 
CFD. I was recently able to influence change through my work, as a consequence of 
this study. Through sharing my research findings with the steering group they became 
convinced that the right way forward was to use the term ‘cystic fibrosis diabetes’ 
instead of ‘cystic fibrosis related diabetes’ in our practice. The reasoning behind this is 
discussed in chapter three but is essentially due to the lack of causal relationship that 
‘related’ implies. The steering group recommended a change in the terminology in 
their document to CFD. 
CFD is associated with increased morbidity and mortality. Insulin is the primary 
treatment; this requires appropriate training, education and additional self-
management activities. DSME programmes have demonstrated effectiveness upon 
diabetes outcomes in people with type 1 and type 2 diabetes. However, no DSME that 
meet NICE criteria exist for people with CFD. This study offers the opportunity to 
better understand the self-management experiences and requirements of people with 
CFD and identify appropriate methods for the delivery of education and support. This 
will inform the development of a self-management education programme specific to 
the needs of people with CFD.  
1.11 The organisation of the thesis 
In this chapter background information about CF, CFD and DSME programmes has 
been provided. Then an outline of the development of my interests with the 
management of CFD followed. The remaining chapters are organised as follows: 
Chapter two provides an overview of the Medical Research Council’s (MRC) 




used to inform this study. This is followed by a review of methodological design for 
each stage of the study. The rational for choice of each methodology is explored 
playing attention to the strengths and limitations of the chosen approaches.  
Chapter three is a meta-ethnography exploring the experiences of people with CFD in 
living with and managing CFD. Six studies, a collective representation of 83 adolescents 
and adults with CFD, were included in this meta-ethnography. A detailed account of 
the methods used, key findings obtained, and discussion are presented.  
Chapter four is an empirical qualitative study which uses interpretative 
phenomenological analysis (IPA) to explore adults with CFD experience of self-
managing their diabetes. Eight adults with CFD participated in this study. The method 
of IPA and key findings are described. Discussion of key findings, which included 
comparison to current theory and influence upon the MAGIC (managing abnormal 
glucose in cystic fibrosis) programme development, then follow. 
Chapter five describes the methods used to develop and review the MAGIC 
programme. Keys findings from stage one along with the use of a stakeholder 
development group consisting of people with CFD and healthcare professionals were 
used to inform the development of the MAGIC programme. Results from the 
development process give illustrative examples to demonstrate design features and 
the theoretical grounding of the MAGIC programme. Results from the MAGIC 
programme reviews are used to demonstrate the face validity of the MAGIC 
programme. The discussion draws together key findings and the implications for future 
studies and clinical practice. 
Chapter six brings together key discussion points from all stages of this study. The 
contribution of these findings to knowledge and relevance to current literature are 
considered. The study’s limitations, strengths, credibility, implications for practice and 
further research are then discussed. 





2 Methodology - the best practice for 
developing complex interventions 
This chapter outlines the methodology for this thesis, the background to complex 
intervention development and the methodological design for each stage of the study 
and associated research questions. 
2.1 Research questions 
The overarching research question for this study is “how can we best meet the self-
management education requirements of people with CFD?”  
Specific research questions for each stage of the study were developed to help answer 
this overarching research question. These are: 
• Stage 1a -what are the experiences of adolescents and adults with CF in living 
with and managing CFD?  
• Stage 1b - what are the self-management experiences of people with CFD?  
• Stage 2 – what does a web-based self-management education programme for 
CFD need to contain?  
The overall aim of this study is to develop a self-management education programme 
for people with CFD. 
2.2 Complex intervention development 
DSME programmes are complex interventions because they contain many 
interconnected components with variable levels of complexity (Craig et al. 2008). This 
includes consideration to: content- this needs to specific to type of diabetes, social and 
cultural needs; method of delivery – is the intervention goup based, 1:1 or web-based; 
context - is the programme for use in primary care, secondary care or home use; and 
what level of support does the programme require? The course from development 
through to implementation of a complex intervention may take a wide variety of 
different procedures. However interventions for behavioural change need to be 




are feasible, acceptable, safe, effective and efficient (NICE 2007). The failure to 
demonstrate intervention effect has been seen in many complex intervention studies; 
this could be a result of true ineffectiveness or unsuccessful intervention design and/or 
failure to implement the intervention (Levati et al. 2016). The Medical Research 
Council’s (MRC) Framework for developing and evaluating complex interventions is the 
most widely used guideline (Corry et al. 2013) and was the chosen approach to inform 
the development of the managing abnormal glucose in cystic fibrosis (MAGIC) 
programme. The rationale for this is discussed below.  
The original version of the MRC Framework (figure 4) consisted of five sequential 
phases for the development and evaluation of complex interventions (Campbell et al. 
2000). Although it was considered hugely influential it was criticised for many reasons, 
these included: its linear approach, problems with contextual issues (Campbell et al. 
2007), and despite highlighting the importance of the early phases of development it 
lacked details how to achieve stages 1 (review of theory) and 2 (modelling) (Hardeman 
et al. 2005). A revised version of the MRC framework which aimed to address these 
limitations was developed (Craig et al. 2008). This is made up of four key phases: 
development, feasibility/piloting, evaluation and implementation. Figure 5 outlines the 
main phases and the key functions and actions at each of them, with the arrows 






Figure 4 Original MRC Framework (Campbell et al. 2000) 
 
 
Figure 5  MRC Framework for developing and evaluating complex interventions 
(Craig et al. 2008) 
To address issues with the linear approach of the original framework in the revised 
version there is some overlap between the first three phases as they follow an iterative 
rather than linear process. The staged approach cannot be removed completely as  




and the intervention developed to a point where it will achieve meaningful impact. The 
issue of context is still not fully addressed in the revised version, with no mention of 
context in the intervention development stage and only minimal consideration to 
contextual factors in modifying the effects of the intervention (Moore & Evans 2017). 
Little consideration is given to examining how interventions interact with context (De 
Silva et al. 2014). Context is important as it helps shape how interventions work; 
interventions should therefore not be viewed as distinct packages of different parts 
described in isolation from their context (Moore & Evans 2017). 
 
The revised version of the MRC Framework expands its description of the many 
dimensions of complexity, in complex interventions, which include: number of and 
interactions between different parts within the interventions (control and 
experimental), number and difficulty of behaviours required by facilitators and 
participants, number of groups or organisational levels aimed at by the intervention, 
number and type of outcomes and amount of flexibility permitted of the intervention 
(Craig et al. 2008). 
The development phase of the MRC Framework is the foundation for the intervention. 
It aims to identify relevant existing evidence base, to identify/generate appropriate 
theory and model process and outcomes. The feasibility and piloting phase aims to 
review the acceptability and feasibility of the intervention for which a variety of 
qualitative and quantitative methods are likely to be required. Refinement of the 
intervention may be required prior to the evaluation phase which aims to test 
effectiveness, understand process and assess cost-effectiveness. There are numerous 
study designs to consider in the evaluation phase these include: experimental designs 
such as randomised control trials, N of 1 design, or preference trials, however the 
approach chosen should be guided by the research question and specific 
characteristics of the study population (Craig et al. 2008). The implementation phase 
aims to evaluate the long-term implementation and effectiveness of the intervention 




evaluation through the combined effect of these phases should therefore produce a 
well-developed, theoretically supported intervention. 
2.2.1 Rational for choice of MRC Framework 
Alternative approaches to the development of health interventions include 
normalisation process theory (May et al. 2007, Murray et al. 2010) and the process 
modelling in intervention mapping (Garba & Gadanya 2017). 
Normalisation process theory tries to address the gaps that exist between research 
and its implementation, aiming to identify what is required for successful 
implementation of interventions into routine practice (normalisation) (May et al. 2007, 
Murray et al. 2010). There are four components: sense-making (coherence), 
engagement (cognitive participation), work done to enable the intervention to take 
place (collective action) and formal and informal evaluation of the benefits and costs 
of the intervention (reflexive monitoring) (Murray et al. 2010). Normalisation process 
theory has more focus on context, which is lacking from the MRC Framework, but its 
main emphasis is on implementational potential and not development, the latter of 
which is the focus of this thesis. However, it may be worth considering normalisation 
process theory in the future to help inform the evaluation and implementation of the 
MAGIC programme.   
Intervention mapping is a framework designed to try to bridge the gap between 
theories and practice. It consists of five stages which follow the course from the 
identification of need or a problem to the recognition of a solution (Bartholomew et al. 
1998). The main focus of intervention mapping appears to be on health promotion/ 
disease prevention e.g. HIV prevention, breast and cervical cancer screening, influenza 
vaccination (Garba & Gadanya 2017). These are not multifaceted or considered 
complex interventions therefore intervention mapping is not applicable to the 
requirements of the development of the complex intervention for this study. 
Regardless of the model researchers should consider three key issues in defining and 




1. Use relevant research evidence systematically in developing the parts of the 
intervention – use of exploratory research seeking expert views as well as 
theory and literature 
2. Improve the definition and measurement of complex intervention outcomes – 
use a framework that will make sure relevant outcomes measurements are 
used to assess all or part of the intervention  
3. Adopt relevant research designs required for each part- consider the use of 
qualitative research methods for clinically related opinions, use of randomised 
control trials (RCT) to establish cause and effect 
In a systematic review aiming to identify the most comprehensive approach to 
developing complex interventions, in nursing, the only identified guidelines used was 
the MRC Framework (Corry et al. 2013). With 9 out of 14 papers describing 
intervention development using this guideline; the remaining five papers did not 
specify the use of the MRC Framework or name another framework they used to guide 
their intervention development. Similar findings were seen in a scoping review aiming 
to identify and synthesise evidence relating to the optimisation of complex 
interventions at the pre-trial stage where 17 of the 27 studies reported using the MRC 
Framework (Levati et al. 2016). Lack of regards to contextual issues was a criticism of 
the MRC Framework (Moore & Evans 2017). Context is an important consideration to 
in the management of CFD because CFD has to be managed within the context of the 
competing demands of managing CF and daily life. What is currently unclear is how CF 
and CFD are managed together and what can be learnt from this to inform the 
intervention development. There are however no other frameworks for the 
development and evaluation of complex interventions that provide sufficient 
guidelines or evidence to support their use. The MRC Framework (Craig et al. 2008) 
was therefore deemed to be the most appropriate choice to inform this study.  
2.2.2 MRC Framework applied to the development of the MAGIC 
programme 
To support the design of the the MAGIC programme, this study will focus on the 




of the evidence base, developing theory and modelling. There is currently little 
available evidence, regarding the experiences of living with and managing CFD, to build 
upon to develop the MAGIC programme. The MAGIC programme will therefore be 
developed in two stages (figure 6). Qualitative evidence synthesis, qualitative patient 
interviews and use of people with CFD and healthcare professionals, as part of the 
MAGIC programme stakeholder development group will provide the evidence for this 
intervention and guidance for its theoretical underpinning. As a starting point the 
stages of the MAGIC programme development have been mapped upon the MRC 











Qualitative evidence synthesis 
of current literature to 
establish
• experiences adults with 
CFD face in living with and 
managing CFD
Transcribe, anonymise and analyse 
data
Arrange and conduct interviews to
• Explore and verify experiences 
of living with and managing 
CFD
• Identify educational and self-
management support needs




Establish                     programme development 
steering group
• 10 healthcare professionals
• Digital content manager
• 10 lay members (people with CFD, carers, PPI 
representatives, adviser from CF Trust)
Recruit  10 people with CFD from 
RB&HFT to interview. Provide 






Stage 2b- review 
with 8-10 
participants
Recruit  8-10  
people with CFD 
from RB&HFT to 
interview. Provide 










Table 7 Work undertaken and mapped onto MRC Framework 
Development phase   
 Aims Work undertaken 





• To gain a greater understanding of how adolescents 
and adults with CF live with and manage CFD 
• To provide a framework to help structure the 
interview topic guide for the qualitative interviews. 
 
• To confirm the findings from the meta-ethnography 
prospectively and to identify any additional 
concepts  
• To establish what are the barriers, facilitators and 
successes that adolescents and adults with CF 
experience in managing their CFD 
 
i. meta-ethnography of adults’ and 




ii. Empirical IPA study with adults who have 
CFD- identify factors influencing self-






• To identify knowledge and skills people with CFD 
require and use for self-management of CFD and 
how they might be incorporated into a programme   
• To help identify content for a CFD self-management 
education programme 
 
i. Empirical IPA study with adults who have 
CFD- identify concepts for DSME programme 
(stage 1b) 
ii. Literature review to identify theoretical 
underpinnings of DSME programmes 
iii. Stakeholder group consisting of lay members 











• To assess if the MAGIC programme has face validity 
(i.e. is a practical, helpful, informative and user-
friendly resource) for promoting self-
management education of CFD 




2.3 Identifying the evidence base using meta-
ethnography (stage 1a) 
 
A qualitative evidence synthesis was chosen to answer the question “What are the 
experiences of adolescents and adults with CF in living with and managing CFD?”  
with the aims being:  
• To gain a greater understanding of how adolescents and adults with CF live with 
and manage CFD 
• To provide a framework to help structure the interview topic guide for the 
qualitative interviews in stage 1b 
A qualitative evidence synthesis was chosen, instead of a narrative literature review, in 
order to go beyond purely describing and summarising findings. This meta-
ethnography will address gaps in evidence by establishing what is known about living 
with and managing CFD from the current literature. It will develop a deeper 
understanding of the experiences of living with and managing CFD, which will provide 
a framework for qualitative patient interviews in the next stage of this study.   
2.3.1 What is qualitative evidence synthesis? 
Qualitative evidence synthesis is the amalgamation of individual qualitative studies to 
generate a new understanding of the topic being studied. Over the last ten years there 
has been an increase in the use of qualitative evidence synthesis (Lee et al. 2015). 
There is, however, no standard method for carrying out the synthesis of qualitative 
studies. Cochrane Qualitative and Implementation Methods Group have recently 
published a series of papers to provide guidance on conducting qualitative and mixed-
methods evidence synthesis (Cargo et al. 2018, Flemming et al. 2018, Harden et al. 
2018, Harris et al. 2018, Noyes et al. 2018a, Noyes et al. 2018b). However more than 
30 methods for synthesising qualitative data have been described (Noyes et al. 2018a). 
Many of these methods are adaptations of four distinct approaches, namely- meta-
ethnography, grounded formal theory, cross case analysis and meta-study (Finlayson & 




Qualitative evidence synthesis methods are generally described as being 
predominately interpretative or integrative (Campbell et al. 2011). Integrative 
synthesis produces a description of the subject under study whereas interpretative 
synthesis produces a new theory of the subject (Paterson 2011). Although the 
approach to qualitative evidence synthesis can differ in methods, epistemology (theory 
of knowledge) and terminologies it shares common characteristics such as: involving a 
research team, arranging the synthesis according to the research objectives and 
synthesising a number of identified studies (Paterson 2011), where the aim is to 
identify concepts from the published findings of individual studies and to 
interpret/integrate them as a collective representation. Noblit and Hare (p28, 1988) 
describe this as “making a whole into something more than the parts alone imply.”  
Qualitative evidence synthesis gives an important overview of reported findings 
around a topic and presents new perceptions of these. Synthesising single qualitative 
studies together increase the evidence base, to create a more powerful explanation 
and higher level of understanding (Doyle 2003). Thus, increasing evidence can result in 
an enhanced transferability of research findings.  
The aim and purpose of the qualitative evidence synthesis should inform the 
appropriate choice of method for synthesis. Researcher’s experience, availability of 
time, audience and type of evidence available also need to be considered when 
planning a qualitative evidence synthesis (Finlayson & Dixon 2008, Paterson 2011, 
Toye et al. 2014). These factors were considered when meta-ethnography was chosen 
as the method of qualitative evidence synthesis for stage 1a. 
2.3.2 Rationale for choosing meta-ethnography  
Meta-ethnography is an interpretative approach to synthesising qualitative studies. It 
uses the interpretations of data collected through interviews for its synthesis (Noblit & 
Hare 1988). Unlike raw data for qualitative research such as participant quotes, which 
are subjected to author’s selection bias, all interpretations are published in the 
research manuscripts. The focus of meta-ethnography on these interpretations means 




data. Through interpretation meta-ethnography tries to make sense of the data rather 
than being purely descriptive. Thus, achieving a higher level of interpretation and 
understanding. This is important in trying to understand the experiences of living with 
CFD where there is a need to understand the experience and also the context of where 
the experiences occur. The use of meta-ethnography is therefore appropriate to 
answer the overarching research question of stage 1a, which is - what are the 
experiences of adolescents and adults with CF in living with and managing CFD? With 
the aims being to gain a greater understanding of how adolescents and adults with CF 
live with and manage CFD and provide a framework to help structure the interview 
topic guide for the qualitative interviews. 
Meta-ethnography is one of the most established and referenced method of 
qualitative evidence synthesis (Campbell et al. 2011). The original focus of meta-
ethnography was with only ethnographic studies however, it is now used to synthesise 
many qualitative research methodologies (Atkins et al. 2008). It has been widely used 
across healthcare research, social sciences and medicine (Campbell et al. 2011, Prorok 
et al. 2013, Woodman et al. 2014).  
The core of meta-ethnography is translation (Britten & Pope 2011). This is the analysis 
process which systematically compares and contrast the concepts from different 
qualitative studies. Noblit and Hare (1988) p38 describe translation as “one case is like 
another except that …” Three types of translations are described: reciprocal (similar), 
refutational (contradict) and line of argument (what can be said about the whole based 
on the parts) (Noblit & Hare 1988). Through synthesising translations, a higher-level 
interpretation of all the primary studies is achieved. Thus, a systematic and in-depth 
understanding of how the primary studies are related is achieved through the 
comparison of concepts within and across the studies. 
2.3.3 Criticisms of meta-ethnography 
Meta-ethnography has received several criticisms (Atkins et al. 2008, Toye et al. 2014, 
Lee et al. 2015). First limited guidance has been given on search strategies (Dixon-




not advocate an exhaustive search strategy. They believed the conceptual insight of 
meta-ethnography is the focus and incorporating large number of studies removes the 
focus from this (Noblit & Hare 1988).  
Secondly what studies should be included. Noblit and Hare’s meta-ethnography (1988) 
pre-dated quality appraisal. However, they recommended the inclusion of studies 
judged upon the usefulness of the findings. There is now a trend towards appraising 
the quality of studies to be included in a qualitative evidence synthesis, using tools 
and/or checklists from organisations such as the Critical Appraisal Skills Programme 
(CASP) (Britten et al. 2002, Pound et al. 2005, Atkins et al. 2008, Toye et al. 2014). 
There is however no consensus which tool should be used (Campbell et al. 2011). The 
CASP criteria for quality appraisal is widely used within the NHS (CASP 2016), is easily 
accessible and each criteria is clearly defined. This is particularly helpful to a novice 
qualitative researcher, like myself, who benefitted from the clear guidelines. Modified 
versions of CASP have been applied to meta-ethnography studies (Campbell et al. 
2003, Malpass et al. 2009). These contain additional screening questions which ask: 
does the study report results from qualitative research and did it involve both 
qualitative methods of data collection and analysis? and is this research applicable to 
the synthesis topic (Pound et al. 2005). Answering no to either of these pre-cursor 
questions would lead to exclusion. These screening questions would be particularly 
beneficial in qualitative evidence synthesis involving large numbers of studies as they 
quickly rule out unsuitable studies. One of the major disadvantages of quality appraisal 
tools is their focus on research methodology and design. Thus, if exclusions are based 
on this, concept rich studies may be missed (Atkins et al. 2008, Toye et al. 2014). The 
modified CASP was chosen to appraise the methodological quality of the studies 
included in this meta-ethnography because of its accessibility, ease of use and previous 
use in similar meta-ethnographies (Campbell et al. 2003). However close attention 
would be paid to the richness and depth of data in the qualitative studies, particularly 
the meaning it has for people with CFD, and studies would not be excluded on the 




The use of meta-ethnography was deemed appropriate to meet the aims of this 
qualitative evidence synthesis because of its focus on understanding and meaning and 
its established use as a form of qualitative evidence synthesis in health and illness 
research. This synthesis was therefore undertaken using Noblit and Hare’s (1988) 
original meta-ethnography method. Further considerations were given to more recent 
interpretations of meta-ethnography, which included: is qualitative synthesis suitable, 
is a synthesis needed, is there an appropriate team of researchers, identifying the 
search strategy, using a systematic search and the role of quality appraisal (Atkins et al. 
2008, Toye et al. 2014). Details of specific methods used will be presented in chapter 
three. 
2.4 Identifying the evidence base and developing theory 
using IPA (Stage 1b) 
Research methodology tends to be classified as either quantitative or qualitative. 
Qualitative research is exploratory and inductive; knowledge is acquired from those 
experiencing the phenomena in their social world. Whereas, quantitative work is 
concerned with cause and effect and hypothesis testing (Finlay 2011, Lyons & Coyle 
2016). A quantitative research design such as a national survey of the experiences of 
people with CFD would not provide a sense of meaning of the experience for the 
individual. It would generate more numeric and categorised data which would be 
deficient in personal meaning. A qualitative approach will capture the depth, and not 
just the breadth, of the experiences. This means not just trying to understand the 
experiences of self-managing CFD, but also the context and circumstances in which 
they occur. A qualitative approach was therefore deemed the most appropriate to 
answer the question “what are the self-management experiences of people with 
CFD?” Finlay (2011, p8) states:   
“Qualitative research illuminates the less tangible meanings and intricacies of 
our social world. Applied to the therapy field it offers the possibility of hearing 
the perceptions and experience of service users.” 
This study will build upon the findings from the meta-ethnography and seek to gain a 




management of CFD. This will lead to a better understanding of what self-management 
experience of CFD means to participants, from their perspective.  
his approach will allow  
2.4.1 Philosophical underpinning of qualitative research 
Mills & Birks (2014, p 18) describe philosophy as “a view of the world encompassing 
the questions and mechanisms for finding answers that inform that view.” An 
individual’s philosophical beliefs will therefore guide the approach they take to 
decipher problems in their daily life. How the social world is studied raises a number of 
philosophical questions, particularly with regards to epistemology (study of 
knowledge) and ontology (nature of reality).  
Ontological assumptions are concerned with what is reality; these are the perceptions 
of how things really are and how things really work, thus contributing to the 
understanding of existence (Lyons & Coyle 2016). How will the interplay between CF 
and the diabetes be lived by study participants and how many different realities of this 
interplay will emerge? Ontological assumptions range along a continuum from realism 
to relativism (figure 7). Realists argue there are elements of our world that exist in 
their own right, separate from people’s beliefs and understandings of it (Ritchie et al. 
2013). In this paradigm, CF must be most important, compared to CFD, because 
maintaining respiratory health in a major factor in survival for people with CF and must 
be the priority of self-care. Thus, there is a difference in the way the world is and the 
meaning and interpretation of that world viewed by the individual; phenomena have 
an independent existence which can be discovered via research. Relativists argue that 
reality does not exist independently of people’s beliefs and understandings; it is reliant 
on the ways we come to know it (Ritchie et al. 2013). Reality is individually created 
through the interactions between language and aspects of the world (Lyons & Coyle 
2016). Thus, meaning is constructed in and through language and language used. 
People with CFD will have had CF for many of years prior to its diagnosis. They will be 
developed experiences in healthcare systems and in managing treatment regimens, 





Figure 7 Ontological continuum (Braun & Clarke 2013) 
Epistemology is the branch of philosophy concerning the theory of knowledge; it 
attempts to answer the question how and what, can we know? (Lyons & Coyle 2016). 
Guba and Lincoln (1994, p108) suggest epistemology questions “what is the nature of 
the relationship between the would-be-knower and what can be known?” 
Epistemological views include: objectivism, subjectivism, dualist and constructionism 
(Guba & Lincoln 1994). Epistemology is frequently considered in conjunction with 
ontology. 
Research paradigms are the frameworks that represent the shared perspectives of 
how the world is viewed and what knowledge is generated from that perspective; they 
guide research conduct and decision making (Silverman 2013). Many research 
paradigms have been described, they include: positivism, post-positivism, post-
modernism, critical theory and interpretivism/constructivism (Mills & Birks 2014). 
Research paradigms are characterised according to their ontology, epistemology, 
methodology (how to acquire knowledge and conduct research) and methods (Guba & 
Lincoln 1994). Thus, generating a holistic representation of how knowledge is viewed, 
how researchers view themselves in relation to this knowledge and the 
methodological approaches used to discover it.   
Quantitative research frequently takes place in a positivist paradigm, which adopts an 
ontological position of realism - where objects/ events/ phenomena have an existence, 
independent of the researcher, which can be discovered via research (Scotland 2012). 




of an objective reality which is impartial and unbiased (Lyons & Coyle 2016). Research 
methodologies are scientific; aiming to establish cause and effect (Creswell 2008) but 
lacking in personal meaning and understanding. 
Although qualitative research takes place within many research paradigms the 
interpretivist paradigm is the major contributor. The interpretivist paradigm adopts an 
ontological position of relativism, where reality is viewed as subjective, it is individually 
constructed and thus varies from person to person (Guba & Lincoln 1994, Creswell 
2008). Epistemology is subjectivism where meaning is created through the interaction 
between consciousness and the world (Scotland 2012). Research methodologies are 
interpretative aiming to understand the phenomenon of interest from an individual’s 
perspective, exploring an individual within the social world they live in. People with CF 
and CFD are very a diverse population in terms of clinical status, age and social 
background and thus will have variable experiences constructed from the world they 











Figure 8  Philosophical assumptions of research paradigms (modified from Mills & 
Birks, 2014) 
The relationship between philosophical assumptions and research paradigms is 
summarised in figure 8, this is not fixed in nature and can be considered as a 




realist ontology of an ordered and structured world associated with positivism towards 
the more subjective epistemology and an ontological view of a world of multiple 
realities constructed by humans associated with interpretivism. Critical realism takes a 
position mid-way between positivism and constructivism/interpretivism, adopting a 
perspective that while a reality exists independent of the observer, the reality cannot 
be known with certainty (Mills & Birks 2014). Critical realists holds a realist ontological 
perspective (belief a real world exists independently of our beliefs and constructions) 
with a constructivist epistemology (our own knowledge and understanding of this 
world is inevitably a construction from our own point of views) (Maxwell 2012). Critical 
realist try to generate knowledge, through interpretation, that captures and reflects as 
truthfully as feasible a phenomenon that is happening in the real world (Willig 2013). It 
is acknowledged that multiple and subjective realities and understandings of the world 
exist instead of one single objective reality (Holloway 2008). Critical realists view 
individual’s beliefs and meanings as equally real to physical objects and processes thus, 
believing the meanings people attach to things have influences on their actions and for 
their physical world (Maxwell 2012). Thus, critical realism assumes our ability to know 
about reality is not perfect and therefore we aim to achieve the best understanding 
possible. 
The approach of critical realism has been adopted within stage 1b. Its location is within 
the interpretivist framework where the importance is in the understanding of 
individual’s perspectives in managing their illness within the context with which they 
live their lives. Trying to understand the experiences of managing CFD from the 
individual’s perspective is really important to allow for the diversity seen self-
management experiences of people living with CF and diabetes. This information will 
inform the development of a self-management education programme, so it is 
important to understand what variability exists so it can be addressed in the 
programme.  
In critical realism there is the ontological view that reality is seen as something that 
exists independently of those who observe it but, it is only available through the 




insights and interpretations of the participants in the generation of varying viewpoints 
and understanding is acknowledged with the aim to discover the complexity and depth 
of reality of their experiences. While acknowledging that interpreted knowledge is not 
totally objective it reflects some truth about the phenomenon, but it is influenced by 
our own interpretations. Figure 9 represents a philosophical overview of stage 1b. 
 
Figure 9 Overview of philosophical foundations for this study 
 
2.4.2 Interpretative Phenomenological Analysis  
A qualitative research design using IPA was chosen to answer the question “what are 
the self-management experiences of people with CFD?” With the aims being:   
• To confirm the findings from the meta-ethnography prospectively and to 
identify any additional concepts  
• To establish what are the barriers, facilitators and successes that people with 




• To identify knowledge and skills people with CFD require and use for self-
management of CFD and how they might be incorporated into a programme   
• To help identify content for a CFD self-management education programme 
In 1996 Jonathan Smith introduced IPA as a qualitative methodology in health 
psychology as an alternative to other established qualitative methodologies such as 
grounded theory (Smith 1996). IPA is concerned with exploring and understanding, in 
depth, the personal lived experience and how individuals make sense of this (Smith et 
al. 2009, Shinebourne 2011). Thus, IPA attempts to understand what the world is like 
from the participant’s perspective. Most IPA work tends to be health, illness or 
impairment focussed (Smith et al. 2009).  
2.4.2.1 Theoretical underpinnings of IPA 
Smith 2009, p46 states “IPA is not trying to operationalise a specific philosophical idea, 
but rather draws widely, but selectively from a range of ideas in philosophy.” IPA is 
based on three key areas of the philosophy of knowledge: phenomenology, 
hermeneutics and idiography. 
2.4.2.1.1 Phenomenology  
Phenomenology is a philosophical approach to researching experience, particularly the 
meaning of experiences for individuals (Smith et al 2009). IPA is significantly influenced 
by Heidegger’s phenomenology work ‘Being and Time’ which represents a 
phenomenological perspective where our world around us and our experiences are 
joined. Thus, a person’s place in the world is always in relation to something, temporal 
and influenced by perception. Larkin et al (2006, p107) describes Heidegger’s position 
acknowledging “that nothing (literally no-thing) is ever revealed as anything (real or 
unreal, thing or no-thing) except when we encounter it and, hence, when it is brought 
meaningfully into the context of human life.” Therefore, any findings made are 
inevitably a function of the relationship that is created between the researcher and 
topic/object of study.  
IPA acknowledges that experience cannot be accessed directly from individual 




essential to help understand the phenomena (Smith 2009). For people with CFD this 
would include decisions about insulin doses, food choices, checking blood glucose 
levels and making treatment decisions such as omissions or prioritisation. Through the 
use of unstructured interviews and using open-ended questions such as “can you 
describe how you learnt to manage your CFD?” participants will be given the 
opportunity to speak in depth, in their own words about their experience of self-
managing CFD thus allowing their ‘being and time’ to be uncovered. The perspectives 
on meaning unique to an individual’s relationships through being embodied and 
situated to the world begin to unfold. Thus, IPA’s phenomenological element aims to 
explore how has this phenomenon has been understood by this individual. 
2.4.2.1.2 Hermeneutics 
Hermeneutics ‘the theory of interpretation’ is the second major theoretical 
underpinning of IPA (Smith et al. 2009). Schleiermacher, a hermeneutic theorist, 
influence on IPA highlighted the significance of context. Interpretation involved both 
grammatical (exact and objective textual meaning) and psychological (author’s unique 
intentions) elements (Smith et al. 2009). Thus, meaning is available for interpretation 
but the wider context in which the text (transcript) was produced needs to be 
considered (Smith et al. 2009). An understanding of the participant as well as the text 
and a perspective upon the participant’s meaning of the text is trying to be achieved. 
Smith et al (2009, p23) claims its relevance to IPA is that it “might offer meaningful 
insights which exceed and subsume the explicit claims of our participants.” Thus, 
through the interpretative process a perspective on the text, which the author does 
not or cannot offer, is achieved. For a population of people with CFD, with many 
diverse characteristics, it is important to consider their unique context within which 
they exist and the social, emotional, physical factors that influence it, such as the 
additional treatment and emotional demands required from someone with CF to be 
able to effectively manage their CFD whilst unwell with a respiratory infection. 
Continually questioning oneself when analysing the text involves interpreting what the 
individual is trying to say beyond describing the experience and attempts to interpret 




Heidegger’s work was again a major influence (Larkin 2006). He acknowledged that 
researchers’ fore-conceptions (assumptions and ideas) contribute to the interpretative 
process but suggests priority should be given to new things instead of the researchers’ 
preconceptions (Smith 2009). As a specialist CF dietitian my knowledge and experience 
is heavily influenced by my 22 years work within this area; the process of IPA thus 
acknowledges this and its contribution to the interpretative process. Other members 
of my research team are from different professions and their expertise in behavioural 
medicine, nursing, respiratory medicine and education will influences interpretative 
processes. They will challenge my interpretations and provide their own individual 
contributions. Researchers therefore always brings their fore-conceptions to the 
interpretative experience; however, these may not be apparent until presented with 
the new. Smith et al. (2009) suggest this form of bracketing is a cyclical and dynamic 
process that can only be partly attained. Thus, researchers should remain open to their 
preconceptions/ assumptions emerging while engaging with the new.  
The hermeneutic circle (table 8) is the dynamic relationship between the part and the 
whole of an experience; to comprehend the part you have to look at the whole and to 
comprehend the whole you need to look at the parts (Smith et al 2009). Thus, the 
meaning of a single word only becomes evident when viewed in the context of the 
whole sentence and the meaning of a sentence is reliant upon the collective meaning 
of the individual words (Smith 2009). This is a dynamic way of thinking, which is 
iterative - moving back and forth through the data rather than completely linearly. 
Thus, double hermeneutics is achieved- the researcher is making sense of the 
individual making sense of a phenomena through the processes of understanding, 
clarification and interpretation. The researcher is attempting to interpret what an 









Hermeneutics is therefore an important theoretical underpinning of IPA. With 
significant contributions from Heidegger who viewed phenomenology as an 
interpretive activity, where IPA is associated with exploring how a phenomenon 
appears, acknowledging the researcher’s role in facilitating and making sense of this 
appearance (Smith 2009). Therefore, IPA’s interpretative element aims to understand 
meaning – what does having CFD mean for this individual, in the context of their life 
when they are also trying to live with and manage CF? 
2.4.2.1.3 Idiography 
Idiography is the third major theoretical underpinning of IPA. It is concerned with the 
particular and with understanding the meaning of an individual’s life instead of trying 
to make claims within a wider population (Smith 2009). Thus, IPA is concerned with 
understanding the depth and detail of experiences and recognises that experiences of 
the same phenomena can be different amongst individuals. IPA creates a theoretical 
generalisability whereby readers can establish relationships between the findings, 
their professional and personal experiences and existing literature (Smith and Osborn 
2003). 
The commitment of IPA to the particular is on two levels: 
1. Sense of detail- systematic analysis with depth 
2. Understanding how the specific observed phenomena have been 
understood from the perspective of that particular individual in a 
particular context 
The part The whole 
 
Single word The sentence in which the word is embedded 
Single extract Complete text 
Particular text Complete works 
Interview Research project 




IPA recognises that there is no direct access to pure experience and it therefore aims is 
to get experience close, where people are seen as ‘meaning makers’ Smith (2009 p33) 
states; “the meaning which is bestowed by the participant on experience, as it 
becomes an experience, can be said to represent the experience itself.” 
IPA therefore has interpretative (hermeneutic), phenomenological and idiographic 
underpinnings; where the main aim is to explore how people make sense of their 
experiences.  In summary the key assumptions that guide the process of IPA are (Larkin 
et al 2011): 
• Understanding of the world necessitates an understanding of experience 
• IPA researchers produce and explore subjective accounts of other people who 
are always-already submerged in a cultural, linguistic, relational, and physical 
world 
•  To achieve a detailed focus on the particular an idiographic approach is 
required 
• Access to experience is achieved through intersubjective meaning-making  
• IPA researchers should recognise and reflect upon their own assumptions and 
experiences to be able to engage with other people’s experiences 
• Interpretation is fundamental to IPA; researchers should reflect upon their role 
in creating these interpretations and ensure they are grounded in participants 
views 
2.4.3 Alternative approaches to IPA? 
Other qualitative approaches were considered when choosing IPA as the research 
methodology for this stage. Phenomenology focuses on individual experience and the 
lived world, IPA shares similarities with hermeneutic phenomenology, but IPA focuses 
more on the individual’s sense-making which is more applicable to the research 
question for stage 1b which is concerned with individual perspectives and unique 
meanings. IPA has a more structured set of analytical steps than hermeneutic 
phenomenology (Finlay 2011), this provides helpful guidance for the researcher in 




Grounded theory was considered because it’s rooted in social science. Grounded 
theory develops an explanatory level account (influences, beliefs, perceptions, impacts 
etc e.g. how do people do x or y. The sample size in grounded theory tends to be larger 
and more heterogenous. Grounded theory is about generalisability and building a 
theory (model) and focuses more on social phenomenon whereas IPA is more 
psychological in its approach and focuses on the meaning making. It therefore focuses 
on action and processes rather than what the experience is like. IPA will be able to help 
develop a greater understanding of the self-management experiences of people with 
CFD. 
In discourse analysis language is seen as a social performance; the process of 
constructing reality and not reflecting upon it. Talk is a medium for conveying 
information and knowledge. It analyses how people use words and language to 
achieve/do certain things. Both IPA and discourse analysis focus on linguistics but IPA 
also uses cognitive and affective reactions. IPA therefore also uses linguistics to 
understand how participants make-sense of their experiences.  
Both IPA and thematic analysis focus on themes however, thematic analysis is less 
detailed and less idiographic. Thematic analysis tends to use larger sample sizes than 
IPA and focuses on generalisability. Thematic analysis does not stem from any an 
underlying philosophical theory and can therefore informed by the researchers own 
philosophical assumptions. Unlike IPA, thematic analysis tends to be more descriptive 
but this will depend upon the philosophical assumptions adopted. Despite the 
similarities seen, thematic analysis was not deemed appropriate to address the unique 
individual meanings IPA would facilitate.  
IPA offers the best integrated methodology to explore the ways people with CF make 
sense of their CFD with their experiences of self-management being the focal point of 
interest. IPA stays close to meaning and by adopting a smaller sample size it allows for 
better engagement. IPA facilitates an understanding of ‘experience’ within its context. 
As IPA is an interpretative approach the context in which the research takes place is 




the complex context in which it is managed, particularly in the context of living with an 
unstable and unpredictable long-term condition like CF. People with CF manage CFD 
within their cultural, social and medical prioritisations. 
2.4.4 Criticisms of IPA 
IPA has been criticised for not demonstrating enough depth of interpretation and 
therefore being more descriptive (Willig 2008, Hefferon & Gil-Rodriguez 2011). The 
interpretative process in IPA is iterative and dynamic of which the hermeneutic circle is 
fundamental (Smith et al. 2009). Thus, the researcher needs to aim to go beyond 
description and through interpretation explore the relationship between the parts and 
the whole. 
The role of language in IPA has also received attention (Willig 2008). Does language 
convey experience or describe it? Thus, what meaning do the words of an interview 
transcript tells us more about the ways in which people talk about a specific 
experience within a specific context rather than about the experience itself? However, 
IPA acknowledges that pure experience is never accessible, and the aim is to gain 
insight into experience. ‘Meaning making’ is achieved through contextual analysis of 
narratives, metaphors and discourse therefore language is entwined with experience  
(Smith et al. 2009). 
A third criticism of IPA is the suitability of accounts, particularly if participants have the 
level of articulacy to convey their experiences and the meanings of their experiences 
rather than just opinions (Willig 2008). IPA recognises a link between dialogue, 
thoughts and emotional state and realises people struggle to express their thoughts 
and feelings. It is therefore the role of the researcher to interpret emotional state 
through what is said and by asking essential questions about what is not (Smith & 
Osborn 2008). The use of field notes taken during interviews can facilitate this by 
recording accounts of non-verbal communication such as facial expressions or body 
language.  
Despite these criticisms IPA was considered the most appropriate methodology to 




will be given to the depth of analysis achieved and the meaning behind language used 
throughout the study. 
2.5 Developing theory to inform the MAGIC programme 
development (stage 2a) 
From chapter one certain elements about CFD have been establish and need be 
considered in the development of the MAGIC programme. These are: 
• the MAGIC programme should be aimed at adults as the mean age of diagnosis 
of CFD is 18-24 years 
• the MAGIC programme will need to be delivered on a 1:1 basis due to cross 
infection guidelines advising against contact between people with CF 
• insulin is the primary medical treatment of CFD and should therefore be the 
focus of the MAGIC programme 
Stage 2a of the research project will answer the question “what does a web-based self-
management education programme for CFD need to contain?” It will aim to develop 
the MAGIC programme as an e-learning resource, where e-learning is defined as 
learning carried out via the Internet (Oxford University Press 2019). e-learning was 
chosen primarily due to the younger age of the CF population, to reduce demands on 
people’s time by limiting additional hospital attendance and because of its suitability 
for 1:1 delivery (this will be explored in greater detail below).   
To inform the theoretical underpinnings and hence methodology for the development 
of the MAGIC programme four considerations need to be explored. These are: what is 
self-management, what are the theoretical underpinnings of DSME, how to design self-
management interventions and why use eHealth technology?  
2.5.1 What is self-management? 
Self-management encompasses all ‘the things people do to help themselves live with a 
long-term condition’ (Self-Management UK 2017). A theoretical framework for self-
management of chronic illness describes three sets of tasks that are required: medical 




figure 10. Medical management includes taking medications, modifying diet and 
monitoring symptoms. Role management concerns maintaining, changing or creating 
new behaviors or life roles which are part of adapting to changes in health state for 
example adjusting to reduced exercise tolerance. Finally, emotional management deals 
with the emotional consequences of having a chronic illness such as thoughts, feelings 
and changes in mood which can affect quality of life (Lorig & Holman 2003). Corbin and 
Strauss’ (1988) work is based upon patients’ perceptions of their chronic illness 
experiences- their concerns and problems about their chronic illness. Therefore, self-
management education programmes, such as the MAGIC programme, need to address 
all three self-management tasks and focus on patient perceived problems.  
 
Figure 10 Self-management tasks 
The main factors influencing the ability of people with type 1 or 2 diabetes to self-
manage are (Wilkinson et al. 2014): 
• Education- the need for relevant, consistent and comprehensible education for 
individuals and their significant others to enable self-management 
• Communication – both positive and negative experiences that impact upon the 
ability to self-manage  
• Support- healthcare providers and significant others can encourage or 
discourage an individual in their self-management 
• Provider issues – quality of care provision and access to healthcare systems 
influence ability to self-manage 
• Personal factors – individual characteristics such as personal beliefs, culture, 
physical symptoms, learning experiences, psychological factors and practical 




People living with diabetes face a huge variety of self-management issues on a day-to-
day basis. The self-management of diabetes is therefore not static but a dynamic 
continually evolving process and will vary between individuals.  
The most common barrier to self-management in older adolescents and adults with CF 
is, treatment burden, this relates to the duration, frequency and complexity of 
treatments (George et al. 2010). It has been reported that people with CF spend 
approximately 2.5 hours per day conducting CF care (Cystic Fibrosis Trust 2018b) 
consisting of a median of seven daily therapies (Sawicki et al. 2009). Work and social 
demands were also considered important and are viewed as conflicts between carrying 
out CF care and the wish to take part in social events or meet work obligations (George 
et al. 2010). There is very little research looking at self-management of CFD thus (as 
discussed above) stage 1b will provide the evidence base for this.  
2.5.2 What are the theoretical underpinnings of DSME 
The MRC Framework highlights the need for a robust theoretical background to 
provide knowledge into how an intervention works, however it does not specify how 
to choose the most relevant theory (Craig et al. 2008). Having a strong theoretical 
background will identify the relevant theoretical constructs to be targeted e.g. 
empowerment, self-efficacy or well-being. This will also be important when 
considering what tools are needed to monitor interventional outcomes. A review of 
evidence of health-related self-management programmes has suggested the 
importance of tailoring interventions to specific conditions (De Silva 2011). This will 
thus inform the selection of patients who are likely to benefit from the intervention. As 
the MRC Framework does not provide information on how to choose the most 
relevant theory to inform complex intervention development existing DSME 
programmes were used as a guide.   
The focus of DSME is encouraging independence and self-confidence to facilitate 
effective self-care (Diabetes UK 2015b). Self-management education is different from 
patient education. The focus of patient education is conveying knowledge whereas 




development of many core skills including: problem solving, decision making, 
identifying resources, taking action and developing partnership with healthcare 
providers (Lorig & Holman 2003).  
As discussed in chapter one there are many DSME programmes that exist within the 
UK, table 9 lists some of these, that meet NICE (2015) guidelines, and their theoretical 
underpinnings. There is variation in theoretical underpinnings between the 
interventions, with no consensus on which theory should be chosen. However, a 
common feature of DSME programmes are they are person-centred, and they 
recognise the responsibility for self-management is within the hands of the individual. 
Table 9 UK DSME programmes 
DMSE Theoretical underpinnings Delivery 
 
Dose adjustment for 
normal eating (DAFNE) 
 
(DAFNE Study Group 
2002) 
Therapeutic patient 
education principles  
 
(Assal et al. 1985) 
Group  
BERTIE type 1 diabetes 
education programme 
 
(Everett et al. 2003) 




Groups +/- online 












(Davies et al. 2008) 
Self-management 
Empowerment 











(Murray et al. 2017) 
Self-management of 
chronic illness framework 
(Corbin & Strauss 1988) 
Web-based, following 
initial consultation with 
facilitator 
 
Due to the management of CFD requiring insulin the MAGIC programme will share 




theoretical underpinnings of these programmes for type 1 diabetes were considered 
more closely. DAFNE (DAFNE Study Group 2002) and BERTIE (Everett et al. 2003) are 
both derived from the Düsseldorf intensive insulin therapy programme (Mühlhauser et 
al. 1987) and share aims of learning how to manage insulin doses compared to 
carbohydrate intake thus allowing greater dietary freedom. The Düsseldorf intensive 
insulin therapy programme is guided by therapeutic patient education principles. 
These recognise that to improve health, patient education involves helping them to 
develop skills to: enable them to better manage their illness, be able to modify 
treatments and develop improved coping processes (WHO 1998). However, the quality 
of therapeutic patient education is dependent upon the abilities and skills of the 
healthcare professionals who deliver it (Petre et al. 2017). BERTIE (Everett et al. 2003) 
has been modified to now incorporate social learning theory (Bandura 1977a). This 
suggests that people learn through observing and copying other people’s attitudes, 
behaviours and the outcomes of these behaviours. Social learning theory is dependent 
on interactions with others and therefore blends itself better to group learning and 
would be less suitable to base the MAGIC programme, which will be delivered 1:1. 
The X-PERT Insulin programme aims to increase skills, knowledge and understanding of 
diabetes and helps people make lifestyle choices to manage blood glucose levels more 
effectively (X-PERT Health 2019). The theoretical underpinnings of the X-PERT 
programmes are empowerment and discovery learning. Empowerment is a concept to 
direct patient and healthcare professional interactions. Patients should be well-
informed active partners in their care and healthcare professionals should provide 
patients with appropriate education, support and advice to help them make informed 
choices to achieve goals and overcome obstacles (Funnell & Anderson 2004). 
Empowerment theory recognises that someone with diabetes is totally responsible for 
the self-management of their illness (Funnell & Anderson 2004). Empowerment cannot 
be given or taught it a process that people do for themselves. Discovery learning sees 
the learner as the problem solver, who gains knowledge through the use of tools, 





Patient empowerment and therapeutic patient education have an emphasis on the 
role of a healthcare professional as an educator/ supporter. At this stage of 
development, it is unclear how much involvement healthcare professionals will have 
with the delivery of the MAGIC programme; this will be based upon evidence from 
stage one and views of the stakeholder development group. It would therefore not be 
prudent to design the MAGIC programme based upon patient empowerment without 
the evidence to support the role of the healthcare professionals in its delivery.   
Reviewing the theoretic underpinning of type 1 DSME programmes did not identify 
strong evidence to support one theory, over another, to inform the MAGIC programme 
development. Therefore, patient reported outcomes used to evaluate DSME 
programmes were reviewed to provide some additional guidance.  
X-PERT diabetes (Deakin et al. 2006), The Diabetes Manual (Sturt et al. 2006b), HeLP 
Diabetes (Murray et al. 2017) and more recent DAFNE trials (Elliott et al. 2012) have all 
assessed self-efficacy as a patient reported outcome. BERTIE was not formally 
evaluated as it was modelled upon DAFNE which had undergone extensive validation; 
instead its impact upon knowledge and diabetes management skills were reviewed 
(Everett et al. 2003). X-PERT Insulin has also not been formally evaluated, it is based on 
the X-PERT diabetes programme which was evaluated by randomised control trial 
(Deakin et al. 2006). Except for the Diabetes Manual (Sturt et al. 2006b) none of the 
DSME programmes reviewed (table 9) were informed by self-efficacy theory. Thus, 
demonstrating the expectation that whatever theoretical framework guided the 
programme development a change is self-efficacy was expected.  
The recognition of the role of self-efficacy theory in diabetes self-management 
behaviours (Mishali et al. 2011) and its wide use as a patient reported outcome 
measure in clinical trials of DSME programmes influenced the decision to use self-
efficacy theory to inform the development of the MAGIC programme.  
2.5.2.1 Self-efficacy theory 
Self-efficacy is an important factor in influencing diabetes self-management 




specific activity or behaviour under certain conditions (Bandura 1977b). Self-efficacy is 
behaviour focussed and plays a significant part in the process of behaviour change 
(Mishali et al. 2011). There are four main influences on self-efficacy: mastery 
experience, vicarious experiences, verbal encouragement and psychological state 
(Bandura 1977b). Therefore, DSME programmes need to address these factors as just 
giving information or educating will not facilitate successful self-management. Table 10 
highlights how these influences may be addressed in self-management education 
programmes. However, the process of changing behaviour often takes time and 
support needs to be ongoing. There is evidence to suggest that proactive self-
management support and focussing on behaviour change and self-efficacy can improve 
clinical outcomes (De Silva 2011). The self-efficacy framework is therefore appropriate 
to help understand and predict self-care behaviours which are relevant to the effective 
self-management of diabetes (Mohebi et al. 2013). 
Table 10 Influences on self-efficacy 
Influence on self-efficacy Activities in self-management education programme 
 
Mastery experience Building up skills, knowledge and experience through 
staged learning 
Direct experience of successfully mastering a task 
 
Vicarious experiences Seeing others overcome a task successfully 
Mirroring of actions 
Observations of similar individuals 
 




Psychological state Paying attention to and addressing mood, stress, 
anxiety and any factors affecting the individual 
 
 
Improving self-efficacy will enhance an individual’s belief in their ability to self-manage 




learning programme delivered on a one to one basis that provides fewer opportunities 
for developing relationships with healthcare professionals or others with diabetes.  
2.5.2.2 Styles of learning 
When considering the theory of self-management interventions, it is also important to 
consider the population and their learning needs. This intervention will be designed for 
people with CFD, be delivered via an eHealth platform and meet NICE criteria for DSME 
(NICE 2016). As it is aimed at adults over 16 years of age, due to this being the most 
likely age from when a CFD diagnosis will be made, consideration to preferences of 
learning are important. Not everybody learns in the same way. Four styles of learning 
have been described these are: visual, aural, read/write and kinaesthetic (Fleming 
2001) although not all learners exclusively learn by just one style. Table 11 
demonstrates how different learning styles will be addressed in the MAGIC 
programme. The four different types of learning styles will therefore be considered 
when developing the MAGIC programme. 
Table 11 Examples of styles of learning in magic programme 
Learning style Activities 
 
Visual Viewing videos 
Use of illustrations 
 
Aural Asking questions/ facilitator discussion 
Web-chat 
 
Read/write Reading text in website 
Making notes 
Completing food, insulin and blood glucose diary 
Reading instructions 
 
Kinaesthetic Completing quizzes 
Practicing scenarios 
Carrying out tasks on computer/ tablet 






2.5.3 How to design self-management interventions 
Self-management programmes are complex interventions aimed at improving the way 
individuals self-manage their chronic illness to improve their health and well-being 
(Mills et al. 2014). These programmes are complex interventions because they 
comprise of different parts, subject areas and formats with which participants will 
work, over a period of time, to try to incorporate into their daily life (Craig et al. 2008).  
The MAGIC programme is for people with CFD, user involvement is therefore a key 
part of its philosophy to ensure the intervention is user friendly and reflects the real 
needs of the people it is designed for. Co-design, co-production and co-creating are all 
terms used to describe working collaborations however they all have slightly different 
meanings. Co-design is collaborative working to address a problem and identify a 
solution, whereas co-production attempts to implement the proposed solution and co-
creation includes the whole process (McDougall 2012). The MAGIC programme 
development is therefore a co-creation process but the main focus of this stage of the 
study is co-design. Feasibility/piloting, evaluation and the full delivery of the MAGIC 
programme into daily life and thus implementation of the proposed solution is beyond 
the scope of this thesis. 
Other methodologies considered as alternatives to co-design included: participatory 
action research and experience-based co-design. Participatory action research (PAR) 
has its primary focus upon working in partnership with communities to reduce health 
and health inequalities (Baum et al. 2006). Although the focus of the MAGIC 
programme involves communities (in terms of people with CFD) stage two of the 
programme was concerning intervention development and face validity, it wasn’t 
looking at change in health. Experience-based co-design brings together patients and 
healthcare professionals its focus is however on service improvements and not 
intervention development (The Point of Care Foundation 2019). Despite participatory 
action research and experience-based co-design both recognising the value of patients 






Co-design is a form of stakeholder engagement; it combines the opinions, 
contribution, knowledge and experience of people with different perspectives to 
address a specific problem (Bradwell & Marr 2008). The process of co-design is based 
around four components (Bradwell & Marr 2008): 
• Participation- co-design is a collaboration. A close working relationship is 
developed between participants who are working together to develop a 
service/intervention. 
• Development - co-design is a development process involving the sharing of 
expertise and knowledge.  
• Ownership and power – co-design shifts power to the process, there is equality 
in the contributions from all involved. It is an empowering process due to the 
shared decision-making across all aspects. 
• Outcome and intent – co-design process is outcome based. 
Best practice for co-design have been described and they include: methodology that 
supports and encourages all components of the co-design process, creation of an 
environment that is a safe-space for participations to contribute and communicate and 
maintaining focus on desired outcome which includes balancing view points and 
maintaining relevant dialogues (Bradwell & Marr 2008). Thus, these factors need to be 
considered when embarking on a successful co-design project. A stakeholder 
development group consisting of people with CFD, healthcare professionals and a 
digital content manager will be established to co-design the MAGIC programme.  To 
reflect different knowledge and experiences attention needs to be paid to recruiting 
the healthcare professional representatives from a diverse range of professionals 
including doctors, nurse specialists, dietitians and psychologists. To reflect different 
management practices these healthcare professionals will also need to be recruited 
from different CF centres. Patient representatives will be recruited from within the 
hospital trust and from other CF centres again to reflect diversity and experiences. The 
stakeholder development group facilitator will have the important role in maintaining 
the dynamics of the stakeholder group meetings to ensure all members of the group 




the group is maintained. An additional challenge for this study will be the use of 
videoconferencing software in the stakeholder development group meetings to allow 
all the members with CFD to be present as they are not allowed to meet face to face. 
The James Lind Alliance top ten research priorities for CF steering group successfully 
used videoconferencing facilities during its workshops involving people with CF and 
healthcare professionals (Rowbotham et al. 2018). As a representative on this group I 
gained first-hand experience of the successful use of videoconferencing in a similar 
situation and also obtained the idea of appointing a ‘link person’ to maintain contact 
with the patient representatives at home.  
The main benefits of using a co-design design approach are: the end product reflects 
customer needs, it generates useful information and it creates a feeling of involvement 
and ownership (Bradwell & Marr 2008). Incorporating stakeholder participation in the 
co-designing of complex health intervention will: help explain the health care problem, 
identify appropriate interventions, ensure relevance and usefulness of the intervention 
and maximise the acceptability and potential effectiveness of the intervention (O'Brien 
et al. 2016). Therefore, the end results of co-design will be of value to all stakeholders 
involved but more specifically to the service users it is aimed at.   
2.5.4 Why use eHealth technology 
Due to the life-limiting effects of CF, the CF population tend to be younger; the median 
age of people with CF in UK is 20 years (Cystic Fibrosis Trust 2018a). CF is a complex 
multi-system disease requiring a significant amount of care every day. The chronic 
nature of CF requires frequent hospital appointments for reviews, with 36% of people 
with CF reported attending 10 or more hospital appointments in the previous 12 
months (Cystic Fibrosis Trust 2018b). However, the CF population is changing with 
more adults now working or studying. Currently 64.2% of the UK population who are 
16 years or older are in work or study (Cystic Fibrosis Trust 2018a). People with CF do 
not want to take more time off work or study than necessary to attend the hospital 
especially when it has been shown that an average outpatient appointment (including 
travel time) for people with CF is 4 hours 46 minutes (Cystic Fibrosis Trust 2018b). 




have CF to minimise the risk of cross-infection (UK Cystic Fibrosis Trust Standards of 
Care Working Group 2011, NICE 2017). Considering the age of the population and the 
demands on care and time the decision was made to develop this intervention using 
eHealth technology. This format can also provide a vehicle for peer support for a 
population that are prohibited face-to-face contact.   
eHealth is defined as “the use of information and communication technologies (ICT) 
for health” (WHO 2017). Mobile health (mHealth) is considered a component of 
eHealth but it specifically relates to use of mobile wireless technologies for public 
health (WHO 2016). Currently within the UK 96% of adults personally own or use a 
mobile phone, with 78% of adults using a smartphone (Ofcom 2018). As a nation, a 
significant number of the population therefore have the accessibility to receive 
eHealth and mHealth technologies. 
mHealth technology increases access to health information, skills and services as well 
as encouraging positive health behaviour changes (WHO 2016). However, research is 
limited into what processes and procedures are key to co-design mHealth intervention 
(Eyles et al. 2016). Key factors to facilitate success of mHealth intervention include: 
active engagement between healthcare professionals and patients and the 
incorporation of positive outcomes (Burford et al. 2015). Co-design is therefore vital 
for development of any mHealth technologies. 
A systematic review has shown that information technology-based interventions have 
been shown to have a positive effect upon glycaemic control and encourage diabetes 
self-management (Riazi et al. 2015). However, their impact on clinical outcomes such 
as diet, physical activity, blood pressure and lipid levels are more variable. A different 
systematic review of internet delivered DSME (Pereira et al. 2015) also demonstrated 
improvements in glycaemic control. It also found improvements in attendance at 
clinics but access to online DSME material diminished over time. On a positive note, 
patients easily adjusted to web-based delivery platforms and the use of asynchronous 
communication for information such as blood glucose diaries and medication changes 




healthcare providers and incorporating peer support within education programmes 
could help sustain patient interest and engagement in DSME activities and provide a 
means of social support from peers. This is therefore an important factor to consider in 
the development of a DSME programme with the role of a facilitator being paramount 
to help maintain this engagement. 
In a systematic review of CF self-management education, improvements in behaviours 
and knowledge seen were mostly short lived and not maintained over time (Savage et 
al. 2014). However, none of these interventions were internet based. A theory-based, 
flexible home learning programme has been shown to be an effective way of providing 
nutrition education and encouraging behaviour change in adults with CF (Watson et al. 
2008) but again this was not delivered via internet technology. The use of information 
technology in the management of patients with CF has focussed mainly on the use of 
telehealth. This is the use of technology by patients so that healthcare professionals 
can remotely monitor data on certain health parameters e.g. oxygen saturations, blood 
glucose levels (NHS 2013). In CF, telehealth has been used for monitoring symptoms, 
therapeutic interventions and reviewing adherence to prescribed treatments. 
However, these studies were mainly small feasibility trials (Cox et al. 2012). One case 
study of behavioural and nutritional treatment delivered to the family of a toddler via 
telehealth, demonstrated significant increase in energy intake and expected increase 
in weight and height velocity (Piazza-Waggoner et al. 2006). There is currently no 
evidence of self-management education programmes being delivered to people with 
CF through information technology. Although, digital communication, via Skype, has 
been used to deliver exercise sessions and clinical reviews to people with CF (Griffiths 
et al. 2018).  
2.6 Review of the MAGIC programme - stage 2b  
Modelling of complex interventions before conducting a full evaluation is 
recommended to establish any areas that need refinement or improvement (Craig et 
al. 2008). Designing the MAGIC programme using a stakeholder group will provide a 




The MAGIC programme will also be reviewed by people with CFD towards the end of 
its development for feedback regarding its face validity and ease of use. Further 
modelling will be required as part of the next stage of evaluation. This will be a study 
to determine feasibility of the of the MAGIC programme and to identify which patient 
reported and clinical outcomes are subject to change. 
This stage aims to: 
• assess if the MAGIC programme has face validity (i.e. is a practical, helpful, 
informative and user-friendly resource) for promoting self-
management education of CFD 
 
Face validity is a method of assessing, at face value, if a questionnaire, test or resource 
appears to measure what it claims to; it is assessed through subjective judgement 
(Keszei et al. 2010). Assessing face validity of the MAGIC programme will therefore 
determine its appropriateness for people with CFD. Face validity has been assessed 
through the use of scales (Maribo et al. 2016), questionnaires (Twohig et al. 2017), 
focus groups (Sturt et al. 2006b) and interviews (Banna et al. 2015). Face validity is 
determined by the use of scoring systems when using scales/ questionnaires (Maribo 
et al. 2016, Twohig et al. 2017) or by the application of participant feedback following 
participant interviews (Sturt et al. 2006b, Banna et al. 2015). As no questionnaires or 
appropriate scales are available to assess the face validity of a unique intervention like 
the MAGIC programme participants feedback will be used. Banna et al. (2016) 
reported face validity was achieved when all the recommendations from the study 
participants had been addressed. This approach will be adopted when assessing face 
validity of the MAGIC programme because it will ensure equality by addressing all 
participant feedback; this will be achievable with the planned participant number and 
allocated timeframe. 
The people with CFD recruited to review the MAGIC programme will be different 
individuals from those who participated in the MAGIC stakeholder development group 
meetings and qualitative interviews. This will uncover perceptions and values about 




will review the different modules of the MAGIC programme. Cognitive interviewing 
techniques will be used to focus on the content of the MAGIC programme modules 
and the cognitive processes involved in understanding and reacting to them. This 
method will therefore provide a more detailed account of the participants’ 
understanding which you would not obtain from quantitative methodology such as 
feedback questionnaires. 
Cognitive interviewing has been widely used in testing survey and questionnaire 
design, initially conducted after the initial design of the questionnaire and before 
piloting (Collins 2015). However its techniques have been applied in a variety of health 
research including: the appraisal of web-based applications (Berry et al. 2010), 
modifying education resources (Anderson et al. 2018), developing patient reported 
outcomes (Holch et al. 2016), and developing/ evaluating nutrition surveys (Carbone et 
al. 2002, Fernandes Davies et al. 2016). What these studies share are the significant 
focus upon comprehension which is a major theory in the cognitive process 
(Tourangeau et al. 2000). Methodologically there is slight variation in cognitive 
interview processes with some studies conducting rounds of interviews with different 
sets of participants and making revisions between each interview (Carbone et al. 2002, 
Holch et al. 2016, Anderson et al. 2018) whilst others just completed one interview 
with participants (Berry et al. 2010, Fernandes Davies et al. 2016). There appears to be 
no consensus when to use which interview approach, but careful consideration needs 
to be paid to the study aims, participant number, timeframes and size of the resource/ 
tool/ questionnaire being appraised. The precise format and content of the MAGIC 
programme will be informed by the stakeholder development group, therefore the 
decisions regarding the approach to interviews will be made once the programme is 
developed and ready for review.  
The background theory to cognitive processes consist of the following (Tourangeau et 
al. 2000):  




• Recall – participants search memory for necessary information to answer 
questions 
• Judgement – participants appraise questions and/or gauge response when 
deciding on an answer 
• Response – participants give information in answer to the question 
Cognitive interviewing techniques will therefore be used to: 
• Establish whether participants understand the content of the MAGIC 
programme 
• Explore if participants can follow information provided 
• Explore if participants are willing to act on information provided 
• Identify if any information is missing 
• Establish how easy or difficult it was for participants to use the MAGIC 
programme 
• Appraise the visual presentation of the website 
Therefore, a range of techniques will be used to review participants’ experiences of the 
MAGIC programme modules these include: exposure to test materials, observation, 
think aloud, task completion and probing  (D'Ardenne et al. 2015). 
2.7 Methodological conclusions 
This study aims to develop an evidence-based self-management education programme 
for people with CFD. This was informed by the MRC Framework for developing and 
evaluating complex interventions (Craig et al. 2008) along with Blackwood’s (2006) 
three key issues, which are fundamental building blocks in defining and evaluating 
complex interventions. Relevant research evidence and exploratory research will be 
used in stage one and 2a to develop theory to inform the MAGIC programme 
development. Appropriate research design has been used to inform each stage of the 
MAGIC programme development, with consideration also paid to alternative 
approaches. Although evaluation is beyond the scope of this study the use of self-
efficacy theory will provide a framework for relevant outcome measurement in future 




therefore be developed with a strong evidence-base, robust theoretical underpinnings 






3 Identifying the evidence base - Stage 1a- 
meta-ethnography 
3.1 Methods 
3.1.1 Research Design 
A qualitative evidence synthesis was chosen to answer the question “What are the 
experiences of adolescents and adults with CF in living with and managing CFD?”  
with the aims being:  
• To gain a greater understanding of how adolescents and adults with CF live with 
and manage CFD 
• To provide a framework to help structure the interview topic guide for the 
qualitative interviews in stage 1b 
This meta-ethnography was registered with PROSPERO International prospective 
register of systematic reviews (PROSPERO 2016:CRD42016048524). 
Conducting a meta-ethnography involves a series of seven stages that overlap and 
repeat as the synthesis continues (figure 11). This synthesis was undertaken using 
Noblit and Hare’s (1988) original meta-ethnography method with more recent 
considerations (Atkins et al. 2008, Toye et al. 2014). 
All members of the research team: SC, JS, SW and AJ contributed to the meta-
ethnography. SC led the meta-ethnography and conducted the systematic literature 
review, translation of studies and synthesis of translations. The other research team 
members contributed to the verification of identified studies and the review and 
exploration of identified concepts. These roles are acknowledged throughout this 
chapter with the individual’s initials. The key findings were also discussed with the 






Figure 11 Seven stages of Noblit and Hare's Meta-ethnography 
3.1.2 Stage 1: getting started 
Noblit and Hare, p27 (1988) describe this as “finding something that is worthy of the 
synthesis effort.” It also addresses if qualitative synthesis is appropriate, is there the 
need for the synthesis, what experiences the researchers have and what resources are 
available (Toye et al. 2014). 
This meta-ethnography was driven by experience of working, as a specialist dietitian, 
with adolescents and adults with CFD; particularly observed difficulties and challenges 




A qualitative evidence synthesis had not been carried out in this subject area, and was 
therefore deemed an appropriate subject choice for this meta-ethnography, which was 
conducted with support from a team of healthcare professionals experienced in 
qualitative analysis. 
3.1.3 Stage 2: deciding what is relevant to the initial interest 
This involved designing the scope of the search, deciding if an exhaustive literature 
search is required and then searching for, screening and quality appraising studies. 
There is a lack of consensus if an exhaustive search strategy is needed for meta-
ethnography, however enough data needs to be included so that identified concepts 
are robust (Toye et al. 2014). Guidelines to how many studies are enough are not 
available and it is therefore left up to researchers’ interpretations. 
From experience of working within this specialist area it was known that there was not 
a wide breadth of qualitative studies exploring the lives of people with CFD, therefore 
a more extensive systematic literature review was conducted to ensure all evidence 
was identified. 
3.1.3.1 Search Strategy 
The sampling involved a systematic literature search of Ovid Medline, CINAHL, EMBASE 
and PsychINFO, conference abstracts, unpublished thesis and hand searching of 
references in identified articles to obtain all relevant studies in this area. Databases 
were searched, by SC, for published journals from 1974 (date data first included in 
database) to 7th November 2018 (date search updated). 
The search strategies (appendices 2-5) aimed to find both published and unpublished 
studies within this topic area.  
1. The initial search was limited to the specialist database Ovid Medline, this is 
considered the most widely used database in qualitative evidence synthesis 
(Hannes & Macaitis 2012) and therefore deemed the most appropriate starting 




• Free text and subject heading search using keywords cystic fibrosis and 
diabetes.  
• The title and abstracts for relevant papers were screened to identify qualitative 
studies which addressed the research question “what are the experiences of 
adolescents and adults with CF in living with and managing CFD? “ 
• All title and abstracts were screened against the inclusion criteria (SC), this was 
double checked by JS and SW to ensure all relevant papers were included. 
• Where study titles, abstract or key word searches met the inclusion criteria the 
full text documents were obtained for further exploration. 
2. To increase sensitivity and specificity CINAHL, EMBASE and PsychINFO were also 
searched (SC). These databases contained nursing, allied health professional, 
health and psychological research papers, which may not have been included in 
Ovid Medline, thereby allowing access to a more extensive research field. A free 
text and subject heading search of title and abstracts using key words ‘cystic 
fibrosis ‘and ‘diabetes’ and ‘qualitative’ or ‘interview’ was conducted. Where study 
titles, abstract or key word searches met this criterion and possibly addressed the 
research question “what are the experiences of adolescents and adults with CF in 
living with and managing CFD?” the full text documents were obtained for further 
exploration. 
3. The reference list of all identified reports and articles were hand searched to 
identify any additional studies (SC). 
4. Conference abstracts proceedings published in Pediatric Pulmonology and The 
Journal of Cystic Fibrosis, from 2006-2018, were hand searched (SC). These journals 
publish abstracts from the annual European and North American CF conferences. 
This timeframe is sufficient to reflect current clinical practice and research. Where 
any abstracts were deemed relevant to this search the primary authors were 
contacted for additional information e.g. further publication of results, access to 




3.1.3.2 Inclusion and exclusion criteria 
Inclusion criteria: 
• Studies with a focus on adults and adolescents, with a mean age greater than 
13 years, who have CFD. Greater than 13 years was chosen as this is an age 
where children are likely to participate in qualitative interviews on their own 
and start to self-manage their condition 
• Qualitative studies concerning the experiences of adolescents or adults living 
with and managing CFD. This will include the home and hospital environment 
• Qualitative findings of mixed-method studies will be considered  
• Studies written in English, from any country  
Exclusion criteria: 
• Studies that focus on the experience of parents/ carers or healthcare 
professionals 
• Studies primarily using quantitative methods 
• Studies about type 1 or 2 diabetes 
• Studies not written in English 
In Microsoft Excel, a worksheet for the search strategy was created. In this all 
identified studies were recorded along with decisions regarding inclusion or exclusion. 
3.1.3.3 Quality appraisal 
Quality appraisal prior to meta-ethnography synthesis was not advocated (Noblit & 
Hare 1988). The use of quality appraisal tools in qualitative research synthesis is 
questioned, as these tools tend to address methodological flaws instead of conceptual 
strengths (Toye et al. 2014). There is however an increase in the use of quality 
appraisal tools in qualitative evidence synthesis (Hannes & Macaitis 2012) and 




modified CASP was chosen to appraise the methodological quality of the studies 
included in this meta-ethnography because of its accessibility, ease of use and previous 
use in similar meta-ethnographies (Campbell et al. 2003). 
One advantage of using a qualitative critical appraisal tool is that it encourages the 
systematic and structured reading of studies and therefore helps familiarisation with 
the data. However, what is needed for meta-ethnography is a tool that facilitates the 
identification of findings, concepts and interpretations (Campbell et al. 2011). Ensuring 
transparency by clearly reporting all processes in data collection and analysis is thus 
important to reflect the completeness of this methodology. 
3.1.4 Stage 3: Reading the studies 
There is a degree of overlap between stages 3-6, and the synthesis involved going back 
and forth between each stage, exploring ideas and looking for patterns across data 
sets that were applicable to the focus of this synthesis.  
Stage 3 entailed reading and re-reading the identified studies, in detail, to become 
familiar with the content and to start the process of establishing emerging concepts. It 
was important to consider what data should be extracted and how should it be done 
(Toye et al. 2014). Noblit and Hare (1988) use the terms metaphors/ concepts, phrases 
or ideas however, it can be hard to distinguish what is meant by these terms. It is 
suggested that concepts are more meaningful ideas, which have some analytical 
properties, whereas findings are more descriptive (Toye et al. 2014). The data that 
form the basis of the meta-ethnography are not those collected through interviews, 
but are the authors’ interpretations and explanations of these findings (Noblit & Hare 
1988). These authors’ interpretations therefore become the data for the synthesis 
(figure 12). These are recorded in either the authors’ own words, paraphrased or 
summarised. Through reading, re-reading and remaining focussed on the aim of the 
synthesis the concepts for each study began to emerge. In Microsoft Excel, a 
worksheet for each study was created, in this I recorded the concepts identified in 
each study and the authors’ interpretations that determined them. I also began to 






Data of meta-ethnography Author’s interpretations of 
participants’ experiences 
 
Synthesis of data Interpretation of author’s 
interpretations 
 
Figure 12 Terminology used in meta-ethnography 
 
Table 12 Example of synthesis of study data 
 
In meta-ethnography, there is more than one level of interpretation. Schutz’s (1962) 
notion of first, second and third order constructs have been adopted in the analysis 
process by some meta-ethnographers (Britten et al. 2002, Campbell et al. 2003, 
Malpass et al. 2009). Where, first order constructs represent the everyday 
understandings of ordinary people (patient views), second order constructs refer to 
the constructs of social science (the author’s views and interpretations) and third order 
constructs interpret findings beyond the original study (interpretations of synthesis 






The data of meta-ethnography are what Schutz refers to as second-order constructs 
(Toye et al. 2014). However, the difference between first and second order constructs 
is not always clear for example authors may use participants’ quotes as part of their 
interpretations. In the published studies authors, have selected the data they present 
and are more likely to choose participants’ quotes/ experiences as ‘good examples’ of 
their interpretations and this therefore is not a representation of the full data-set of 
participants. The use of author’s interpretations is thought to be more insightful as 
they propose an explanation of the observed phenomena (Atkins et al. 2008). Atkins 
(2008) suggests that all reported data are in fact the subject of author interpretations 
and therefore the usefulness of Schutz notions is unclear. Therefore, due to the lack of 
clarity with regards to the classification of orders of constructs and their benefit this 
meta-ethnography uses the authors’ interpretations as its data source. If the notion of 
Schutz constructs were applied to the terminology used in this thesis (figure 12) 
second order constructs would be the same as concepts and third order constructs the 
equivalent to themes. 
The concepts identified for each study were recorded alongside the authors’ 
interpretations that determined them. Views and interpretations that started to arise 
as part of the data analysis were also noted.  
3.1.5 Stage 4: Determining how the studies are related 
The relationships between these studies were explored to ascertain how they were 
related. Similarities within the studies included: participant characteristics because 
they were all adolescents or adults with CFD and the concepts identified within the 
studies e.g. CF is worse, CFD is intrusive, CFD is part of CF. Therefore reciprocal 
translation of each study into each of the other studies could be conducted (Noblit & 
Hare 1988). From this reciprocal translation, a line of argument was developed. 
3.1.6 Stage 5: Translating the studies into one another 
Through repeated reading of the studies, common and recurring concepts were 
identified. Noblit and Hare (1988) do not give clear guidelines how to conduct this, 




into chronological order and the concepts of paper one were compared with paper 
two. The synthesis of papers one and two was then compared with paper three, 
concepts from this synthesis were compared with paper four and so on until all the 
studies had been translated into each other. 
The synthesis may be influenced by the order in which the studies are compared 
(Atkins et al. 2008). Some authors suggest starting with a key paper by an expert 
within that field (Campbell et al. 2003). For this synthesis, such a paper or key author 
does not exist as the pool of studies was small. This synthesis was therefore carried out 
in chronological order as described by Atkins (2008). There were however only eight 
years between the publication dates of the studies therefore the impact of 
chronological order is likely to be insignificant. 
3.1.7 Stage 6: Synthesising translations 
The identified concepts were written on index cards and through the process of 
constant comparison between each concept they were placed into groups which had a 
common meaning (figure 13). Through interpretation, asking questions such as what 
does this mean? does this impact on another group or it meaningful on its own? what 
is the relationship? these groups were developed into themes to reflect these shared 
meanings (SC). 
 





The research team (SC, JS, SW, AJ) explored all the themes and the rationale behind 
them, and challenges to interpretations were reflected upon. Themes were reworked 
upon reflection (SC), reading and re-reading the studies until it was felt that they best 
represented all the identified concepts.  
These themes were then looked at holistically to develop a line of argument synthesis 
(SC, JS, SW, AJ). This is the development of an interpretation – the discovery of a whole 
amongst a set of parts (Noblit & Hare, 1988). It represented the overarching 
perspective of adolescents and adults in living with and managing CFD. A visual 
representation was then developed to reflect the line of argument synthesis. 
3.1.8 Stage 7: Expressing the synthesis 
This stage involves dissemination of the findings for maximal impact. The synthesis is 
presented in the results and discussion sections that follow. 
There are currently no reporting guidelines for meta-ethnography; these are currently 
being developed and will address methodological and reporting standards to maximise 
the quality of meta-ethnographical research and its contribution to health services and 
patient care (France et al. 2015). ENTREQ guidelines for improving transparency in 
qualitative evidence synthesis are available (Tong et al. 2012). However, these are 
generic and are not being widely used to inform meta-ethnography reporting as they 
are not designed for the distinct synthesis process of meta-ethnography (France et al. 
2015).  
3.1.9 Quality in qualitative evidence synthesis 
To address quality this meta-ethnography aims to demonstrate transparency in the 
reporting of its processes of data collection and analysis. Strengths and limitations of 
the study will also be explored and reflected upon. 
3.1.9.1 Reflexivity 
Given that this meta-ethnography is concerned with the synthesis and interpretation 
of qualitative research, it is important to be transparent about the researcher and their 




years of experience working with adults with CFD, I have a vast knowledge of what I 
believe CFD management involves. However I am mindful that I have only ever worked 
in one CF centre and that practices between CF centres and individual patients can 
vary. I will therefore remain open to new insights and experiences. Findings and 
interpretations will also be explored with the research team to ensure they are true 
reflections of the data. I am also the lead author of one of the identified studies but as 
meta-ethnography does not involve the re-analysis of raw data but the synthesis of 
author’s interpretations of participant’s experiences this was not regarded as a conflict 
of interest. 
3.2 Results 
3.2.1 Appraisal of included studies 
This meta-ethnography synthesised qualitative research studies concerning 
adolescents and adults with CF experiences of living with and managing CFD.   
A total of 1584 records were identified after duplicates were removed (figure 14). The 
title and abstracts for each record were screened by a single author to identify 
qualitative studies which addressed the research question “what are the experiences 
of adolescents and adults with CF in living with and managing CFD?” Full text articles 
were read if these criteria were met or there were uncertainties in methodology 





Figure 14 Flowchart of study selection process 
All six included studies were appraised using the modified CASP criteria (Campbell et 
al. 2003), this consisted of two pre-appraisal questions followed by 10 standard CASP 
questions which focussed on validity, results and clinical relevance (table 13). All 
identified studies met the pre-appraisal questions and were therefore further 
appraised according to CASP criteria. When appraising a study using CASP there is the 
option of yes, no or can’t tell answers. Table 13 demonstrates that most of the CASP 
criteria was met by the majority of included studies. No studies were excluded as a 
result of this critical appraisal. There is debate about whether including a poorer 




rich in data (Campbell et al. 2011). However, in this meta-ethnography no studies were 
excluded based on quality; they were excluded if they didn’t report qualitative findings 
and they had insufficient focus on CFD.  
Table 13 Modified CASP criteria 




Does the study report results from qualitative 
research and did it involve both qualitative 
methods of data analysis and collection? 
 
1,2,3,4,5,6   
Is this research applicable to the synthesis topic? 
 
1,2,3,4,5,6   




Was there a clear statement of the aims of the 
research? 
 
1,2,3,4,5,6   
Is a qualitative methodology appropriate? 1,2,3,4,5,6   
Was the research design appropriate to address 
the aims of the research? 
1,2,3,5,6  4 
Was the recruitment strategy appropriate to the 
aims of the research? 
1,2,3,4,5,6   
Was the data collected in a way that addressed 
the research issues? 
1,2,3,4,5,6   
Has a relationship between researcher and 
participants been adequately considered? 
1,3,6 4 2,5 
Have ethical issues been taken into 
consideration? 
1,2,3,4,5,6   
Was the data analysis sufficiently rigorous? 1,2,3,5,6  4 
Is there a clear statement of findings? 1,2,3,4,5,6   
How valuable is the research? 
Contribution of study to existing knowledge or 
understanding 
Identify new areas of research  
Translations of findings to other populations or 













Table 14 summarises the key characteristics of the six studies included in this meta-




analysis and participant details (age, gender and where available treatment of CFD). 
This meta-ethnography is a collective representation of 83 adolescents and adults with 
CFD from three different countries. The three earlier studies were conducted in the UK 
(Collins & Reynolds 2008, Tierney et al. 2008, Richmond 2012) with the remaining 
three being conducted in the USA or Canada (Dashiff et al. 2013, Millington et al. 2014, 
Sylvain et al. 2016). It is important to consider the setting of the studies as there are 
differences in healthcare provision between these three countries. All studies used 
qualitative methodology involving interviews as the source of data collection. In the 
mixed-methods studies (Dashiff et al. 2013, Millington et al. 2014) the quantitative 
results were excluded from the synthesis. Only data from adolescents or adults with 
CFD were included in the synthesis, accounts from parents (Millington et al. 2014) and 
those with normal glycaemia or impaired glucose tolerance (Sylvain et al. 2016) were 
excluded. This is because the focus of this study is on the experience of living with and 
managing CFD. It was not clear in some of the studies what treatment all the 
participants were receiving (Richmond 2012, Sylvain et al. 2016). However most of the 
treatments alluded to by the participants tended to focus on the use of insulin. Where 








Table 14 Summary of included studies 
Paper number 
Authors and year 
Country of 
study 
Aims Method Participants 
Paper 1 
 





UK To explore the views of people with 
CFD and type 1 diabetes on the 
diagnosis and management of diabetes 
Semi-structured interviews (face-
to-face or telephone) 
 
Framework analysis was used to 
analyse the data 
 
11 adults with CFD, mean age 30.4 years 
6 female 
all on insulin injections 
 
Did not include analysis from people with 












UK To examine the experiences of adults 






analysis (IPA) was used to analyse 
the data 
22 adults with CFD, mean age 34 years 
10 female 
20 on insulin injections 










UK To evaluate a structured dietary 





Framework analysis was used to 
analyse the data 

























USA To describe parents’ and older 
adolescents; experiences and 
perceptions of the diagnosis of CFD 
and its management. 
 
To describe parents; and adolescents’ 
perceptions of parental behaviour that 
supported self-management. 
Mixed methods- semi-structured 
interviews were used to capture 
participants’ perceptions  
 
Questionnaire to measure 
parental support and autonomy. 
 
Qualitative analysis as described 
by Sandelowski 
 
10 adolescents with CFD, mean age 16.6 
years 
3 female 
9 on insulin injections 
1 on insulin pump 
 
Only adolescents’ experiences and 
perceptions from the qualitative 












USA To examine the reactions of children 
and adolescents, their parents, and 
adults with CFD to CFD management 
and factors that facilitate or impede 
treatment adherence 
Mixed-methods- semi structured 
interviews (face-to-face or 
telephone) and CF quality of life 
questionnaire 
 
Phenomenological analysis used 
to analyse the interview data 
Ten children and adolescents (mean age 
14.6 years) with CFD, 3 female 
1 participant on insulin pump, 9 insulin 
injections 
 
10 adults with CFD (mean age 29.5 years), 
3 female 




Only accounts of adolescents and adults 
with CFD were included. 
Paper 6 
 






Canada To explore patients’ representations of 
CFD to better understand the 
discrepancy between patients’ 
expected and observed health 
behaviours 
 
Semi-structured face to face 
interviews 
 
Qualitative data methods (Miles, 
Huberman & Saldana, 2014)- 
thematisation was structured 
around Leventhal’s five 
dimensions of illness 
representation 




Only adults with CFD included (not those 
without dysglycaemia or those with IGT) 
 




3.2.2 Synthesis findings 
There is a degree of overlap between the processes of reading, deciding how the 
studies are related and translating one study into another, therefore these results are 
presented together. Table 15 highlights how concepts were initially identified in one of 
the studies through the processes of repeated reading. Throughout the process of 
translation, common and recurring concepts were identified in all the studies, these 
are summarised in table 16. These identified concepts were then synthesised into 





















Main themes from papers Summary of author’s interpretations Concepts 
Paper 1 
 











Conflicts occur between CF and diabetes management 
Considerations needs to be given to how people with CF 
view diabetes, some view it as part of CF. This may influence 
its management. 
Having CFD makes CF visible. 
There is a sense of trying to manage in 'normal CF life' 
CF life limiting  
CFD associated with a deterioration in health 
Having CF is seen as both a help and hindrance to CFD 
management 
Having diabetes can help and hinder CF management 
Is CFD part of CF? 
CF more important 
Living with CFD 
Learning to live a new normal 
CFD makes CF visible 
Try to live ‘normal’ life 
CF life limiting 
Health deterioration, progression of primary disease 
CF can help or hinder CFD management 
 













• Emotional response to 
diagnosis 
• Looking for an 
understanding 
• Learning to live with 
diabetes 
• Limiting the impact of the 
diagnosis 
 
initial feelings about diabetes shaped by experiences with 
CF 
Diabetes was a nuisance 
confront difficult feelings about CF, which may have seemed 
well-controlled & normal 
Conflicts occur between CF and diabetes management 
 
CFD perceived as an additional practical demand on their 
health-management strategies 
Apply CF coping strategies, lifestyle patterns & attitudes to 
the new challenge of managing diabetes 
lack energy associated with CF made it difficult for some to 
live with diabetes 
not as significant as living with CF 
Is CFD part of CF? 
 
CFD is a nuisance 
CFD makes CF visible 
 
How they see CFD influences how they manage, do 
you have to accept the diagnosis to manage well? 
Increase anxiety regarding CF 
Trying to manage in ‘normal CF life’ 
CFD requires additional more practical 
demands/attention 
Having CF helps/hinders CFD management 
 








Difficulty and uncertainties in balancing CFD particularly 
diet and blood glucose 
Diabetes coincided with serious worsening of CF in some 
provoking feelings of powerlessness and depression 
Knowledge and support are key to managing CFD- this is 
relevant to patients, healthcare professional and peers/ 
family. 
Control and balance 
 
Impact on health  
 
 











• Patient’s perspective on the 
impact of CFD 
o Coming to terms with the 
diagnosis 
o Living with the constancy 
of CFD 
• Patient’s perspectives on 
the management of CFD 
o Blood glucose monitoring 
o Administering insulin 
injections 
o Lifestyle considerations 
and flexible treatment 
regimes 
There is an individual variation to how participants see 
having CFD. 
Generally, found CFD much harder to deal with as they 
grew up living with CF 
Acceptance of CFD was seen to facilitate management 
Constancy of CFD felt by patients and increased treatment 
burden to be completed alongside CF treatment  
You can't hide from CFD, it also needs to forward plan. 
 
Lack of CFD control impacts on CF health. 
Knowledge is key to managing CFD. 
 
Individual view of CFD 
 
CFD is hard to deal with 
CF is the normal 
Acceptance of CFD will facilitate management 
 
CFD need continual attention- increases treatment 
burden  
CFD is always there 
 
Impact on CF health 
Knowledge is key 
Paper 4 
 







• Adolescents’ experiences 
and understanding of CFD 
• Adolescents’ perceptions 
of their self-management 
of CF and CFD  
• Adolescents’ perceptions 
of parental autonomy 
support 
Conflicts with other types of diabetes can help or hinder the 
management of CFD 
Having CFD increases the treatment burden and requires 
more practical demands 
Diabetes needs looking after but it can be difficult to deal 
with diabetes. 
CFD management becomes part of CF routine/adaptation. 
Having CFD can promotes CF care 
Parents help support adolescents with disease management 
tasks. 
Help or hindrance from other forms of diabetes 
 
Increase burden of treatment 
 
Need to look after CFD 
CFD difficult to deal with 
CFD becomes part of CF routine 
 
CFD promotes CF care 








Knowledge and ongoing support are key to managing CFD- 
this is relevant to patients, healthcare professionals and 
peers/ family  
 
 
Knowledge and ongoing support key for all involved 
Paper 5 
 








• Prior knowledge of 
diabetes 
• Reactions to CFD 
management 
• Barriers to CFD treatment 
adherence 
• Factors promoting CFD 
treatment adherence 
• Patient responsibility for 
CFD management   
• Role of the healthcare 
team 
Screening for CFD helps increase the awareness of the 
possibility of developing CFD. 
Having CFD increases the treatment burden and requires 
more practical demands and attention  
the addition of CFD management is a risk factor for 
compromised adherence to both regimens 
Management of CFD needs to be part of routine CF care. 
Having CFD makes CF visible. 
CF more important than CFD 
Having CF is seen as both a help and a hindrance CFD 
management. 
the diagnosis of CFD signifies a major disruption to their 
'normal life' 
Present CFD represents a significant disruption 
Lack of CFD control impacts on CF health. 
CFD management needs to become part of CF 
routine/adaptation. 
Parents help support adolescents with disease management 
tasks 
Diabetes needs looking after but it can be difficult to deal 
with and impact on daily life. 
Knowledge and support from healthcare professionals are 
key to managing CFD-  
 
Screening increases awareness CFD 
 
Increase burden of treatment 
Living with CFD increases treatment burden  
Additional treatments compromise adherence 
 
CFD becomes part of CF routine 
 
CFD makes CF visible 
CF more important 
CF can help or hinder CFD management 
 
CFD disturbs life 
Learning to live a new ‘normal’ life 
 
Controlling CFD affects health 
Part of routine CF care 
 
Parental help (adolescents)  
 
Influence of CFD on CF health 
 










CF more important than CFD as CF is a life-limiting disease. 
However, there is acknowledgement that diabetic 
complications can occur. 
patients tended to view CFD as a permanent problem 
CF is life-limiting 
CF more important 
Diabetic complications can occur 
CFD permanent 














Quality of life is important - need to strike a balance with 
doing treatment and quality of life. Patients choose to 
selectively non-adhere on occasions. 
The rigorous treatment of diabetes coming second 
CFD is not thought of as being the same as other forms of 
diabetes. 
There is a close link between CF and CFD but conflict if CFD 
is part of CF. 
Influence on CFD management from those close to the 
patients, such as family, friends and work colleagues., 
Knowledge of healthcare professionals was essential to 
patients, they reported a lack of knowledge and a conflict in 
knowledge about CFD amongst cares and families 
CFD representation is intertwined within the experience of 
living with CF. 
Selective non-adherence 
 
Treatment CFD not always important 
CFD different from other diabetes 
 
CFD is a distinct disease 
CFD is part of CF 
 
Influences outside the care system 
 
Knowledge is key 
Lack knowledge carers/ families 
Conflicts in knowledge 
























Table 18 Identified themes 
Theme 
A need to develop a perspective on CFD 
Struggling with identity 
A representation of morbidity and mortality 
In control or being controlled 
Need for knowledge and support 
 
Five themes emerged from synthesising translations. These are: a need to develop a 
perspective on CFD, struggling with identity, a representation of morbidity and 
mortality, in control or being controlled and need for knowledge and support (table 
18). These themes acknowledge the core experiences that influenced the management 
of CFD, with the central phenomena concerning how to achieve a sense of balance 
between CF and CFD. With the exception of Dashiff et al. (2013), which did not have 
concepts relating to the theme struggling with identity, all papers had concepts 
relating to all the identified themes (table 19). A detailed description of each of these 
themes are presented below.   
Table 19 Occurrence of themes 
























A need to develop a 
perspective on CFD 
√ √ √ √ √ √ 
Struggling with 
identity 
√ √ √   √ √ 
A representation of 
morbidity & mortality 
√ √ √ √ √ √ 
In control or being 
controlled 
√ √ √ √ √ √ 
Need for knowledge & 
support 






For the ease of reading in the following section the papers will be referred to by 
numbers (as identified in table 19 rather than authors). 
3.2.2.1 A need to develop a perspective on CFD 
How CF is viewed and managed influences individual’s thoughts and feelings about 
CFD (2). CFD needs to be managed in a world of competing treatment demands and 
pressures associated with managing CF, with most seeing CF as more important to 
them (1,2, 5, 6). 
If I didn’t have cystic fibrosis and I was just diabetic, and I didn’t feel so shitty all 
the time, then I probably could do it, but because I find my CF sort of takes over, 
and that makes me feel ill and there’s stuff I can’t do and I can’t cook my 
dinners and…I want to just lie in bed and feel like I’m dying. Then my diabetes, 
you know, just kind of takes a second…thing. (2) 
it’s been a pain with the insulin and stuff…but the CF’s worse than the diabetes. 
(3) 
There were conflicts in perceptions as to whether CFD was part of CF or a distinct 
entity. Despite some recognising the close link between CF and CFD they sometimes 
considered it a distinct disease treated separately by a different doctor and additional 
treatments (1, 6). The representations of CFD were described as intertwined with the 
experience of living with CF (6). For others it is difficult to separate the two conditions 
which both directly impact upon each other. 
I just kind of treat it purely as a weight thing rather than a separate disease. (1) 
As long as I see diabetes as a secondary disease, I can’t put the two together 
and compare them like that. It’s like they’re two different things even though 
they go with the same health problem’. (6) 
Being diagnosed with CFD provoked mixed emotions and was more significant for 
some. Many reported negative feelings at the time of diagnosis (2-5), which included 
descriptions such as 'shocking,' 'bad,' 'hard,' 'terrible,' 'depressing' and 'agitating ‘(4). 
One study found that CFD was generally regarded as much harder to deal with in terms 
of control, acceptance and impact on daily life and it took time “to come to terms with 
it” (3). Conversely having CFD was also seen as easy and “not a big thing” (4). A relief at 





explanation of recent symptoms (2, 4). Routine annual CFD screening highlighted the 
possibility of being diagnosed with CFD and helped acceptance when diagnosed (5). 
The experience of having CF helped people come to terms with the diagnosis and 
management of CFD by applying existing lifestyle patterns, routines, coping 
mechanisms and strategies (2, 5) and through being accustomed to living with a 
chronic illness (1). There are lots of uncertainties from living with an unpredictable 
long-term condition like CF (6). One of the biggest uncertainties experienced in 
managing CFD were with regards to managing diet and CFD, where potential or 
recommended dietary changes were seen as distressing for some (5) and no changes 
were met with a sense of relief (1). Difficulties were seen in balancing diet and 
controlling blood glucose (2). Dietary differences were also the main dissimilarities 
highlighted between CFD being different to type 1 or type 2 diabetes (1,5,6). 
If I didn’t have CF and weight wasn’t such an issue, the sugar side of the 
diabetes wouldn’t be so bad because I’d, I could just eat a healthy diet and not 
worry too much about…trying to eat a lot of food with the CF side of things and 
trying to keep my sugars balanced as well. You know, it’s very difficult to do 
both. (2) 
 
3.2.2.2 Struggling with identity 
CFD did not "fade into the background" in the same way that CF did; its treatments 
could not be ‘hidden’ the same way as CF treatments (3), people had to deal with 
managing their health in public (5), for example checking blood glucose levels or 
administering insulin injections (3, 5). Therefore, for many the development of CFD 
made CF visible. This disrupted ‘normal’ identity, interfered with lifestyle (5) and 
brought feelings about CF to the foreground (2). However, managing CFD did not 
define their life and they tried to live life as ‘normally’ as they could despite having CFD 
(1). 
Cus like most of my treatment for that (CF) as well can be done at home behind 
closed doors and everything else but with that (CFD), you don’t, or many times 
you don’t have a choice but to do it out and about and even in today’s day and 
age, people have got issues with it. Even work colleagues and everything else 





issue with it, I’ll just leave it or whatever but I’ve come to the conclusion now if 
they’ve got an issue with it, that’s their problem. (3) 
 
I saw it as something that would hamper my lifestyle. Something that would, 
you know, interfere… for the most part until then I just had to worry about 
taking some enzymes maybe an antibiotic. During the day it didn’t really impact 
me…other than a few little things here or there I was living ‘a normal life.’ So, 
that was kind of a major hurdle major for me. (5) 
 
3.2.2.3 A representation of morbidity & mortality  
A lack of glycaemic control had negative impact on weight, lung function and overall 
health (1, 3, 5, 6). When unwell with CF-related illnesses, such as respiratory 
exacerbations, it was more difficult and challenging to control blood glucose levels due 
to the increased demands made upon self-management (1, 5), lack of energy (2) and 
the increase in and impact of some CF treatments, noticeably corticosteroids (5). For 
some the development of diabetes marked the point when their CF health started to 
deteriorate, or they worried their health was going to deteriorate (1, 2).  
It was something that you didn’t want to accept because it’s an acceptance of 
the disease progressing … I had to wrestle with the fact that it was a 
progression of the CF. (1) 
 
As my health dropped, as it did at that point because my sugars were so high, I 
suddenly became prone to infection…I was in Hospital X for about 4 weeks. I 
was really quite poorly, I was really quite fed up, so there was only two times in 
my life I’d ever say I was clinically depressed…I think that was one of the times. 
(2) 
 
The CF, it does what it wants to do really. So you just have to deal with it rather 
than prevent it. With the insulin, you’re avoiding a problem; with the CF you’ve 
got to deal with a problem once it’s happened … especially as I’m getting older. 
You do what you can but things happen. (1) 
 
In terms of the overall impact on health CF was regarded as worse because it was 
considered life-limiting (1, 2, 5). Although the impact of the development of CFD on 
morbidity and mortality were acknowledged (5), the possibility of diabetes related 
complications was not of great concern for health (1, 6) with the likelihood of 





I know about the long-term consequences, blindness, the circulatory problems, 
the kidney disease, bla bla bla. I have to say that my viewpoint is … if the 
diabetes ever gets to the stage where it causes me those sort of problems I’ll be 
dead chuffed because I’ll still be here. I won’t be happy that I’m suffering them, 
but I suspect the CF will get me first. (1)  
I couldn’t let my diabetes go any more just because the repercussions are long 
term. So now if I don’t inject my insulin this evening, say, my glucose is going to 
go up, which could be dangerous long term … While if I take my treatment [for 
cystic fibrosis] this evening, I know I’m going to feel the effects right away. (6)  
 
 
3.2.2.4 In control or being controlled 
The development of CFD was associated with an increase in burden of treatment and 
monitoring (1-3, 5) which impacted upon all aspects of daily life (2, 3, 5). Diabetes had 
to be managed in a world which was already full of treatment demands and pressures 
(1). The addition of ‘one more thing’ to be completed alongside complex CF treatments 
was frustrating (2, 3). This compromised adherence to both CF and CFD regimens 
which influenced control in terms of CFD management, but also feelings of being in 
control (5). Incorporating CFD management into daily CF regimens (1, 5) and 
experience drawn from managing CF and its associated treatments helped achieve 
control of CFD and a sense of balance of disease management (4). 
Some people let it affect their whole life, whereas it doesn’t need to. You 
shouldn’t let it rule your life. You should try and fit your life in with it. (1) 
 
Again I thought it was, oh another thing I’ve got to deal with, but at the time 
that was when…my CF was quite under control and it was just like, right I can 
deal with another thing, that’s fine…and I just coped with it…and, yeah, I got 
positive about it. Although it was an extra hassle, I could deal with it. (2) 
 
‘I don’t like it [insulin] but in the end it’s really a very simple solution to control 
something that’s really hard to control’. (6) 
 
CFD required more continual attention than CF, particularly monitoring blood glucose 
levels, administering insulin and making decisions about food (1, 4); its management 
required more forward planning (3). The constant attention of CFD management 
required treatments to be conducted outside the home. Monitoring blood glucose 





embarrassment when giving insulin or monitoring blood glucose levels in public was 
experienced (3, 5). Remembering, lack of time, poor knowledge and pain were reasons 
for not monitoring blood glucose levels (1, 3, 5). Preserving quality of life was 
important and in order to maintain this CF treatments were often prioritised (1, 6).  
You can’t just go out and do what you want, when you want, you’ve got to think 
hard and plan it a bit better. It’s inconvenient. (1) 
 
Even though all my glucose testing stuff is on my desk, in plain sight, it’s like my 
brain doesn’t see it in the same way it does my bottle of enzyme pills’. (6) 
 
So all the blood, erm checking my blood sugars and everything else, it’s pretty 
much constant all the day and then if I’m doing sport when it comes to having 
my meals or whatever, I have to take into account like last week I had my tea 
and then I was going playing football so I had to balance it out with the insulin 
and everything else so if I’m being honest I’d probably say it has more of an 
effect than the CF. (3) 
 
 
3.2.2.5 Need for knowledge and support 
People with CF lacked knowledge and understanding about CFD (2-6); this was 
primarily related to what caused CFD and how to manage it. Many people with CF 
were not aware CFD was a potential complication of their CF (1-3, 5). There was also a 
lack of knowledge and clarity about CFD amongst friends, families and some 
healthcare professionals, such as general practitioners (1, 2). This was particularly 
related to dietary advice (2, 3, 5, 6). Where CFD was not understood by others a sense 
of despondency was expressed (1). Segregation, to minimise the risk of cross infection 
between individuals with CF, prevented face-to-face support from others with CFD (1, 
3). 
He’s (GP) very up to date on the diabetic side but not in relation to CF so I spoke 
to him about it and he said … ‘I don’t understand how it relates to the CF’, so I 
had to kind of go into that with him a little bit because he understood CF 
separately. He just wasn’t aware of them together. (1) 
 
Most people received advice about CFD from their CF teams or specialist CFD services 
(3, 5, 6). There were difficulties into trying to access information regarding CFD in the 





address concerns specific to CFD, such as weight or lung function (1). Healthcare 
professionals need to ensure that people with CFD feel well supported and informed 
about this condition (1-3), due to its association with poor health outcomes. 
Healthcare professionals need to be aware that although these patients are 
experienced at managing CF it does not necessarily promote confidence to manage 
CFD (2,3). CFD management needs to be comprehensive, integrated into routine care, 
and adaptable to consider changes in health status (1, 2, 4-6).  
3.2.3 Line of argument synthesis 
Themes were considered holistically and developed into a line of argument synthesis. 
This is the development of an interpretation – the discovery of a whole amongst a set 
of parts (Noblit & Hare 1988). What emerged as important from this synthesis is how 
people perceive their CFD in the context of their CF. This synthesis demonstrates that 
people with CFD are struggling to put perspective on CFD and this influences how they 
view and manage the condition; is it viewed as part of CF or a separate entity? There 
was a difficulty in balancing the two conditions. The development of CFD challenged 
identity and how individuals saw themselves with illness where CFD brought illness 
into the foreground by making illness visible. Negative impact on health was observed 
but CF was regarded as more significant with difficulty balancing both treatment 
regimens. Knowledge deficits contributed to uncertainties in managing CFD with more 
support required. These are very negative findings that lead to poor disease 
management choices. New perspectives on CFD management are therefore needed. 
The aim of synthesis of qualitative research is to achieve a level of understanding 
beyond that attained in the individual studies. This synthesis supports a line of 
argument that recommends for CFD management to be effective CFD needs to be 
considered and managed as part of CF. To conceptually represent this an integrated 
model of CFD management was developed (figure 15). This illustrates the complex 
nature of issues involved in balancing the management of CFD and CF. This model 
suggests CFD should be viewed and managed as part of CF. When considered as one 
condition CFD is managed as part of routine CF care; all treatments, therapies and self-





together; what affects CFD will directly impact CF and vice versa. Incorporation of CFD 
as part of routine CF care resulted in better control and sense of balancing treatments 
and management. Regarding CFD as part of CF will help integrate identity and facilitate 
how individuals view CF. The emphasis needs to be placed upon CFD being a common 
complication of CF. Therefore, healthcare teams need to start thinking differently to 
facilitate this and develop services geared to help and support individuals to develop 
effective self-care strategies and integration of CFD management into routine CF care. 
 
Figure 15 Line of argument synthesis: striking the balance between CF and CFD  
 
3.3 Discussion 
This meta-ethnography provides a greater understanding of how adolescents and 
adults with CF live with and experience CFD. It demonstrates that living with CF and 
CFD is a complex multi-dimensional process where the two conditions are closely 
intertwined. It identifies the key issue in responding to CFD is how CFD is viewed - is it 
part of CF or a separate entity? This directly impacts management because everything 
that is done to treat CF directly affects CFD and vice-versa. Living with CF and drawing 





acceptance and management of CFD. Incorporating CFD management into CF 
regiments helped achieve a sense of control of CFD. An integrated model has been 
developed, it recommends CFD should be regarded as part of CF; it is a natural 
progression of CF that is seen with ageing. Due to the close links between nutritional 
status, lung function and diabetic control, managing CF and CFD as one condition will 
ultimately influence survival. It is not just about just treating the blood glucose levels, 
but a balancing act. CF care therefore needs be individualised and constantly evolving 
to meet these changes in clinical status. 
The concepts which emerged from this study are similar to those seen in other 
qualitative evidence syntheses concerned with the experiences of managing multi-
morbid conditions (Liddy et al. 2014, White et al. 2016, Cheng et al. 2018). These 
included maintaining a normal life, keeping a positive mental attitude, adapting to 
change, hierarchical ordering between chronic diseases and coping in a social context 
(Cheng et al. 2018). In this study, CF was often seen as the most important illness 
because it is life-limiting but having CFD further impacts survival (Lewis et al. 2015). 
This is not unique to the management of CF and CFD as people often have to prioritise 
conditions or personal values to manage multi-morbid conditions (Liddy et al. 2014, 
White et al. 2016, Cheng et al. 2018). Trying to retain a positive mental attitude and 
developing skills and coping mechanisms so individuals can adapt to change are 
important factors in trying to maintain a ‘normal life’ when managing multi-morbid 
conditions (Liddy et al. 2014, Cheng et al. 2018). Despite the differences in signs, 
symptoms and effects of different multi-morbid conditions the experiences of people 
with these conditions are comparable.  
Some people with multi-morbid conditions reported being overwhelmed at times but 
many more appeared to be resilient and determined to persevere despite challenges 
(Liddy et al. 2014). In the CFD populations within this study there was not a sense of 
being overwhelmed, CFD was seen as more of an inconvenience and nuisance. It led to 
disruptions in daily life. It challenged identity by bringing illness into the foreground 
because treatment needed to be conducted outside the home and could no longer be 





with healthcare systems can help the management of subsequent illness (White et al. 
2016). The majority of people with CF have attended hospital and clinics from a very 
early age. Through this they have developed knowledge of their condition, experience 
of managing complex treatment regimens and become familiar with healthcare 
systems. This would have facilitated the adjustment needed to accommodate CFD into 
their lives, with more successful management seen when CFD was managed as part of 
CF and incorporated into pre-existing routines.  
Only one systematic review into the experiences of living with CF has been conducted; 
this involves children rather than adults (Jamieson et al. 2014). However, there are 
similarities in the experiences observed which include: gaining resilience (regaining 
control, redefining normality), lifestyle restrictions, resentment of chronic treatment, 
temporal limitations (taking risks, valuing time), emotional vulnerability and transplant 
expectations and uncertainty (confirmation of disease severity). Children with CF 
become adults. What informs their self-identity experiences and beliefs will be with 
them for life, and are therefore important foundations of who they are and what CF 
means to them. 
3.3.1 Strengths and limitations 
This meta-ethnography demonstrates that there is very limited qualitative research 
exploring the experiences, particularly with regards to feelings and emotions, that 
adolescents and adults encounter in living with and managing CFD. However, it 
increases the evidence base and enhances the strength of its findings (Doyle 2003) by 
including unpublished work (a research thesis) which was previously only available as 
an abstract for the 2012 European CF Conference (Richmond 2012). This qualitative 
research increases knowledge of patients’ experiences of CFD and this will contribute 
to identifying changes needed in patient care. 
Meta-ethnography brings together studies to create a new interpretation (Noblit & 
Hare 1988). However, the interpretative nature of meta-ethnography recognises that 
there is variability in interpretations between researchers due to differences in 





and experience therefore influenced my interpretation of the findings. The wider long-
term condition perspectives of other members of the research team contributed to 
exploration and challenges in making interpretations. Challenging personal 
interpretations are vital to ensure rigor in qualitative research (Toye et al. 2014). 
Therefore, the use of more than one reviewer within this study contributed to 
increasing rigor. The key findings were discussed with the study project management 
group, which consisted of lay and professional representation and this therefore 
contributed to enhancing the credibility of the findings within this part of the study. 
The author of this meta-ethnography was the first author of one of the included 
papers (Collins & Reynolds 2008). Meta-ethnography does not involve the re-analysis 
of data; it uses the author’s interpretations of their data (concepts) as its data. The 
concepts from Collins and Reynolds (2008) were not treated any differently from those 
of the other included studies, therefore only the published work within that paper was 
subject to analysis. Other meta-ethnography studies have been published where one 
of the authors contributed to a paper within the synthesis, without this being 
acknowledged (Britten et al. 2002, Pound et al. 2005, Hughes & Noblit 2017). Being 
open about this and the acknowledgement of treating all concepts equally contributed 
to transparency within this study. 
Quality appraisal has received criticism in meta-ethnography (Atkins et al. 2008, Toye 
et al. 2013, Toye et al. 2014). This study asked two screening questions, prior to quality 
appraisal, these were: does the study report results from qualitative research and did 
it involve both qualitative methods of data collection and analysis? and is this research 
applicable to the synthesis topic (Pound et al. 2005). These questions were more 
helpful than CASP screening, which was time consuming. If these two criteria were not 
met, the studies were excluded. CASP focussed on methodological flaws in qualitative 
research and none of the included studies had major methodological flaws. Using CASP 
therefore didn’t contribute any more than just using the two screening questions. The 
two mixed-methods studies included less supportive qualitative data, but still added to 
the experiences (Dashiff et al. 2013, Millington et al. 2014). Each study therefore 





Meta-ethnography reporting guidelines were published on 15th January 2019 (France 
et al. 2019) this was after this meta-ethnography was completed. The guidelines 
consist of 19 reporting criteria. Each of these reporting criteria have been 
subsequently compared in relation to this study (appendix 6). All of these reporting 
criteria were met within the study, the criteria concerning how the studies were 
related to each other (number 11) was brief and could have benefitted from a bit more 
detail. 
3.3.2 Implications for practice and further research 
In agreement with recommendations from the majority of studies that formed this 
meta-ethnography, CFD management needs to be comprehensive, integrated into 
routine care, and adaptable to consider changes in health status (Collins & Reynolds 
2008, Tierney et al. 2008, Dashiff et al. 2013, Millington et al. 2014, Sylvain et al. 2016). 
CFD should be regarded as a natural progression of CF, these two conditions are so 
closely intertwined. Normalising CFD management as part of routine CF care will help 
achieve a sense of balance because all treatments, therapies and self-care strategies 
are integral to each other.  
As discussed in chapter one, this meta-ethnography was the driving force to reconsider 
the name cystic fibrosis related diabetes. On reflection of the findings it was felt that 
the term ‘related’ does not infer a direct causal relationship but more of an 
association. The name cystic fibrosis diabetes, which is in line with type 1 diabetes or 
type 2 diabetes, is considered a more appropriate term and was adopted as a 
preferential term in this thesis. Adopting the name CFD in clinical practice would 
encourage people with CFD and their healthcare professionals to see the condition as a 
combined entity, as per figure 15, and influence approaches to care and management.  
Adjustments to the new health status needs to be recognised following new diagnosis 
and identity need to be considered by healthcare professionals as illness perception 
can change. People with CFD need help preparing for how treatment is managed 
outside the home to reduce feelings of self-consciousness about the visibility of 





care, from healthcare professionals as a continual part of their care. This should 
include assessing for difficulties in adapting to diabetes at diagnosis and changes in 
health perceptions that may occur due to fluctuations in clinical status.  
CFD is the most common co-morbidity affecting people with CF, however despite 
earlier screening and treatment survival in people with CFD remains reduced. Further 
research is needed to explore CFD self-management experiences and requirements, 
and to how to best deliver appropriate support and education to these people. This 
research should adopt a qualitive approach to obtain detailed accounts which will 
reflect individual experiences and the diversity seen in CF populations. Findings from 
this meta-ethnography which need further investigation include: exploring the 
thoughts and feelings that people with CFD hold about the perceived relationship 
between CF and CFD; reviewing self-management behaviours - this should include 
looking into barriers, facilitators and successors of CFD self-management; identifying 
what individuals require to manage their CFD on a day to day basis - this should 
consider support mechanisms, resources and knowledge. This research will help 
improve CFD management and knowledge and optimise glycaemic control as a 
significant contributory factor to survival (Adler et al. 2011). 
3.4 Conclusions 
Striking the balance between CF and CFD highlights that individual perception of CFD 
directly affects its management. The close link between nutritional status, lung 
function and glycaemia is a fundamental part of management and directly influences 
survival. CF and CFD are intertwined; there is a direct relationship between them. CFD 
therefore should be regarded as part of CF and education, psychosocial support and 
management should be tailored around this, as part of routine care, rather than 
separating out CFD management. Education should not just focus on people with CFD 
but must also include healthcare professionals and families/carers. Further research is 
needed to explore self-management support experiences and requirements. It is also 





fibrosis diabetes which acknowledges that diabetes is not associated with but caused 
by CF.  
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4 What are the self-management experiences 
of people with cystic fibrosis diabetes? 
4.1 Methods 
4.1.1 Research design 
A qualitative single occasion interview design, guided by the principles of IPA (Smith et 
al. 2009) was used to answer the question “what are the self-management experiences 
of people with CFD?” IPA is concerned with understanding and exploring the lived 
experience of a particular phenomenon; specifically, the meaning people attach to 
their experience (Smith 2004). The theoretical underpinnings of IPA (as discussed in 
chapter two) are idiography (individual perspective), phenomenology (person’s direct 
experience) and hermeneutics (interpretation) (Smith et al. 1999, Smith 2004, Smith et 
al. 2009). 
With the aims being:   
• To confirm the findings from the meta-ethnography prospectively and to 
identify any additional concepts  
• To establish what are the barriers, facilitators and successes that people with 
CF experience in managing their CFD 
• To identify knowledge and skills people with CFD require and use for self-
management of CFD and how they might be incorporated into a programme   
• To help identify content for a CFD self-management education programme 
All members of the research team: SC, JS, SW and AJ contributed to the IPA study. SC 
led the IPA study by collecting and analysing the data. Five of the transcripts were 
independently reviewed by members of the research team (transcript 1- JS, SW, 
transcript 3- SW, JS, AJ, transcript 5 – SW, AJ, transcript 6 – SW, JS and transcript 7 -AJ) 
to explore and validate identified themes and ensure reliability. These roles are 
acknowledged throughout this chapter with the individual’s initials. The key findings 
were also discussed with the study project management group, which consisted of lay 





4.1.2 Research setting 
All participants received their care at a Regional Adult CF centre. All interviews took 
place in a private room within the research facility at this CF centre.  
4.1.3 Participants 
Participants were recruited from the CF centre’s patient database. IPA works with 
homogenous samples therefore, the participants were purposely sampled to meet the 
inclusion criteria of having CFD, being over 16 years of age and taking insulin (table 20).  
Table 20 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
• CFD -treated by insulin 
• >16 years old 
• Treated by oral hypoglycaemic agents (OHA) alone 
(currently <2% of centre’s CFD adults take OHA) 
• Inability to participate in an interview due to 
instability or severity of underlying cystic fibrosis 
lung disease 
• Unable to understand/read English 
 
Forty-four letters were sent out, to people identified as meeting the inclusion criteria, 
inviting them to take part in the study. Eight people responded to the letters and 
agreed to participate in this study. The remaining 36 people did not respond. All 
participants were known to the researcher in a clinical capacity, therefore so as not to 
coerce people into participating, follow up contact was not made. Letters of invitation 
were sent out in stages until the recommended number of participants were recruited. 
The idiographic nature of IPA leads to the recommendation of a smaller sample size; 
the main concern of IPA is with the detailed account of individual experiences. 
Guidelines for what constitutes a reasonable size for when using IPA have been 
suggested as three to six participants at undergraduate or master’s level and between 
four to ten for professional doctorates, however sample size is contextual and should 
be considered on a study-by-study basis (Smith et al. 2009). In his review evaluating 





more than eight participants (Smith 2011). However there is no correct answer to what 
the sample size should be (Smith et al. 2009). There is the need for each individual 
perspective to understand how the phenomenon is experienced but cross-case 
analysis is needed (unless it is a case study) to be able to move closer to the core of the 
phenomenon. Practical considerations such as time frames, the research question and 
participant availability also need to be considered. Eight people with CFD were 
interviewed between July and October 2017, this is a typical sample size seen in IPA 
research (Smith 2011). Participants received a £20 ‘thankyou’ voucher for taking part 
in the study, and if required travel expenses were reimbursed. 
4.1.4 Ethical considerations 
Prior to commencing the study approval was received from: London-South East 
Research Ethics committee- 17/LO/0377 (appendix 7), NHS Health Research Authority 
(appendix 8) and Royal Brompton and Harefield NHS Foundation Trust (appendix 9). 
Informed written consent, including agreement for digital audio-recording, was 
obtained prior to starting the interviews. A copy of the participant’s consent form was 
stored in their electronic patient record. A private transcription service was used for 
transcription. To ensure confidentiality all recorded interviews were uploaded via an 
encrypted server to the transcription company. A confidentiality agreement was 
agreed with the transcription agency (appendix 10). All names, places and other 
identifiable details were then removed from the transcripts prior to analysis.  
4.1.5 Data collection 
Semi-structured interviews were used; the interview topic guide focussed on the 
experience of living with and self-managing CFD. Existing literature (Collins & Reynolds 
2008, Segal 2008, George et al. 2010, Withers 2012, Dashiff et al. 2013, Millington et 
al. 2014, Wilkinson et al. 2014) and the findings from stage 1a (chapter three) provided 
key themes and prompts for the interview topic guide which focussed on: living with 
CF, the diagnosis of CFD, managing CFD, the impact of CFD and self-management (see 
appendix 11). From existing literature key areas concerning self-management in people 
with CF and diabetes were considered when constructing the interview topic guide. 





in older adolescents and adults with CF (George et al. 2010) such as the influence of 
work and social demands and the role of CF clinic were considered an important part 
in informing CF self-management decisions. In adults with type 1 and type 2 diabetes 
key factors influencing the ability to self-manage included five key areas namely: 
communication, education, personal factors (beliefs, physical, practical, psychological), 
provider issues and support (Wilkinson et al. 2014). Studies by Collins & Reynolds 
(2008) and Millington et al. (2014), although included in the meta-ethnography, 
provided additional information to inform the interview topics guide and its prompts 
as their papers included examples of their interview questions used within their 
studies. Questions and prompts in the interview topic guide were designed to reflect 
the five keys themes identified in the meta-ethnography: a need to develop a 
perspective on CFD, struggling with identity, a representation of morbidity and 
mortality, in control or being controlled and need for knowledge and support 
(appendix 12). 
The interview questions were open-ended and designed to be used as prompts, this 
gave the interview schedule greater flexibility. Participants were encouraged to tell 
their experiences in their own words; the questions were intended to facilitate this 
process of gathering rich, in-depth data rather than narrowing it to predetermined 
categories. Interviews were digitally recorded and transcribed verbatim. 
4.1.6 Data analysis 
Interview transcripts were analysed using the process of IPA, which consists of several 
stages. These stages are summarised in table 21 (Smith et al. 2009). Examples of the 
data analysis process are given in appendices 13-18. The process of data analysis is 
systematic, but it is designed to be flexible and not prescriptive. Researchers need to 
become close to the data with the aim of trying to step into the participant’s shoes as 
far as possible (Pietkiewicz & Smith 2014). It is therefore important to ensure that the 
participant is the focus of analysis as the process of entering their world begins. 
Exploratory coding has three main areas of interpretation: descriptive, linguistic and 
conceptual (Smith et al. 2009). Focus should be on that particular moment, staying 





used and what does the data actually mean. These three steps of exploratory coding 
are unique to IPA. Table 22 highlights the focus and practical application of exploratory 
coding. Data analysis consists of word-for-word, line-by-line review. The focus of data 
analysis is to remain on the sense-making experience from the individual to the shared 
and from description to interpretation (Smith et al. 2009).  
Table 21 Stages of IPA 
Step  Process Example 
Step 1 Reading and re-reading Familiarise and stay close to the 
data 
 
Step 2 Initial noting Word-for-word, line-by-line review 




Step 3 Developing emergent 
themes 
Aim to map interrelationships, 
patterns and connections between 
explanatory notes 
Transform initial notes into more 
specific themes and phrases 
Appendix 
14 
Step 4 Searching for 
connections across 
emergent themes 
Establish connections between 
themes 






Step 5 Moving to the next 
case 
Move to the next transcript 
Repeat the process 
 
Step 6 Looking for patterns 
across cases 
Compare and contrast clusters 
across participants 




Step 7 Development of super-
ordinate themes 
Clusters may be merged together to 









Table 22 Focus and practical application of exploratory coding 
Exploratory 
coding 









describing the content of what is 
said 
 




engaging more at an 
interrogative and conceptual 
level 
Subject of talk within transcript 
What jumps out at you? 
 
Look for unusual, imaginative or 
quirky words or phrases 
Use of metaphors 
 
What does the data actually 
mean? 
Challenge and question 
underlying meaning 
 
First, ensuring an idiographic approach, each transcript was analysed individually 
before moving onto the next (SC). Each transcript was read multiple times making 
descriptive, linguistic and conceptual notes in the right-hand margin of the transcript 
(appendix 13). Once this was completed for the whole transcript, I returned to the 
beginning of transcript and began to develop the exploratory comments into a set of 
emergent themes that highlighted key features of experience developed from the 
participant’s account. A Microsoft Excel workbook was created, to assist with data 
analysis, for each participant. In this, emergent themes were recorded with illustrative 
quotes from the participant to ensure that they reflected the participant’s meaning 
(appendix 14). The emergent themes were then merged together to reflect their 
shared meanings (appendix 15). This was carried out by visually exploring all the 
emergent themes which were recorded in the Microsoft Excel workbook. These 
themes were then further clustered together and given a label which reflected the 
shared meaning or the wider concept of the theme (appendix 16). The next case was 
then moved onto and the process repeated. Once all the transcripts had been 
individually analysed a process of cross-case analysis was undertaken. Table of themes 
for each participant were compared, with close attention paid to instances of 
divergence and convergence (appendix 17). The themes were grouped, according to 





superordinate themes which focussed on a central concept (appendix 18). Data 
analysis continued throughout the process of writing up, where closeness to the data 
remained.  
4.1.7 Quality in qualitative research 
Yardley’s work (2000) has been recommended to provide a framework to evaluate and 
demonstrate the quality of IPA research (Smith et al. 2009, Hefferon & Gil-Rodriguez 
2011). It provides a flexible approach, with many opportunities, to assist IPA 
researchers to demonstrate quality in their work  (Smith et al. 2009). The four key 
dimensions for quality in qualitative research namely: sensitivity to context; 
commitment and rigour; transparency and coherence; and impact and importance 
were considered throughout this study (Yardley 2000). Sensitivity to context was 
demonstrated through the analysis by giving participants a voice through verbatim 
quotes; this also allows the reader to trace back the interpretations. Commitment to 
rigour was demonstrated through the detailed commitment to the idiographic and in-
depth nature of IPA, by following guidelines for representing the identified themes in 
an appropriate number of participants (Smith 2011) and by involving more than the 
researcher in the data analysis process. I conducted the primary data analysis, and the 
supervisory team (JS, SW, AJ) reviewed five transcripts to explore emergent themes 
and interpretations at the end of each individual case and on completion of cross case 
analysis. Interpretations and emerging themes were challenged to ensure the analysis 
was thorough and grounded within the data. Each step of the research process is 
clearly outlined in the data analysis section to aid transparency.  
4.1.7.1 Reflexivity 
In IPA it is important to consider how the researcher’s experience, role and knowledge 
influenced data collection, analysis and interpretation. I acknowledge that my 
experiences of working with people with CFD for over 20 years has informed the 
research process and may have influenced how I have collected and analysed the data. 
I also knew some of the participants in the study reasonably well, and had my own 
understanding of them, their life and disease management. Throughout the interviews 





asking prompts rather than being guided by my assumptions or prior knowledge. As 
IPA involves double hermeneutics whereby the researcher interprets the participant’s 
interpretations of their experience it is important that the researcher is aware of prior 
assumptions and knowledge that might influence their interpretations. A reflective 
journal was kept throughout the research process in order to raise my awareness of 
any difficulties I encountered during data collection and analysis and to acknowledge 
any pre-conceived thoughts or feelings that challenged me. This awareness helped me 
to be more open-minded and less judgemental. I was able to personally reflect upon 
any difficulties encountered and how they impacted upon me. Where I felt that I 
needed further assistance I sought help through supervision or from peer support at a 
regional IPA group.   
My role and how participants within this study would have previously known me is an 
important consideration. I was a clinician who was part of the CF team delivering 
clinical care to these individuals, but for the purpose of this study I am a researcher. It 
was important to remain mindful that some participants may struggle with this. This 
could lead them to withhold information as they may be concerned about the impact 
of what they say upon their clinical care or they may respond in more favourable ways. 




Eight adults (4 female), aged between 22-48 years (median 31.5 years), participated in 
the interviews. Seven were on basal-bolus insulin regimens and one was just on basal 
insulin. Participants HbA1c ranged from 5.3-10%/ 35-86mmol/mol (median 7.6%/ 59.5 
mmol/mol); BMI ranged from 17.7-23.9 kg/m2 (median 21.6kg/m2) and lung function 
(FEV1) ranged from 33-81% (median 50.5%). The interviews for six of the participants 
coincided with visits to the hospital for clinic appointments. The other two participants 
chose to attend for interviews at a different time convenient to them. The interviews 
lasted between 49 and 82 minutes (median 57 minutes). All participant’s names 





The findings are presented as superordinate themes, subordinate themes and 
participants’ quotes. The superordinate and subordinate themes identified from the 
data analysis are listed in table 23. 
Table 23 Superordinate and subordinate themes 
Superordinate theme Subordinate theme 
Forming a relationship with CFD CFD- impact, constancy and exposure 
The conflicts, complexities and unpredictability 
of CF and CFD 
Facing morbidity 
 
Balancing the CFD self-
management triad 
Insulin- understanding and uncertainty 
Blood glucose monitoring – comprehension, 
confusion and compromises 
Managing nutrition- the challenges and 
frustrations 
 
The unmet need for information 
and support 
The need to feel informed, skilled and 
supported 
Creating systems to deliver information and 
support 
 
4.2.1 Forming a relationship with CFD 
This superordinate theme explored the relationship that participants developed with 
their CFD from diagnosis through to incorporation into daily life. 
4.2.1.1 CFD- impact, constancy and exposure  
The diagnosis of CFD was met with many emotions and feeling, most of which were 
initially challenging to deal with, but diminished with time.  
Erm well you’re not delighted, obviously.  I mean you’d be pretty upset, pretty 
upset that you’d gotta do it.  But then, as I say, I think because I was so unwell it 
was – and then between that and the overnight feeding you saw a gradual 
improvement and you could see it made sense to do it. (Tom) 
Erm, at the time, I think I, I was a bit upset with it but I think I’ve been like that 
kind of every time you get a new diagnosis.  You know, I’m upset for about a 






For Paul it wasn’t the diabetes itself that was “hard” for him it was the development of 
“something else to keep an eye on and something else takes concern,” that “extra 
thing to think about.” 
The significance of diabetes became more apparent and significant with the realisation 
that it was not going to go away especially for some, as it was a sign that their health 
was starting to decline. 
Erm, so at the time, it was like, ‘Okay’.  I hadn’t understood really what that 
meant.  Erm, to me, it was just – Oh, just another treatment but actually, it was 
– you have diabetes. It’s not going to change. It’s not reversible and not only 
that, you need to take insulin forever. (Brian) 
I mean it’s an indication that your body is... it’s sort of chipping away or like 
there’s a deterioration that erm, is, is causing permanent – this is, you know, 
now permanent and erm... and that’s – you know, that, that idea that you’re on 
a downward slope, rather than up and down is er, is quite heavy. (Ben) 
Having a pre-existing routine to manage CF helped with the management of CFD by 
incorporating the treatments together; this lessened the impact of CFD. 
so I’ll go and eat, when I’m sitting down for a meal making sure that I can have 
my insulin beside my creon pot because I always go for the creon pot because I 
need to have that so there’s the insulin beside it which makes sense.  Er, keep 
things together, trying to build patterns and routines as much as possible. (Paul) 
on a day-to-day level, it’s just kind of – it’s almost automatic.  You know, it’s just 
like taking those tablets in the morning.  I just get up and do it and you just get 
on with your day kind of thing.  You just kind of – you go into just automatic 
robot.  You don’t even notice what you’re doing really. (Ana) 
“Just got on with it,” “just took it in my stride” and “adjust to new normal” are 
examples of positive attitudes and coping strategies which aided the participants 
ability to manage the addition of CFD.  
For Mary, CFD was more in control of her than she was of it. Despite her engaging with 
trying to identify her problems with blood glucose management she showed feelings 
of despondency and frustration. There was a sense that Mary felt alone and was trying 
to manage this on her own. Reminders of the damaging effects of CFD further added 





Because I just can’t get to grips. You know, you, your, erm, sugar levels even 
when I think that I’m trying my best just don’t seem to work out.  You know, I, I 
had, er, an implant thing on my arm once for three days, I think Dr XXX done 
that.  I wrote down everything I ate, this, that and the other and they were still 
coming out high and I just think, ‘Where, where am I going wrong?  What am I 
doing wrong?’  And it’s, it’s running my life because I can’t get it 
under control.  And then the doctors say it’s like a vicious circle.  Sugar in 
your blood, then the bugs eat off your blood and then you get chest infection 
and it’s like a vicious circle so yeah, that’s how I feel it controls. 
The constancy and invasiveness of CFD had a significant impact upon life and was a 
barrier to successful management. Ana described the analogy of having CFD as “it’s 
like a pet in a way,” she related this to something that also needed constant 
monitoring and feeding regularly to “keep it happy.” Planning and constant attention 
around the management of CFD in daily life were seen as an inconvenience and 
annoying.  
The injection and it – I think it’s the invasiveness of the treatments; so the 
invasiveness of doing all the BMS erm, and then they’re minor, they’re minor 
compared to other things but actually, erm, having to inject and do things like 
that, I just, I just find it irritating [laughter]. (Brian) 
Erm, it can, can be a bit of a pain because […] I have to plan and organise, you 
know, my meals, what I’m going to have, erm, what snacks I can, I need to think 
ahead constantly.  I’m already doing that with my CF and I have to do that 
again for my diabetes. (Karen) 
Difficulties coping with the constancy of CFD were not just observed in the initial 
period of learning to live with CFD. Brian has had CFD for more than 20 years and the 
constancy required to manage CFD was still problematic for him. He demonstrated 
honesty by confessing he wasn’t managing his CFD. A fact that he appeared to be 
hiding behind.  
..but in my heart, I’d know I’m not really managing it but actually, I am, I am, I 






For Mary, who found CFD management exceptionally challenging, the presence of CFD 
disrupted her life. She was angry and frustrated. The constancy of CFD management 
for her wasn’t the doing but the thinking about what the not doing meant. Mary was 
insightful that her CFD needed more consideration, but she described no actions 
indicating that she was responding to this insight. 
My CF was in a routine.  My diabetes makes my life not in a routine because it’s 
constantly there.  It’s ‘cause you’re constant, even though I don’t do it I’m, I 
constant, I do think about it and everything and the repercussions and 
everything but it’s something that I think needs to be more looked after than 
what my CF is, do you know what I mean? (Mary) 
Many treatments for the management of CF are conducted privately at home; these 
therefore do not attract the attention from others. Unlike treatments required for CFD 
such as injecting insulin and the monitoring of blood glucose levels which are very 
visible to others. This visibility generated a sense of unease and an awareness of 
consideration needed towards other people. 
it’s very inconvenient to be checking all the time you know when you’re out and 
about and you have to get your finger pricker out and yeah it’s you can’t really 
do it well I don’t feel comfortable doing it in front of strangers erm you know it’s 
the same with insulin if you’re out and about some people will just do it in front 
of people I’m much less comfortable doing that I’d rather take myself off to a 
loo or something private and if that’s not accessible then I will wait until I can 
get to a place where I can do it privately which isn’t great because that’s when 
erm if I’ve eaten then I have to wait before I do my insulin and stuff like that. 
(Jane) 
I find it really difficult doing injections, er, when out with other people.  Erm, it’s 
finding – finding the space to do it, finding the right sort of appropriateness. 
(Paul) 
Brian displayed a sense of shame and stupidity that he could not possibly admit after 
many years with CFD that he needed some support for him be able to manage his CFD. 
I suppose the other bit – and this is going to sound really weird – you know, I’m 
– but I’ve had it [CFD] for over half my life – longer and I sort of feel it would 
be a bit strange, for all intents and purposes, for me to admit that I need a bit of 





pressing reset.  It, it sounds weird.[…]  In my mind, I’m thinking, ‘You kind 
of can’t – you can’t do that. Don’t, don’t be stupid’ erm, but yeah, be-, being 
honest, that’s...  
Mary described CFD as being a “pain in the arse and brain damage.” She was being 
displayed as a failure as she could not control or cope with CFD. However, on a positive 
note, following psychological support Mary experienced a huge sense of relief and 
realisation she was not the only person with CFD to feel this way. 
Because it does my head in.  It really does do my head in.  Yeah.  I’ve seen a 
psychologist twice in here about it […].  Erm, I said to her, ‘I feel like it controls 
me’, and, and do you know what she said, you know, which really helped.  She 
went, ‘You’re not the only person that feels like that’, and I honestly thought I 
was.  And I do, and I did, that’s the truth.  I thought I was on my own.  I, I was 
the only one that couldn’t cope but she said, ‘No, you’re not’.  She said, ‘Other 
people, you know, are out there as well’, she said, ‘And they’re, they’re not 
dealing with it’, which made me feel a bit better because I, I did, you know, it’s 
the only thing that I struggle with. 
4.2.1.2 The conflicts, complexities and unpredictability of CF and CFD 
One of the major challenges in the management of CFD was how the relationship 
between CF and CFD was viewed and managed, however this was not straightforward. 
There was a hierarchical comparison between CF and CFD: the impression that CF was 
developed first, was more significant and the effects of not doing treatment for this 
were more serious and instantaneous when compared to that of CFD. CF impacted 
more on “physical” health than CFD, this would likely be due to the associated effects 
of CF on respiratory function. 
I suppose when it comes to kind of the, the crude way of looking at it, it’s 
the consequences of me not doing something for my – for the CF side of things 
are more immediate than the diabetes side.  I know it’s the wrong way but it’s 
just how I can sort of rationalise maybe some of my wrong choices. (Brian) 
[…] if I skip NovoRapid with a meal, I won’t, I won’t feel it. I mean if I were to 
get up and leave the house without taking m-, my Salbutamol, or Seretide, or 
DNase, or... or nebulised antibiotic, I’d probably – I’d feel significantly worse. 
(Ben) 
Oh my god. It’s nothing’ [laughter].  It’s [CFD] nothing in the grand scheme of 





There was ambiguity in some participants if CFD was part of CF or something different, 
with links between the two conditions mainly concerning medical treatment and 
dietary management. 
[…] I see them linked and interacting, erm, because of, particularly because of 
medical, medicine interactions, erm, and dietary. (Paul) 
I probably see it as being part of my CF.  But I use this ‘probably’ to justify 
getting away with eating stuff I shouldn’t because it doesn’t feel like proper 
diabetes in inverted commas. (Tom) 
Mary and Brian, who have tended to regard their CFD as a separate condition 
experienced more issues with trying to achieve a sense of control and balance. 
Well because they are separate.  One’s CF, one’s diabetes, isn’t it?  And I can see 
that, the thing between the two of them like I said with that vicious cycle but 
they are two different things, aren’t they. Yeah. (Mary) 
Brian’s separation for the management of his CFD goes beyond just managing it. It was 
part of his partial acceptance as he believed CFD was “something that’s been done” to 
him as he developed it related to steroid therapy. He says “I’ve kind of boxed diabetes 
off as a separate entity and I’ve, and I’ve always kind of treated as a, as a – to punish it, 
in my mind.” However, Brian did reflect that his strategy to management was not the 
best and his advice to others would be to treat them as one condition. 
‘It’s part of CF and this is how you’re – how to manage it in conjunction with the 
CF. Don’t do what I did and treat them as two separate entities. Sort of entwine 
them as one (which I suppose they are) erm, and have a treatment plan and a 
regime that complements both’. (Brian) 
 
How the CFD service was delivered further impacted upon CFD management. The 
centres specialist CFD clinic was held on a different day to general CF clinics, with CFD 
specialists, thus by dividing up the service healthcare professionals are influencing how 
people with CFD construct their understanding of it. The provision of service in this 





It does feel like it’s separate.  And I don’t know as well if – it might be different if 
you saw someone in a CF clinic for CF related diabetes at the same time.  So 
psychologically you’re going to a different clinic and that sort of in your mind 
separates it as well. (Tom) 
 So, if I was having an issue with the diabetes yeah okay that needs fixing but 
again its straight back onto the chest so I think erm its almost that even in clinic 
the two are separated very much. (Jane) 
Participants demonstrated knowledge that there was a relationship between high 
blood glucose and respiratory pathogens. The direct link between high blood glucose 
and the harmful consequences it has on CF respiratory symptoms was a significant 
factor in promoting management. 
the only thing that directly affects me is the, well the side effects of the high 
sugars onto the chest. (Karen) 
I do accept that when my blood sugars are, are, you know, continually high that 
when I’ve got bugs in my chest, they thrive off the glucose and high blood 
sugars.  So that’s always in the back of my mind to try and stay on top of. 
(Brian) 
 I can see what the doctors are saying.  I see the vicious cycle of the sugar in 
your blood, then the bugs feed off your blood where the sugar is and then you 
get obviously the bacteria and the phlegm in your chest, which can cause a 
chest in, I can, I can see that.  In paper and in my mind, I can see that cycle. 
(Mary) 
Living with CF was viewed as being “unpredictable.” This contributed to difficulties in 
managing CFD. CF directly impacted the management of CFD and changes in 
treatments or respiratory symptoms contributed to the unpredictability and warranted 
more attention; that was something else participants reported they needed to think 
about.  
suppose yeah, I mean day-to-day, it’s, it’s – tends to be – I’m pretty routine 
about it but if – I suppose yeah, if, if I’m feeling worse or I’ve had a change in 
medication, then it’s a fear that that – that’s about – it’s adding – that my high 
blood sugars are adding to my poor situation; that that, that I’ll check it more to 
make – just make sure that that’s under control and that’s not an a-, - an 
additional factor. (Ben) 
I think it, erm, I think maybe once when I had an infection it was a bit less, well 





sugar was low even though I was eating loads and insulin, like doing my 
normal dose of insulin.  Erm, so I think it [CF] can sometimes make my sugars 
slightly sporadic and unpredictable but that’s more when I’m having IVs I think. 
(Karen) 
That’s what I find quite difficult is that it can be quite erratic the erm yeah to if I 
can eat, if I eat the same things, do the same things, have very similar days, my 
insulin requirements can be quite different and I’ve always put that down to 
maybe something different is happening with my chest and that’s causing you 
know slightly different, different readings so that’s why it can be quite difficult 
to keep on top of as well erm because it isn’t just as straight forward as have 
the same doses all the time so yeah. (Jane) 
The complexities of trying to manage CFD was highlighted by Jane. She had identified a 
relationship between CF and CFD by suggesting “the worse my chest is the worse my 
diabetes is and the worse my diabetes is the worse my chest is” but she acknowledged 
“trying to keep them both under control is incredibly difficult.” However, Jane 
recognised this relationship did not always exist, there was an element of 
unpredictability and therefore multiple layers of complexity that were not always easy 
to understand. 
the two are very much directly related and just because just if my CF is good 
doesn’t mean that my CF is, if my chest is good doesn’t mean my diabetes will 
be good though if that makes sense? And if my diabetes is good it doesn’t mean 
my CF will be good it might just be easier to manage but I can have one bad and 
one good. Does that make any sense? (Jane)  
Participants who received steroid treatments as part of their CF management 
experienced elevations in their blood glucose levels that proved very challenging and 
aggravating. A new sense of loss of control was seen, accompanied by a sense of 
looking for a new understanding.  
it’s taking that prednisolone it’s whacked up to 40mg and you just see your 
blood sugars shoot through the roof. Erm, and yeah I think the first time I 
remember seeing that particularly at the time I was taking 10/12 units of 
NovoRapid with a meal time and over that inpatient stay that was more than 
doubled just to try to get on top of my blood sugars. (Paul) 
steroids you know you’re doing that’s actually something beneficial for your CF 





that’s always difficult to then especially with a constantly changing dose of 
steroids to keep on top of that yeah as well as all the other things so. (Jane) 
Erm, I just – yeah, it was – the sugar just seemed uncontrollable erm, and... 
yeah, I just didn’t really know – th-, that – I think, I think part of the reason I 
found it difficult was because I had come from such a stable erm, diabetic 
control and this was kind of catapulted in – into a complete rollercoaster, you 
know, and I was getting extreme highs of like, you know, 18-20 erm, and it was 
– you know, I was on really high steroids. (Ana) 
I’ve been on a high dose of steroids and had like a nasty chest infection as well 
and it’s – there just doesn’t seem to be enough insulin that you can put in your 
body to – for it to get down to. (Ben) 
There was a sense that healthcare professions had not prepared participants for the 
consequences of steroid treatment or provided sufficient support and reassurance 
during the course of treatment. Participants experienced fear and uncertainty over 
what to do. There were both emotional and physical barriers to increasing insulin 
doses, which created a real fear of the unknown which for some could be drastic. 
for me, in a way erm, I was almost psychologically afraid to give that much 
insulin to myself because I was like, ‘I’m definitely going to low. That’s going to 
kill me. I’m going to go low and go unconscious.’ (Ana) 
Paul was trying to balance a conflict between being told by the team “not to worry 
about” the sugars as they were “just going to deal with the chest because the sugars 
will sort themselves out [...]” This response challenged Paul and he didn’t want to be 
defeated as he was aware of the “long term implications” of high blood glucose. The 
experience was like a battle to Paul, with opposing sides and significant consequences. 
Brian had an extremely negative relationship with the use of steroids. He resents 
steroids and blames them for causing his diabetes, a problem that he has never felt 
that he has fully come to terms with because he felt it was inflicted upon him during 
his adolescence.  
in my mind, I had a chest infection, what I was being given to help with the 
chest infection, as a side effect, has caused me to become diabetic and that’s a 
real struggle.  I was very angry about that – very angry for quite some time that 





4.2.1.3 Facing mortality 
Thoughts for the future were predominated with CF rather than CFD. Participants were 
very aware of the limiting effects CF will have upon their lives. For this reason, CF 
management was often prioritised over CFD.  
I know that I’m going to die from CF and not from diabetes [laughs]. (Mary) 
No, ‘cause the lungs will kill me first [laughs] so if I’m honest. (Karen) 
CF is the more here and now erm, and that, for me, is what’s going to, in my 
mind, trip me up first. (Brian) 
Participants were aware that they were at risk of diabetes related complications, 
especially eye damage but they didn’t ruminate on these, they just put their thoughts 
concerning this in the background. 
the idea of my eyesight deteriorating as a result of that is quite a concern to 
me.  I ha-, - I mean, luckily er, so far, they’ve told me that it hasn’t affected my 
eyesight at all but like the i-, - the idea that it would is – as well as it affecting 
my chest is something that I don’t want – I don’t, I don’t want to have. (Ben) 
I’m aware of, you know, the possibilities with – when you inject and when – in 
terms of your blood sugar levels and the tedious effect it can have on your sight 
and whatnot.  But erm – so yeah you’re obviously aware of that. (Brian) 
when you go and get the annual eye test sort of okay, how are things, is this 
realistic you know that, er, I’m going to end up losing part of my sight, is that 
something that’s conscious but it’s something that you know you get looked at 
every year but you just sort of know that that’s there. (Paul) 
4.2.2 Balancing the CFD self-management triad 
Blood glucose, insulin and nutrition were identified as the most influential components 
in the self-management of CFD. There was a complex interaction between balancing 
blood glucose, insulin and nutrition; each component was related to, and directly 
influenced by, each other.  
4.2.2.1 Insulin – understanding and uncertainty 
The use of insulin posed many self-management questions, with how much insulin is 
needed being the most daunting. There was a sense of uncertainty, loss and 





because of lack of understanding, a reflection of the complexity of CFD or a 
combination of both. 
Mary displayed feelings of loss and bewilderment concerning how to manage her 
insulin. She showed a lack of understanding about how her background insulin worked 
and this contributed to poor adherence with it because she didn’t “see any benefit in it 
because it’s, ‘cause it’s long, long lasting.” She had limited comprehension about her 
insulin dosing and this contributed to her not managing her blood glucose levels 
effectively. She also demonstrated a lack of insight into the associated risks of not 
controlling her blood glucose to avoid hypos.  
I don’t know [laughs].  I don’t know.  I just think, ‘Right’.  I don’t know honestly, 
****.  I just used to make it up as I go along, yeah, and that’s, that’s the honest 
truth and I’d rather take too little than too much because of a hypo. (Mary)  
Paul and Ana learnt how to manage their CFD through more experiential learning, 
reflecting the fact that CFD was changeable and tricky to manage. CFD management 
required individuals to be more self-directed and pragmatic. 
I think my experience of diabetes is like there’s actually no way of prescribing 
for it in a way.  Erm, you know, there’s – you can’t actually just say, ‘Right, this 
is your dose and take this and it will be fine’.  It’s not like, you know, with your 
antibiotics and it’s one gram twice a day, or whatever, you know, or ‘Take this 
three times a day’.  There’s no, there’s no way of prescribing insulin.  I think 
erm, that is purely – like I said, you know, you could eat the same food on a 
different day and you could need totally different insulin requirements.  So that 
learning was all just getting used to myself and how I erm, kind digest those 
carbs and stuff like that and just then learning how to add in insulin into that. 
(Ana)  
Erm, that’s always an intriguing one, slightly frustrating, er, because there are 
times when you just don’t, I’ve felt I just can’t quite get a grip on it or a handle 
on it enough and you think well why, am I doing something wrong, what am I 
missing.  Erm, but then there are other times when you think well and you 
realise that perhaps actually you should have had a bit more insulin with that 
particular food and you correct it and then the next time you eat that particular 
food and test your blood sugars afterwards, you’ve cracked it, your blood 
sugars don’t rise as high. (Paul)  
There was recognition that insulin should be taken before food, although this was not 





hunger and not wanting to inject in front of others. Some undesirable consequences of 
taking insulin at incorrect times were observed, these included the direct impact on 
respiratory symptoms and blood glucose levels.  
Sometimes I’m forgetful and, you know, I’ll have my insulin at the end of a 
meal, that seems to be quite, erm, common recently, erm, and I do, you know, 
as a result I will be quite tight chested for however long and then my insulin will 
kick in. (Karen) 
if you’re out and about some people will just do it in front of people I’m much 
less comfortable doing that I’d rather take myself off to a loo or something 
private and if that’s not accessible then I will wait until I can get to a place 
where I can do it privately which isn’t great because that’s when erm if I’ve 
eaten then I have to wait before I do my insulin and stuff like that. (Jane) 
Ben understood that he should take his insulin before he ate so his insulin “should be 
kicking in as the food is being digested.” A reason he attributed to not taking his insulin 
was the minor inconvenience of having to go and get it from “his bag,” he felt silly 
saying it, but stated “my food’s right in front of me and it’s hot and I’m hungry.” 
Another influencing factor on Ben’s adherence was that Ben saw “no real immediate ill 
effects” of not taking his insulin, suggesting he would not “feel rubbish” if he doesn’t 
take it. However, Ben was insightful that “the long terms effect will be bad.” 
Demonstrating that having the knowledge and understanding doesn’t always result in 
doing.  
4.2.2.2 Blood glucose monitoring- comprehension, confusion and 
compromises 
Ana felt that despite being a “big thing” blood glucose testing was essential to 
understanding blood glucose and “yourself.” Blood glucose levels were checked to 
inform treatment decisions regarding insulin dosing and as part of the experiential 
learning process to try to gain an understanding of what was happening to blood 
glucose levels.  
So I take my er, blood sugar readings when I – just before I take the NovoRapid, 
just to gauge how much I should be taking. (Ben)  
doing lots of testing, I think, is quite key because, you know, like... even if I’m – 
you know, if I’m about to have a sugary snack, I would absolutely test 





start off with being, you know, five or if you start off being 7.5; that will be – 
you know, maybe a unit in the difference of how much NovoRapid I’d take erm. 
(Ana)  
Participants demonstrated a lack of clarity when and how often blood glucose levels 
should be checked. There was a lot of guilt and downbeat association surrounding 
blood glucose monitoring with self-judgement about their own expectations common; 
this included: “I know I could do better,” “not good at,” “not great with,” “I know I 
should be doing,” and “very guilty of.” 
In the management of CFD there is more of a focus on post-prandial BG because most 
people with CFD lose their post-prandial response first. These were the blood glucose 
readings that were much more difficult and trickier for participants to perform.  
I’m not very good at, erm, taking my sugars after.  I always do it before I’ve 
eaten.  Two hours after, erm, I might have gone out and left it indoors.  I don’t 
necessarily take my kit everywhere with me, you know, so I’m not very good at 
the post blood things, do you know what I mean? (Mary)  
it’s fairly quick, it’s fairly easy to do.  I think the difficult ones to remember are 
the two hours after a meal, erm, remembering to do it pre-meal was easy, dead 
straightforward because you’ve got to sit down and think … (Paul) 
..I know I could do better erm I do check my blood probably about four times a 
day but I know I would do better if I was doing it more particularly after meals, 
I’m good at doing it before meals but not so good at doing it after meals. Erm 
and that’s probably, possibly why I do yoyo because I don’t know what’s 
happening after I’ve eaten whether it’s been too much or too little or whatever.  
(Jane) 
Checking blood glucose levels was an intrusive and visible part of diabetes 
management; it was the one element of care which was compromised the most. 
Selective adherence formed a part of CFD management with choices being made 
regarding if and when to check blood glucose levels. With CF treatment often being 
prioritised over blood glucose monitoring. 
like when I do remember I will do it but it’s the one thing I feel like I can, erm, be 
ever so slightly more relaxed on because I’ve got such a hectic schedule.  I do 
need, like, I do need to, erm, you know, have a little bit of flexibility and that’s 





For Brian the “pressures at home or work” interfered with his blood glucose 
monitoring and he suggested when things get busy “doing my BMs- it’s almost like the 
first thing that drops off the radar.” 
Karen’s argument for not checking her blood glucose levels very often was because she 
felt “very instinctive” in sensing what her blood glucose were.  
Like I’m, if I’m high I will know and then I will sometimes check, double check to 
confirm that and then if I’m, I, I can tell if I’m even the slightest bit low, so. 
(Karen)  
There was some uncertainty with regards to who blood glucose levels were checked 
for. Tom expressed that he only checked his blood glucose “when I’ve got the diabetic 
clinic” demonstrating he was checking more for the healthcare professional than 
himself. He argued that testing more felt like “one compromise too many” in his life, 
having already made the compromise to check prior to his CFD clinic.  
4.2.2.3 Managing nutrition – the challenges and frustrations 
Optimising nutrition is one of the primary goals in the management of CF. For some 
participants nutrition had always been a problem and they faced difficulties in 
balancing CF and CFD to improve their nutritional status. Brian suggests “the biggest 
conflict was when it came down to the, the high calorie diet,” a concept he found “just 
really frustrating.” As a consequence of adjusting dietary intakes for CF, participants 
had to pay more attention to their blood glucose levels and insulin doses because if 
blood glucose control was not optimal increasing weight was seen to be difficult. 
I think the biggest thing was, yeah, I was so conscious that I needed to put on 
weight and I couldn’t do it if my sugars were just all over the place.  So it was – 
yeah, that was just kind of something that was quite frustrating, I guess. (Ana) 
the last clinic my weight was down a little bit, could have put a bit more weight 
on again so upping the diet, increasing the calories invariably means you know 
more blood sugars to have to then think about as well. (Paul) 
For Jane a “lack of appetite” caused further concern to her and she required oral 
nutritional supplements. She described these as “really sugary” and they had a knock-





having to keep “a much closer eye” on them. There was a sense of frustration for Jane 
in trying to balance out the benefits of the nutritional supplements with the negative 
effects they have upon her CFD. 
Yeah, yeah particularly when I’m having to have such high sugar supplements I 
think it was so much better before I had to rely on those but because I have to 
rely on them so much it’s not just one or two a day its really kind of trying to 
pack them in that, that just throws you all over the place. (Jane) 
Jane’s experiences of managing her nutrition were exceptionally demanding and 
frustrating. To a point she suggested, albeit in jest, “I would have great levels if I didn’t 
eat [laughs] and it’s the eating and things that seem to throw them into chaos.” 
Over time Mary began to realise, and demonstrated understanding, that her diet in the 
form of snacking, especially nocturnal snacking, contributed to her high blood glucose.  
I eat during the night as well and I could get up, wake up and think, ‘Ooh, I’m a 
bit hungry.  I’d like one of them’.  And I’ll go and eat a bag of crisps, you 
know, me chip sticks or a cream egg or something and I’ll go back to bed 
and fall asleep, and, you know, that’s it.  So I wake up in the morning, my 
levels are high so I’ve got to get out of that snacking. 
This enabled her to identify that she needed to make changes to her diet. Mary 
suggested “I can’t snack and eat as, like I used to and everything. Like my, erm, levels 
are always high, always.” 
Tom reflected on changes he made to his diet from both a CFD and health perspective. 
He had “cut down” on crisps, fizzy drinks and sweets but described his weakness as 
“stupid gummy sweets,” which he “used to love” but now only has as treats for 
example when at the cinema. Tom was not upset and did not demonstrate a sense of 
loss for these foods, part of which could have been facilitated by the choice being his 
and he still allowed himself treats. There wasn’t a sense that it was difficult for Tom to 
have made these adjustments. 
Brian didn’t let his CFD get in the way of his eating, instead he made changes to his 





I just inject a bit more and that is, I suppose, a way of combating that and managing 
it.”  
The role and appropriateness of carbohydrate counting in the management of CFD is 
not fully established and experiences were mixed. Learning about carbohydrates was 
individually driven and required time, self-motivation, confidence, support and a desire 
to gain a better understanding. 
Through experiential learning Ana and Karen had become accustomed to how 
different foods affected their blood glucose levels, so they no longer routinely 
carbohydrate counted. 
I don’t carb count, per se, but I’ve good idea like, you know, what kind of effect 
certain foods will have on my blood sugars and kind of act accord-, accordingly. 
(Ana) 
Ben suggested that he wasn’t going to embrace carbohydrate counting as he felt his 
CFD didn’t affect him “greatly enough to, to do maths [laughter].” And, he “hates 
maths.” He also demonstrated a reluctance to take on the additional burden of tasks 
and interference in mealtimes that carbohydrate counting, would mean to him.   
it’s enough faff for me to remember to take my insulin once there’s a hot meal 
in front of me to then think about calculating carbs is something I’m not going 
to do when I’m about to enjoy a meal. (Ben) 
Despite Brian’s acknowledgement “that I need to start looking properly at that” he 
described a lack of confidence in trying to start and engage with carbohydrate 
counting. For Brian this could be another reflection of the shame in having had CFD for 
a long time and not being able to ask for help. 
Jane found learning to carbohydrate count helpful, it wasn’t difficult for her and she 
learnt it “pretty quickly.” It contributed to increasing her knowledge and 
understanding of the roles of insulin and carbohydrates as she didn’t realise that there 






4.2.3 The unmet need for information and support 
This superordinate theme explored what information and support was needed and 
how it should be provided. 
4.2.3.1 The need to feel informed, skilled and supported 
Participants were aware that CFD was not the same as type 1 or type 2 diabetes, but 
demonstrated little insight or understanding as to why this was. This led to feelings of 
uncertainty and wanting to “know why it’s different.”  
 And also I’ve been told from the very beginning CF diabetes is different from 
diabetes 1. How is that?  I don’t, you know, ‘cause obviously everyone that I 
know that has got diabetes, they, you know, it’s different and I don’t see how. 
(Mary) 
For Ana the barrier to understanding the difference between type 1, type 2 and CFD 
was in being able to explain this “effectively to other people” to prevent their 
“judgement.” She gave an example, which to her was amusing, concerning the dietary 
differences of CFD which was one of the biggest conflicts between CFD and type 1/ 
type 2 diabetes. This reflected how society portrays diabetes particularly the influence 
of people’s ideas of what food is suitable for people with diabetes.  
You’re like, ‘Oh, I’m diabetic’ and then you eat cake and you’re like, ‘It’s fine. 
I’ve got CF diabetes. It’s okay’ [laughter]. (Ana)  
Participants’ knowledge of the impact of CF on CFD and vice versa was limited, it was 
difficult to ascertain if this was because they have not been told this information or if it 
was something they didn’t understand. Karen was very insightful of the harmful link 
between high blood glucose levels and “bacterial infections” in the lungs however she 
acknowledged this was unfortunately not commonly known amongst others with CF. 
She suggested “a lot of people on this ward that I’ve spoken to, you know, friends of 
mine or whomever, they, they are completely unaware of the link and it is, it is 
integral.” 
Mary was aware of the link between CF and CFD which she represented as a vicious 
cycle. This could partly be because it is what the medical team told her it was, but it 





was not coping or managing CFD well and in her eyes not being supported. There was 
the representation of just going around and around this cycle, with no way out.   
The impact of high blood glucose was a common occurrence amongst the participants. 
Tom was the only person who wanted to understand about any relationship between 
low blood glucose and CF. 
actually maybe more information about – in terms of the impact of er low blood 
sugars on, on general health would be good, in terms of how they interact with 
CF and vice versa would be good. (Tom) 
People with CFD felt the need to be more supported to help alleviate the general 
feelings of uncertainty including the lack of knowledge and experience to “know if 
you’re doing it right.” There was a need to be supported by healthcare professionals 
experienced in CFD management. Brian was diagnosed with CFD as an adolescent and 
supported by a paediatric type 1 diabetes nurse. Reflecting back Brian demonstrated 
doubt that she was experienced in CFD management and there is a sense that he 
hadn’t received the specialist care to meet his needs. 
although it was a Diabetic Nurse, she didn’t really – I’m sure she knew about CF 
but it wasn’t her speciality.  It wasn’t her forte, so her background was diabetes 
and that was very different, and she was used to treating for the children that 
she saw.  They were Type 1 diabetics that, you know, had a completely different 
er, complexity about their condition, erm... (Brian) 
Support to manage CFD was more than just being told what to do. It was about 
learning and developing a level of understanding. Karen described the understanding 
of why treatments needed to be done as pivotal in the management of CFD and that it 
was “slightly condescending” to not be informed. She suggested that increasing 
understanding “will empower patients to want to take better care of their health if 
they know why they need to do whatever they need to do.” 
For some individuals support was not just providing education and assistance to 
develop self-management skills it was also about providing a balance between 
educational support and emotional support to help the development of coping skills to 





struggles with CFD where she was not receiving appropriate support to meet all her 
needs, which left her with feelings of frustration and anger.  
I wish that I knew more about how to look after it instead of being told how to 
do it. I wish I had more care about, erm, how to cope with it, that’d be one big 
thing, how to cope with it and that, erm, and, and more support of how you get 
on with it and, and, er, yeah. (Mary) 
The acquisition of skills in all three components of the CFD self-management triad 
(insulin, nutrition and blood glucose) were essential to the effective management of 
CFD. Blood glucose monitoring was considered the most intrusive form of 
management and the most likely to be compromised; there was the desire for practical 
and realistic advice. Tom, the only participant on once daily insulin, checked his blood 
glucose levels just prior to attending clinic appointments. He wanted to know “the 
minimum you should, you could get away with, from the point of view of it’s useful for 
the doctors to know.” His view on blood glucose testing were more about providing 
information for the medical team than guiding his management. This demonstrated his 
questionability in the values of checking blood glucose when only taking basal insulin 
and provided an insight if different perspective on blood glucose monitoring according 
to treatment type are required. 
More support in helping participants with the challenges of trying to understand the 
relationship between their blood glucose and what it means in terms of their insulin 
doses was required. For Mary this was about being seen as a person with a life and not 
just a source of numbers that represented her CFD control. She desired some insight 
from healthcare professionals about the impact of CFD upon her life. She was angry 
and irritated about the way that she was treated in her consultations, this affected her 
self-worth as she needed more positive reinforcement to support her and to 
acknowledge her efforts.  
IV […]  I think, like I say, in clinic you’re being told to do with your levels to 
change them, this, that, and rather than someone helping you.  There’s 
a difference between being told what to do rather than someone 
sitting there helping you, yeah. 





IV: ‘Cause they’re looking at, they’re looking at numbers on a piece of 
paper whereas you’re looking at it as a way of life and doing your best 
[sighs].  
Information and support regarding insulin management also needed to focus upon 
what individuals should know to effectively self-manage their CFD. This will help 
increase understanding and includes: how insulin works-both “physically and 
biologically,” what is the optimal time to take insulin and why, and how and where to 
administer it.  
The need for dietary information was more individualised and depended upon 
nutritional status. How to manage meals was difficult for some. Jane was uncertain 
how to manage her meals times demonstrating a lack of knowledge and ability. 
Erm mmm how to manage meal times cos I still don’t think I have that down 
because I still when I eat seem to go up really high. I don’t know if that’s normal 
and then I’ll come down straight away. (Jane) 
There was uncertainty if information on carbohydrate counting would be beneficial or 
not in the management of CFD. Brian felt that support on carbohydrate counting 
“would be a really good tool to help someone with diabetes manage their condition 
better,” however he has generalised this to people with CFD and not personalised to 
himself. This could further reflect his lack of personal engagement seen earlier. 
4.2.3.2 Creating systems to deliver trustworthy information and support 
Peers and healthcare professionals had an active role in providing information and 
support to people with CFD. The use of web based social media for communications 
such as Twitter or CF forums was generally helpful in these circumstances.  
I think it’s a really good mechanism to get people that can’t meet face-to-face 
to actually talk and share problems and share solutions. (Brian) 
Participants found “reassurance” in knowing that other people with CF were also 
experiencing similar signs, symptoms or experiences to them. Ana felt that this helped 





[…] nice to know that other people have experienced something that you’re 
experiencing and, and... to get their take on it and, and to know what helped 
them. (Ben)  
So I think having that kind of ability to interact with other people – I think it just 
probably normalises your situation and then that kind of just reassures you but 
yeah, there were other people who had had similar erm, (Ana)  
By giving you different ideas about how to cope, letting someone know that, 
you know, how they think and that they’re going through the same and, you 
know, it’s just something like that. (Mary)  
However, there was a need for reliable and respected peer support from trustworthy 
websites and forums and by establishing relationships with “the people whose 
opinions you trust.” 
So you get to know the people whose opinions you trust; erm, who you know 
are not hyperbolic and erm, who, you know, you can actually kind of – you 
share those ex-, - kind of same views and values with. (Ana) 
 On the negative side, due to the variability in the clinical course of CF, not everyone 
using the forums or social media were at the same stage of disease. For some this was 
depressing and led to unhelpful thoughts about the future or brought up emotions 
that people were not ready to explore.  
I did look at forums once or twice and just found a lot of very morbid, negative 
sort of comments […] (Paul) 
I think because there’s a lot of people, you get some people who are really into 
it but they might be further along in their condition than you and they talk 
about things that are potentially in your future and you just don’t wanna, don’t 
wanna be there that yet. Its erm its too heavy… (Jane)  
Ways to provide information included the use of written information, videos and via 
the Internet. The usefulness of leaflets was limited; they tended not be highly valued 
and contained more generic rather than specific advice. There was the questionability 
of “do we read them?” and a sense of leaflet fatigue as they were provided by most 






I think they’re initially helpful, erm, because you’ve got something there 
tangible to actually to deal with.  Erm, however they, then you end up sticking 
them in a folder or they get lost in a pile of paperwork somewhere so then there 
needs to be something longer term to go back to as a reference point. (Paul) 
Information on the Internet was deemed to be more preferential than written 
information in leaflets. It was felt to be more helpful by alleviating the issue of storage 
and by being more up to date, relevant and long term. 
Erm, but obviously you want something that’s going to be easily accessible 
longer term so be it on a website or something that’s just, as a reference point 
for when the leaflet gets lost or forgotten or something like that. (Paul) 
So I think it’s always good to have something that you can refer back to but 
written literature on a website is probably going to serve a better purpose than 
a leaflet that you’ll take home, forget where you’ve put it, find it in two months, 
read it and go, ‘Oh yeah. (Brian) 
All participants, except Mary, were happy to “Google” information on the Internet for 
themselves. Mary did not view this as beneficial and she felt it was not something she 
should be doing. For Mary there was a mismatch between what information was 
needed for education and what was needed in terms of ‘what is help for her,’ which 
may have been emotional support.  
You know, it’s not something that I think I should get off me arse and look at 
meself, I think someone should be helping me how to cope with what I’m going 
through. (Mary) 
Videos as a source of information were generally felt to be helpful, particularly for 
people who learnt in a more “visual” way. However, to be beneficial they needed to be 
“relatively short” to “ingest.” Other CF team staff had already produced videos for 
patients and the experience of using these was “really useful” and helped to go back 
and “revise” what had been taught. For people starting out with CFD videos 
concerning giving insulin and testing blood glucose were suggested. 
here’s a few videos on YouTube to watch about, you know, the pen, the insulin 
and putting a cartridge in, and this is a BM machine, and this is how you do it, 
and this is...’ you know, little things that you could visually see you know, watch 





Erm, so I don’t know whether it’s, yeah, kind of videos around, I guess, for 
people starting out; like how to test and how to inject yourself erm, and what 
you need to do and stuff like that.  That would be probably useful. (Ana) 
Healthcare professionals were the primary point of contact for people with CFD and a 
trusted source of advice and hence held a very important role in the management of 
CFD. The recognition of “professional first-hand” advice, which was aimed at the 
individual was highly regarded, with more impact than just “reading” something for 
yourself. However, not all participants were getting the correct sort or level of support 
they needed. 
Ana needed support and “reassurance” to assist her adjusting her insulin dose, so she 
felt “safe.”  
[ …] you know, talking to somebody at a clinic or, you know, even a phone call 
erm, just to be like, ‘Yes, you’re doing the right thing’. (Ana) 
Karen was angry because she didn’t feel supported and there were discrepancies 
between what she perceived support to be and what she received.  
Not, I don’t think what they class as support is necessarily, I don’t think it’s 
support, I think it’s just bombarding you with, you know, printouts of 
regurgitated, outdated information. (Karen) 
Mary was frustrated and annoyed that she was not getting the type of support she 
needed; this was a source of distress for her. 
Well with a bit more help and motivation.  You know, it’s all right sitting there, 
someone telling you what to do because then I get angry and think, ‘Well, you 
know, fuck you.  You’re not going through it’, do you know what I mean? (Mary)  
The CFD clinic was a limiting factor in provision of support due to time commitment 
and barriers caused by the provision of separate CF and CFD clinics. Time was in terms 
of how much patient’s time it required to attend an additional clinic. Jane was angry 
and resented attending CFD clinic because the time of her journey significantly 
outweighed the benefit she saw of attending the clinic because “nothing changes.” 
I do find the appointments quite difficult [..] it will take me an hour and a 





I’ve got the whole journey home. So, which erm so it often feels like I’ve come in 
for nothing because a lot of the time nothing changes erm so I’ll come in they’ll 
ask me a few questions and then and then that’s kind of it. So, it does feel like 
it’s a lot of effort to have to, to do the diabetes appointments as well that is 
yeah. (Jane) 
Time was also a reflection of how infrequently CFD clinics were held. Mary was 
irritated about this; she felt the service provided was not supportive of her needs. 
I think, erm, just a bit more frequent than every bleeding six months when you 
can get an appointment in a diabetes clinic ‘cause they’re not helping you 
they’re just telling you what to do. There’s no help there, is there? (Mary) 
Suggestions to improve CFD support included treating CFD and CF “harmoniously” as 
they were currently being “treated separately.” Incorporating CFD care into CF clinics 
was suggested to: improve efficiency, increase attention paid to CFD management and 
integrate CFD management into routine CF care. 
I think it’d be good to get, yeah, and I think that’s where having someone in a 
CF clinic – a diabetes specialist in a CF clinic, to talk to CF related diabetics 
would be good.  And you’d be able to get more out of that I think. (Tom) 
Erm that would be nice if the two could be combined just to, I don’t know, I 
know erm logistically that probably would, is difficult but it just reduces given 
the amount of erm trips these days anyway I’m having to make to the hospital 
it erm would just be erm yeah. (Jane) 
4.3 Discussion 
The key findings, from each superordinate theme, are discussed in relation to the 
research question “what are people’s experiences of self-managing their cystic fibrosis 
diabetes?” findings from the meta-ethnography (chapter three), current literature and 
theories. Clinical implications of the research findings, methodological issues, ideas for 
further research and study reflection will then follow.  
4.3.1 Forming a relationship with CFD 
This superordinate theme was divided into three subordinate themes: CFD- impact, 
constancy and exposure, the conflicts, complexities and unpredictability of CF and CFD 





relationship with CFD appears to be around developing a balanced relationship 
between CF and CFD. 
4.3.1.1 CFD-impact, constancy and exposure 
The development of CFD had both physical and emotional impact on the lives of 
people with CF. Attitude and perception of CFD helped facilitate CFD management but 
the constancy of it posed one of the biggest challenges. Developing CFD heightened 
the sense of exposure through illness visibility.  
Participants described feeling a range of emotions, mostly negative, when diagnosed 
with CFD. This led to uncertainty and confusion especially with regards to the 
significance of having CFD. This is consistent with experiences of people with type 1 
diabetes who also reported negative emotions such as confusion, sadness, shock and 
fear upon diagnosis (Schur et al. 1999, Celik et al. 2015, Robinson 2015, King et al. 
2017) and seen in people with CFD (chapter three). Age at diagnosis was an important 
consideration in the adjustment to having CFD. Adolescence is a particularly 
challenging time due to physical and psychological changes and the greater emphasis 
placed on self-caring. Half of the participants, in this study, were diagnosed with CFD 
during adolescence; they all acknowledged this was a challenging time emotionally and 
physically, but the majority took CFD within their stride.  
Maintaining a positive attitude and viewing CFD as part of CF facilitated acceptance 
and management, and limited the impact of CFD. Where CFD was viewed as part of CF 
then management tasks were incorporated into established CF routines. All but two 
participants accepted their CFD and reported just getting on with it. People who 
develop diabetes have to learn how to live a new way of life with diabetes (King et al. 
2017). Time is an important factor and gradually over time people with diabetes 
become able to incorporate having diabetes into their sense of self (Robinson 2015). 
Limiting the impact of and adapting to CFD involved the process of normalisation, this 
is recognised as a basic strategy used in people with chronic illness to deal with the 
challenge of their illness (Kelleher 1988). Seeing oneself as ‘normal’ or getting on with 





(Taylor et al. 2008). For people with CF this is about trying to achieve a sense of 
balance between self-care activities and daily life. 
Control over diabetes is a fundamental aspect of management and is an important 
feature of adaptation and coping (Schur et al. 1999). People with diabetes aim to be in 
control; in order to cope, they attempt to control diabetes so that it fits in with, rather 
than dominates, their daily lives (Freeborn et al. 2017, King et al. 2017, Nishio & Chujo 
2017). Being unable to cope with CFD was linked to not accepting it and trying to 
manage it as an addition to CF, thus increasing treatment burden and management 
activities.  
On its own CF is a disease that requires attention to time, planning and organisation 
but it was the constancy and invasiveness of CFD into daily life that was considered a 
barrier to its management. Participants needed to plan ahead and be organised- CFD 
was always there and there was therefore a loss of spontaneity. The inconvenience 
and inference of diabetes, particularly with regards to administering insulin and 
monitoring blood glucose levels, is also a challenge for people with type 1 diabetes 
(Freeborn et al. 2013, Celik et al. 2015, Robinson 2015, Jull et al. 2016) and thus not 
unique to the management of CFD.  
Developing CFD increased the visibility of CF. Many people with CF chose not to 
disclose about their illness, they carry out most of their treatments in their own homes 
and disclose on a need to know basis. People with CF choose carefully who to tell 
about their CF to avoid being judged or stigmatised (Gjengedal et al. 2003, Borschuk et 
al. 2016). They modify their behaviours in order to minimise the impact of any 
treatments, such as pancreatic enzyme replacement therapy, which are required on a 
more frequent basis and thus need to be taken outside the home. CFD requires 
treatments and monitoring that are more difficult to hide and thus make it visible and 
attract attention from others. People with type 1 diabetes (Freeborn et al. 2013, 
Chilton & Pires-Yfantouda 2015, Robinson 2015) experience a strong sense of feeling 
different from peers because of their illness. Diabetes is a visible disease in terms of 





fear of being discovered as different and of being judged by others as less acceptable 
than the norm (Robinson 2015). Adaptations in behaviours occur to maintain identity 
as a well person, Schur (1999) terms this ‘stigma management’. In this study changing 
habits were seen particularly around eating with others, where participants would 
administer insulin away from the tables to avoid drawing attention to themselves. It 
has been suggested that individuals have both public and private accounts of illness 
and, within social contexts people often try to convey an identity which is acceptable 
to others (Kelly & Field 1996). Thus, administering insulin or checking blood glucose 
levels in public to some individuals would not be considered socially acceptable to 
them and expose too much of the personal private self.  
4.3.1.2 The conflicts, complexities and unpredictability of CF and CFD 
Conflicts and complexities exist in how CFD and CF care is managed and the 
relationship between them is portrayed. Both conditions are unpredictable in nature 
and this further complicates management. 
Both CF and CFD are complex conditions that require life-long management and often 
complicated treatment regimens. The relationship between CF and CFD is hazy but a 
very important consideration in terms of management. Some participants saw links 
between CF and CFD only in terms of medical and dietary management but not in 
terms of CF causing diabetes or the impact of CF on CFD and vice versa. Whereas other 
participants recognised a relationship between high blood glucose levels and 
respiratory infections and the difficulty there was in trying to achieve a balance 
between them. These links are fundamental to management and more consideration 
should be given for treating CFD as part of CF and not a separate entity. When 
considered as one condition management was incorporated into established CF 
treatment regimens. These links between the two conditions echo those seen in 
chapter three which prompted the consideration to the name CFD. 
This CF centre contributed to the further separation of the two conditions and created 
a barrier by having a separate CFD clinic. This service provided very little overlap 
between respiratory and diabetes management because diabetes issues were 





complicated management for patients. CF care pathways may therefore have a role in 
supporting people to develop a stronger notion of inter-dependence that may have life 
extending impacts. 
The role of corticosteroids in the development of CFD and the complexities it added to 
the management of CFD was a significant finding within this study; it has not 
previously been reported as such a major concern to people with CFD (chapter three). 
One participant had an extremely negative relationship with corticosteroids and 
blamed them for his diagnosis of CFD; this led to his inability to fully accept CFD. When 
corticosteroids were used to treat respiratory symptoms difficulties in managing blood 
glucose levels were described; there was a sense of loss of control and more 
difficulties and uncertainties in trying to gauge insulin doses. Participants did not feel 
that they had been prepared enough by healthcare professionals for the consequences 
of corticosteroid treatment or supported enough throughout the treatment.  
Living with CF is unpredictable due to day-to-day variability in clinical symptoms this 
can affect blood glucose levels and ultimately the management of CFD. Living with this 
unpredictability is challenging. People with CFD had to continually make treatment and 
management decisions that changed frequently. CF is a progressive illness: as health 
begins to deteriorate then life can start to become more restricted and treatments 
more complex and demanding, increasing treatment burden further. This can impact 
on quality of life as the severity of disease increases (Gee et al. 2000). Managing CFD 
was also tricky and challenging and for some it has a sense of unpredictability which 
further added to the complexity. Reasons for this are not clear as numerous factors 
affect insulin secretion and sensitivity.  
4.3.1.3 Facing mortality 
There was awareness amongst participants that complications of CFD exist, with 
primary concern being for eyesight. Thoughts for the future were however 
predominated by CF, including the understanding that they would succumb to CF first. 
This led to prioritisation of CF management and sometimes compromised the 
treatment and management of CFD. In individuals with co-morbidities life needs often 





long-term effects of diabetes has been seen in people with type 1 diabetes (Dickinson 
& O’Reilly 2004, Celik et al. 2015) however diabetes was the only chronic illness these 
participants had. CF was the most serious condition to participants in this study; there 
was recognition that it was a progressive life-limiting disease and therefore the long-
term effects of this took precedence over CFD. However, with increased life 
expectancies people are likely to be living with CFD for longer. Thus, the importance of 
glycaemic control is exceedingly important to prevent a rise in diabetic complications 
and associated demands on health services.  
4.3.2 Balancing the CFD self-management triad 
CFD management aims to achieve a balance between keeping blood glucose as near 
normal as possible/controlling symptoms with preventing respiratory and nutritional 
decline. The self-management of CFD focussed around three interlinked components: 
insulin, blood glucose and nutrition. 
4.3.2.1 Insulin- understanding and uncertainty 
Uncertainty regarding insulin use was problematic. This concerned how much insulin 
was needed and the most appropriate time to take it. This reflected insufficient 
knowledge and therefore demonstrated inadequate understanding of insulin and how 
it worked. There was acknowledgement that insulin dosing was not fixed and needed 
to be adjusted according to dietary intake, changes in treatments and clinical status. 
However, this was a dynamic process which required knowledge, motivation and 
support to sustain. The unpredictability of CFD itself made insulin dosing challenging 
and difficult to manage. 
The use of carbohydrate counting to inform treatment decisions forms an integral part 
of type 1 diabetes self-management programmes and has been shown to be an 
effective method of management (Edwards 2015). However, the use of carbohydrate 
counting amongst people with CFD within the study was variable. This could be for 
many reasons. First, there are no formal structured self-management education 
programmes for CFD. Secondly, people with CF are taught about dietary fats from a 
very early age to help manage pancreatic exocrine insufficiency and the need to also 





counting requires adequate numerical skills, which not everyone possesses (Marden et 
al. 2012). Due to the integral part of carbohydrates in diabetes management there is a 
need to for people with CFD to receive some education to increase carbohydrate 
awareness, to help inform decisions regarding insulin dosing, and for some this may be 
carbohydrate counting. Thus, achieving a balance of what is the most applicable to 
each individual with CFD is a more appropriate approach. 
4.3.2.2 Blood glucose monitoring- comprehension, confusion and 
compromises 
Blood glucose monitoring is an essential part of the management of CFD; it is a key 
part of the experiential learning process to develop knowledge and understanding. It 
was used to inform self-management decisions such as insulin dosing and to monitor 
for changes in blood glucose levels due to illness or lifestyle factors. However, there 
was a lack of clarity regarding when and how frequently to check blood glucose. It was 
the part of self-management that was compromised the most.  
Blood glucose monitoring posed many challenges for people with CFD, in this study,  
with the invasiveness and inconvenience being the most predominant. This is not 
limited to the management of CFD as it has also been reported in people with type 1 
diabetes (Freeborn et al. 2013, Robinson 2015, Jull et al. 2016). The need for post-
prandial blood glucose levels in the management of CFD caused additional challenges 
as these were the blood glucose which were found the most difficult to check, 
predominately due to untimeliness. Participants in this study made informed choices 
regarding blood glucose monitoring which included making compromises and for some 
prioritising CF treatments. Not checking blood glucose levels is also common in the 
management of type 1 diabetes (Celik et al. 2015, Chilton & Pires-Yfantouda 2015).   
There was conflict and confusion between what healthcare professionals 
recommended with regards to the frequency and timing of blood glucose monitoring 
and what participants understood and were actually doing. Tom, who was on just basal 
insulin, only checked his blood glucose levels prior to his CFD clinic appointment; which 
was annually. He did not use his blood glucose readings to inform his treatment 





professionals to review in clinic. It could be argued that his need for blood glucose 
monitoring is less that someone on a basal bolus regimen and he would not use it to 
inform decisions around meals as this is not the mode of action of basal insulin. 
However more individualised recommendations appropriate to his needs were 
required. Conflicts between blood glucose monitoring recommended guidelines, 
healthcare professionals’ expectations and patients’ motivation have been seen in 
people with type 1 diabetes (Celik et al. 2015). Where there is a trend to check blood 
glucose ‘passively’ to please others rather than as a self-management tool (Celik et al. 
2015, Chen & Chang 2015). Thus, self-management of blood glucose levels needs to be 
seen as being of benefit to people with all types of diabetes. A sense of balancing 
blood glucose monitoring into their lives needs to be achieved. For people with CFD 
other routine treatments and management needs to be considered and balanced with 
when and how frequently blood glucose levels need to be monitored.  
4.3.2.3 Managing nutrition – the challenges and frustrations  
Achieving and maintaining optimal nutritional status is a key part of the management 
of people with CF; the addition of CFD presented further challenges to this. Seeing a 
dietitian forms part of routine CF care; people with CF are assessed and given dietary 
recommendations appropriate to their individual needs (Cystic Fibrosis Trust 2016).  
Managing nutrition was a challenge to the participants within this study. The need to 
further increase dietary intake through food or oral nutritional supplements further 
exacerbated this. Making these dietary changes led to further attention needing to be 
paid to blood glucose levels and adjustments in insulin doses to achieve balance. 
Difficulties in dealing with dietary aspects of CFD and balancing it with maintaining 
weight has been previously reported (Lake 2010). Managing nutrition is not just a 
problem in people with CFD; in one study of young adults with type 1 diabetes diet 
was deemed the biggest problem. These young adults had knowledge of what not to 
eat and when to eat but some of them did not have knowledge of carbohydrate 
counting (Celik et al. 2015).  
To manage CFD some participants chose to make modifications to their diet. These 





improvements in nutritional status seen in people with CF is it no longer unusual for 
some dietary modifications to be recommended for managing CFD, however in this 
study these changes were decided by the individual. It is understandable that some 
individuals may want to snack less to avoid additional insulin injections and to eat less 
carbohydrate to reduce the amount of insulin required. This highlights the importance 
of healthcare professionals assessing the appropriateness of this on an individualised 
basis. In this study there wasn’t a sense of dietary changes being detrimental to health, 
they were individual’s choices in how they wanted to manage their own situation. 
As previously discussed, the use of carbohydrate counting in the participants’ 
management of CFD was variable. The appropriateness and benefit of carbohydrate 
counting for people with CFD is not fully established although some participants in this 
study have found it helpful. Currently carbohydrate counting tends to be taught on an 
ad-hoc basis and not to form part of routine education (Cystic Fibrosis Trust 2016). This 
may be because there are no established self-management education programmes for 
the management of CFD.   
4.3.3 The unmet need for information and support 
4.3.3.1 The need to feel informed, skilled and supported 
As also demonstrated in chapter three there was a lack of knowledge and 
understanding concerning the differences between CFD and type1/ type 2 diabetes; 
participants were aware that it was different but were uncertain how and why. There 
was also a lack of understanding of the impact of CFD on CF and the physiology of CFD. 
This is not unique to CFD as people with type 1 diabetes have also expressed a desire 
to know more about the physiology of diabetes (Roper et al. 2009). Thus, there is a 
need to provide people with CFD information about what CFD is, what causes it and 
how it impacts on their CF and hence their health and well-being.  
Participants demonstrated limited knowledge of the relationship between the impact 
of CF on CFD and vice versa. Mary’s representation of this relationship was as a vicious 
cycle. However, Mary was struggling with management and the cycle representation 
only further added to her anxiety as it was difficult for her to see a way to get out of 





should be informed about this relationship from diagnosis, to help inform 
management decisions.  
Education and support regarding the CFD self-management triad needs to be practical, 
realistic and helpful. This should include: recognition of what is achievable in terms of 
blood glucose management, advice on managing insulin, clearer information how to 
achieve good CFD control whilst also maintaining weight and increased carbohydrate 
awareness. What is important is that individual needs are assessed and accounted for 
when tailoring education and advice. This was also identified as essential for people 
with type 1 diabetes (Wilkinson et al. 2014, Celik et al. 2015, Jull et al. 2016). 
A general lack of support to participants with CFD in this study was observed. Clearly 
this gap in service provision needs to be addressed and more support provided to 
facilitate the self-management of CFD. However, attention needs to be paid to the 
type of support provided. With the need for educational support to help develop 
knowledge and self-management skills and emotional support to address the 
psychological impact of CFD. Participants want support from people who have 
knowledge, understanding and experience of CFD. Collaborative planning of care 
between healthcare professionals and people with type 1 diabetes has led to feelings 
of support (Spencer et al. 2010) therefore, actively involving individuals with CFD into 
their care planning may be one way to facilitate support and achieve the sense of 
feeling supported. 
4.3.3.2 Creating systems to deliver trustworthy information and support 
The segregation of people with CF due to infection control policies within CF centres 
prevents face-to-face peer support (NICE 2017). This has been shown to create a sense 
of isolation in people with CFD (Tierney et al. 2008, Richmond 2012). Despite 
segregation not being an issue, feelings about being alone have also been seen in 
people with type 1 diabetes (Celik et al. 2015, Robinson 2015). 
The participants with CFD in this study did not report a sense of isolation or being 
alone except for Mary who gave the impression of struggling alone, with insufficient 





their CF. This however needed to be from a trusted source to be considered helpful. 
Lack of control of information online is a disadvantage of this means of support (Kirk & 
Milnes 2016). Pearson & White (2014) conducted a study examining nutritional 
queries, over a 6-month period, on the online forum of a CF charity. They found that 
CFD was the most frequently raised topic; with a lack of understanding of it regularly 
identified (Pearson & White 2014). Online support groups have been shown to enable 
young people living with CF to share their experiences and feelings with their peers, 
this can support their self-management and help empower them in their interactions 
with healthcare professionals (Kirk & Milnes 2016). 
The use of the Internet was considered a more preferential medium for information 
than leaflets. With all but one participant happy to source information for themselves 
on the Internet. The use of videos was considered useful for visual learners, however 
careful consideration to their duration should be given. There was a preference for 
short videos. Some participants had already experienced using videos produced by 
members of the CF team which they found to be helpful. 
Healthcare professionals were the first point of contact for the participants. There was, 
however, a need for healthcare professionals to show a greater insight and 
understanding of the experiences of living with CFD. There was a need for support 
rather than being told what to do. The management of diabetes needs to be 
considered in a wider context beyond the disease itself by adopting a more person-
centred approach which considers social, emotional and lifestyle issues (Wilkinson et 
al. 2014, Celik et al. 2015, Jull et al. 2016).  
The CFD clinic was a major drawback in the provision of CFD care within this centre. 
This was due to time, specifically the amount of time it took for patients to travel to 
attend CFD clinic, the infrequency of CFD clinic, and lack of synchronicity with routine 
CF care. People with CF already attend hospital regularly for reviews, with average 
outpatient appointments taking 4 hours 46minutes (Cystic Fibrosis Trust 2018b), and 
the frequency of contact increasing with the severity of disease; there was generally a 





and expense also need to be considered. Alternative methods to delivering CFD 
specialist care which will have less impact on time and patient expenses such as 
remote clinics or incorporation into routine CF clinics is therefore more appropriate to 
meet the needs of this population. 
4.3.4 Strengths and Limitations 
This IPA study is methodologically congruent in including this small sample of adults 
living with CFD (Smith et al. 2009). IPA is an inductive approach and gives participants 
freedom to express their experiences in their own words, with a trend in this study for 
more of a focus on the problems of self-management rather than solutions to it. The 
use of IPA allowed the aims of this study to be met. A more structured methodology 
may have given more positive experiential ideas for developing the self-management 
education programme, which IPA has not fully facilitated but it may not have produced 
such a detailed representation of individual experiences. The stakeholder development 
group in stage 2a will contribute to positive experiential ideas to inform the 
development of the CFD self-management education programme.  
This study aimed to describe experiences of both adolescents and adults with CFD. 
Twenty-two of the 44 invitation to participate letters were sent to people less than 26 
years old. Unfortunately, only one of these responded, highlighting the difficulty 
recruiting this younger population. All the participants in this study had CFD for six 
years or more. The self-management experiences of younger adults or those with new 
or relatively newly diagnosed CFD may therefore not be fully reflected in these 
findings. The experiences of the participants, within this study, are from one CF centre 
and may not be fully transferable to other CF centres where variations in the 
management of CFD may exist. However, they are reflective of the results from 
chapter three which represented findings of people with CFD from six different CF 
centres situated in the UK, USA and Canada.  
It is also important to consider that those who volunteered to participate in this study 
may be more highly motivated and manage their illnesses better and are therefore 





dissatisfaction could be viewed as her motivator to participate. Thus, the findings may 
not be completely reflective of the whole CFD population at this centre. However, their 
self-management experiences and effectiveness at managing CFD were still very 
varied. There are limited studies looking at the experiences of CFD indicating a need 
for further qualitative studies exploring these experiences to be undertaken. 
My role as a researcher also needs to be considered. I was previously known to the 
participants as a dietitian, within the CF team, who had a role in patient care. This may 
have led to some participants withholding information although confidentiality and 
anonymity was discussed and assured. However, I felt the participants spoke freely and 
willingly during the interviews and I have no reservations about how the interview 
process went.  
As discussed in chapter two, IPA adopts an ontological approach of critical realism 
which is located within the interpretivist framework. A reality exists independent of 
the observer, but it can only ever be partially known and is only available through the 
insights and interpretations of the individuals experiencing it. There is the 
acknowledgment that interpreted knowledge is not totally objective, it reflects some 
truth about the phenomenon, but it is influenced by our own interpretations. 
Therefore, as an IPA researcher I become heavily immersed in the data and ultimately 
my interpretations had an influence upon the results. Data analysis was reviewed by all 
members of the supervisory team with discussions of interview transcripts, key 
findings and interpretations. The results were also presented to the PhD Project 
Management Group, consisting of lay and healthcare professionals, for their support 
and advice. 
4.3.5 Implications for practice 
Many knowledge deficits were identified within this study; a lack of understanding of 
the link between CF and CFD was a key finding. This included what caused CFD and 
how its management impacted CF and vice versa. Other identified knowledge deficits 
concerned the CFD self-management triad- the three key interlinking components to 





identified, will be used to inform the development of a self-management education 
programme for people with CFD. The MAGIC programme stakeholder development 
group will give consideration to these findings and decide how they will be used to 
influence the design of this intervention. These key findings will therefore help inform 
the MAGIC programme’s content and structure and help address the educational 
needs of people with CFD. Improving knowledge will facilitate understanding, 
empower decision making and boost confidence to self-manage. However, the 
educational needs of healthcare professionals were also deficient and this also 
requires attention. The aim of this study was to develop a self-management education 
programme for people with CFD, it didn’t take into consideration the requirements of 
healthcare professionals. The MAGIC programme could be used, in CF centres, by 
healthcare professionals to enhance their knowledge about the management of CFD. 
For healthcare professional specific CFD programmes more research is required to 
identify their particular needs. In the future the MAGIC programme could be adapted 
into a healthcare version to meet these needs. 
Healthcare professionals were regarded as the first point of contact for people with 
CFD but a lack of support or the wrong type of support was reported. This needs to be 
addressed, by CFD teams, so that people with CFD can make more effective self-
management decisions in a helpful and encouraging environment. However, it is not 
enough just to tell people what to do, individuals need an integral part in planning of 
treatment and management and the wider context beyond the illness itself needs to 
be considered.  
Both CF and CFD are complex life-limiting diseases and require daily treatment and 
management that impacts on all aspects of life. CFD should be regarded as part of CF; 
it is a complication that occurs with ageing and due to CF pathophysiology. The CF 
centre further contributed to separating the two conditions by the way its specialist 
clinics and services were structured. Both conditions should be treated as one; 
individuals should be encouraged to incorporate CFD management into their routine 
CF care. Quality improvement aspects of gaps in service for people with CF and CFD 





CF do not want to attend the hospital more frequently than needed; time is a very 
important aspect within their lives. People with CF are willing to embrace new 
technologies provided they are from reliable and trusted sources. Consideration 
should be given to integrating the CF and the CFD service, with appropriate multi-
specialist input, into the clinical team. Thus, care delivery pathways, including digital, 
need to be developed to provide continuity of care, education and support with known 
healthcare professionals. This will help support the integration of people with CFD in 
treatment and care planning.   
4.4 Conclusion 
This study demonstrated impact and importance because despite being a very 
common complication of CF very limited qualitative work looking at experience of self-
managing CFD has been conducted. This study has increased knowledge of the 
treatment and self-management challenges that people with CFD experience and 
identified implications for practice.  
The management of CFD is a complex multi-dimensional process. The findings suggest 
that the self-management of CFD was met with many challenges which included: trying 
to balance CF and CFD, receiving insufficient support from healthcare professionals 
and having deficits in knowledge to make appropriate self-management decisions. A 
self-management education programme for people with CFD is needed to address 
these identified deficits to facilitate self-management. The provision of appropriate 
and timely person-centred CFD care and support also needs to be addressed. 
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5 MAGIC programme development and 
review 
This chapter focuses on the process of integrating the findings, from the previous 
stages of research, with relevant theories to inform the development of the MAGIC 
programme. This stage of the study will answer the question “what does a web-based 
self-management education programme for CFD need to contain?” In this chapter the 
methods and results for the MAGIC programme development and the MAGIC 
programme review will be discussed separately. The findings will then be consolidated 
into a joint discussion and conclusion.  
5.1 Method - Stage 2a MAGIC programme development 
5.1.1 Research design 
This study aimed to develop the MAGIC programme as an e-learning resource. The 
development phase outlined by the MRC Framework supported the design of the 
MAGIC programme (chapter two). Hence, the development of the MAGIC programme 
was informed by findings from stage 1a and 1b, co-design using a stakeholder 
development group and relevant theories/ criteria (figure 16). 
 






5.1.2 The MAGIC programme stakeholder development group 
The stakeholder development group consisted of expert healthcare professionals, from 
CF centres throughout the UK, and people with CFD (table 24). Nine healthcare 
professionals were recruited through professional groups and by invitation based on 
their recognition as experts in CFD management. Seven people with CFD were 
members of the stakeholder development group; they were recruited via the CF Trust, 
social media (Twitter) and the CF centre; five of these attended the stakeholder 
development group meetings and two contributed to the group via email (e.g. 
reviewing modules, videos and content). These were not the same people with CFD 
who participated in the IPA study described in chapter four. Four other people (one 
parent, two people with CFD from other CF centres and a person with CF) initially 
agreed to be a part of the stakeholder development group but they did not respond to 
further contact and thus did not contribute to the MAGIC programme development.  
Table 24 Stakeholder Development Group 
Stakeholder development group members 
• Project lead  
• 7 people with CFD (4 female) 
• 1 CFD nurse specialist 
• 1 CF nurse specialist 
• 4 CF Specialist Dietitians 
• 2 Consultant Endocrinologists 
• 1 CF Specialist psychologist 
• Digital content manager 
• Supervisory team 
 
Other people who contributed to the stakeholder development group meeting 
included:  
• Digital content manager- responsible for designing the web-based programme 
• Supervisory team –expertise in DSME, chronic disease management, delivering 
education, cystic fibrosis and behavioural medicine. They contributed to 






• Student nurse on research elective- supported literature reviews on theoretical 
underpinnings of DSME programmes, helped with taking notes during the 
meetings 
The stakeholder development group was regarded as a study group; by volunteering 
people were consenting to contribute to the development of the MAGIC programme. 
Ethical approval was therefore not required as these people were not regarded as 
study participants. No financial rewards were received for being part of the 
stakeholder development group, however travel expenses were reimbursed. All data 
presented to the stakeholder development group from stage 1b was anonymised; no 
identifiable data were shared.  
To prevent cross infection in people with CFD we needed to use videoconferencing 
software to facilitate contact between group members. The efficacy, ease of use and 
cost of different options for videoconferencing were considered. There are numerous 
videoconferencing services available e.g. Zoom meeting, Adobe connect, BlueJeans, 
Skype, Google chat etc. I had experience of successfully using BlueJeans 
videoconferencing service via work as steering group member with the James Lind 
Alliance top ten research priorities for CF group. I was also familiar with using Skype. 
These were therefore the two chosen preferences considered as a starting point. On 
three test runs BlueJeans was found to be more reliable and easier to use than Skype; 
all test participants could log onto BlueJeans and participate in the video call, whereas 
this was not achievable with Skype. The cost of BlueJeans was reasonable and was met 
through the programme development budget. The decision was therefore made to use 
BlueJeans videoconferencing service for these meetings. 
5.1.3 The process of developing the MAGIC programme 
A series of four stakeholder development group meetings were held between January 
and November 2018 (figure 17). The process of co-design recognises equality in the 
contribution from all involved (Bradwell & Marr 2008) therefore, all stakeholder 
development group members had an active role in decision making rather than just 





As the project lead it was my role to facilitate the stakeholder development group 
meetings, to create an environment that put participants at ease and encouraged 
them to contribute freely to discussions. I also had to ensure that perspectives were 
balanced and that all group members had the opportunity to express their opinions. 
The direction of the meetings needed to be maintained to ensure conversations were 
relevant and focussed on the desired outcome of developing the MAGIC programme. 
As the people with CFD were attending remotely it was important to ensure 
interactions with them were maintained throughout the meetings and that they were 
included in all conversations. This was done by actively asking opinions, using the chat 
feature on BlueJeans, which allowed participants to type messages, and identifying a 
member of the stakeholder development group to be a link person with the people at 
home. The link person monitored for questions and identified any technical issues that 
occurred with the videoconferencing software. Notes were taken during the 
stakeholder development group meetings and audio recording were made. This helped 
inform development and identified action points.  
 
Figure 17 Flowchart of MAGIC programme development 
 
The development of the MAGIC programme was an iterative process, which followed 
five steps (figure 18). In the first step, the findings from stages 1a and 1b and their 





development group. These findings and their influences on the MAGIC programme 
development are summarised in table 25. They were classified into three components: 
emotional health and well-being, physical care and service issues. The practical 
application of these findings on the development of the MAGIC programme were 
considered by the group.   
 


















Table 25 Influence of findings from stage 1a and 1b on intervention design 
Findings Influence on intervention design  
 
Emotional health and well-being 
 
• Forming a relationship with CFD 
o Managing initial diagnosis CFD – negative emotions 
 
o Impact day-to-day life  
▪ Change in health status (maintenance wellness) 
▪ View CFD as part of CF 
▪ Normalisation 
▪ Balance vs control 
▪ Constancy and invasiveness 
 
• Balancing CF and CFD 
o Unpredictability of CF 
o Incorporate CFD into routine CF care 
o Impact of CFD upon CF (knowledge deficit) 
o Treatment with corticosteroids 
 
• Future concerns 





Attention to both physiological and psychological issues of 
managing CF after the diagnosis of CFD and throughout period of 
adjustment 
 
Use of peer support- videos/ vignettes of people with CFD 
experiences 
 
Provision of adequate education and support to be able to respond 
to day-to-day variabilities and health changes 
 
Provide education to help increase understanding of relationship 
between CF and CFD and why should be managed as one condition 
(basic physiology CFD) 
 
Individual care planning- consider wider context of CFD, not just 
about achieving the numbers but achieving a sense of balance in 
life, realistic and achievable 
 
Provision of adequate education and support to increase 
understanding of effect of corticosteroids upon CFD and 








Physical care- CFD self-management triad 
• Insulin 
o Uncertainties re dosing 
o When should insulin be taken 
o adherence 
 
• Blood glucose monitoring 
o When to test 
o Frequency of testing 
o Why test 
 
• Nutrition 
o Challenges/ conflicts 
o Role of carbohydrates 
o Dietary changes 
 
Provision of education about insulin therapy for CFD: basic 




Provision of education about what, when and how to check blood 
glucose levels 
Individual care planning- consider wider context of CFD, realistic 
goals (patient centred) 
 
Provision of education about: food groups, meeting dietary 
recommendations (consideration to weight maintenance and 




• Insufficient knowledge 
o Difference CFD and type 1/ type 1 diabetes 
o Impact of CFD upon CF 
o Physiology of insulin 
o Insulin dose adjustment 
o Practical BG checking advice 
o Carbohydrate awareness 
 
• Lack of support 
 
 
Provision of education will address these areas where insufficient 






Coordinator of the intervention will support learning and 








o How to look after CFD rather than being told what to do 
o Not focus just on numbers 
o CFD clinics implications on time 
o In adjusting insulin doses 
o Managing steroid therapy and impact on blood glucose 
levels 
 
• How to deliver support 
o Need for practical, realistic  
o From people with knowledge and experience CFD 
o Demonstrate insight into experience of living with CFD 
o Recognition of the individual not the disease 
o Incorporate individual into care planning 
o Role of peer support 
 
• How to provide information/ education 
o Not just telling people what to do 
o CFD clinics lack synchronicity with routine CF care 
o Manage CFD as part of CF 
o Use of Internet 
o Incorporation of short videos 
o Limited benefits of leaflets 
o Trusted source of advice 
 
Provision of resources to support insulin dose adjustment and 
steroid therapy 
 
People with CFD to be active partners in setting goals and 
individual care plans 
 
Healthcare professionals to receive training to deliver the 
intervention 
 
Usefulness of peer support identified- consider setting up peer 
support group for people with CFD participating in the intervention 
(blog, face book or WhatsApp)- this will be moderated to ensure 
advice/support is reputable and trustworthy 
 
Service issues outside remit of this intervention will be presented 
to and discussed with CF centre 
 
Secure web-based platform to perform the staging of the 
intervention 
 
Use of technology such as videos, internet-based resources 
 
CFD will be considered as part of CF and education/support/advice 





In the second step ideas for the content and design of the programme were generated. 
The stakeholder development group also considered what current resources were 
available to people with diabetes, what improvements were required to make them 
relevant to people with CFD and where the deficits were. 
In the third step of the programme development attention was paid to the design of 
the MAGIC programme, this included how it would be structured and what it would 
look like. Considerations to the use and format of videos, personal experience 
vignettes and the use of pre-existing resources were made. A prototype of the website 
was reviewed by the stakeholder development group. People with CFD who were 
happy to share their experiences with others either in the form of videos or vignettes 
were recruited from the centre’s CFD clinic and from within the stakeholder 
development group. Ten people with CFD were approached when they attended CFD 
clinics to explore the possibility of them assisting with personal experience videos and 
vignettes. The project was explained to them along with the purpose of the videos/ 
vignettes. A follow up phone call was made a week to ten days later to verify if they 
were happy to help. Six people were happy to assist with vignettes, two with videos. A 
member of the stakeholder group also volunteered to assist with videos. Those who 
helped with vignettes gave written permission for their anonymised quotes to be used 
in the MAGIC programme. Individuals who helped with videos gave written permission 
for their self-recorded videos to be used in the MAGIC programme.  
The fourth step involved the stakeholder development group working through the 
programme content to check language, illustrations, appropriateness of videos, use of 
personal experience vignettes/videos and identified resources.  
The fifth stage of the development of the MAGIC programme involved the stakeholder 
development group revising and making any necessary amendments to the 
programme. 
The MAGIC programme was developed in partnership with the digital content 
manager. A close working relationship between the project lead and the digital 





group meetings to develop ideas and gain understanding of the practical requirements 
of the programme. The platform was developed using HTML5, CSS and JavaScript 
technology for the front end (visible parts of the website) and PHP5, PHPMYADMIN for 
the back end (infrastructure and data bases). The MAGIC programme is hosted outside 
the NHS network but runs on an encrypted certified hosting service. The connection 
between the hosting and the client is secured by Secure Sockets Layer (SSL). When a 
user enters the SSL-protected Platform, the SSL certificate automatically creates a 
secure, encrypted connection. The SSL certificate uses a SHA-2 digest method and 
2048-bit encryption to protect sensitive data. The whole platform and its database are 
backed up daily on the hosting solution. This will secure the content and data in case of 
data loss. The platform is password protected and can only be accessed by a given 
username and password. Users will need to be pre-registered to obtain a personal 
login to access the content of the modules.  
5.2 Results 
5.2.1 The stakeholder development group meetings 
In line with the recommendations of stage 1a the stakeholder development group 
discussed the use of the term CFD. The decision was made to use the term CFD for this 
project; it was believed that this highlighted the greater causal relationship between 
CF and diabetes and promoted more harmonious management. Throughout the 
development of the MAGIC programme the stakeholder development group remained 
mindful of its focus on ‘managing abnormal glucose in cystic fibrosis.’ To remain true 
to this, and taking the timeframe into consideration, the group decided to focus the 
programme on the knowledge and skill acquisition required to self-manage CFD. This 
was identified as the CFD self-management triad (insulin, blood glucose, nutrition) and 
‘what is CFD?’ It was decided that the MAGIC programme should have a basic nuts and 
bolts module, which was aimed at people new to CFD, progressing to more advanced 
modules for advanced learning. 
The four stakeholder development group meetings lasted from 10.00 to 15.00 with a 





members were asked, at regular intervals throughout the day, if they required a break. 
Additional comfort and refreshments breaks were then held as and when required.   
As part of introductions in the first meeting the co-design process was discussed - this 
included equality. It was discussed with the stakeholders that people with CFD and 
healthcare professionals were considered equal and that everyone had a say in the 
decision-making processes. At least one member of my academic team attended each 
stakeholder meeting. They were not an expert in CFD or directly involved in designing 
and producing the programme and were therefore able to be non-biased. They were 
able to provide support throughout the meetings by seeking clarification, stimulating 
discussion and challenging ideas. To try and ensure that all group members had the 
opportunity to comment or contribute to the development of the MAGIC programme I 
would ask for additional comments and encourage involvement from all group 
members at regular intervals throughout the meetings. A link person was appointed 
for each meeting. Their role was to maintain contact with the stakeholders at home 
and monitor for questions that may have occurred via the chat feature of BlueJeans 
and to identify any technical difficulties encountered. The stakeholder group meetings 
were relaxed and informal to facilitate discussion and put members at ease. Content 
including text, videos and illustrations for the MAGIC programme was also emailed to 
group members between the meetings giving further opportunity for comments and 
input. This was particularly useful in areas that we struggled with during the meeting. 
For example, there was a difference of opinions between medical professionals in the 
group and people with CFD with regards to sick days rules and how to make insulin 
adjustments. People with CFD didn’t want to have to have to do calculations when 
unwell they wanted simple rules on what to do with their insulin whereas some of the 
medical professional felt we should be giving patients the tools to make decisions 
rather than tell them what to do. After discussing responses and experiences the 
stakeholder group made the decision to follow the view of people with CFD as they 
have firsthand experience of such situations and how they would like to manage them. 
The MAGIC programme was developed through a shared decision-making process, by 





expertise between people with CFD and healthcare professionals caring for people 
with CFD. 
The first meeting generated the topics, considered the structure and discussed the 
theoretical underpinnings of the MAGIC programme. Figures 19 and 20 were 
developed after the meeting, they summarised the ideas for the content and structure 
of the MAGIC programme. The content for modules one and two was then written by 
the project lead between the first and second meeting.  
In the second meeting the stakeholder development group reviewed the proposed 
ideas and modules for the MAGIC programme and its structure, making modifications 
where it was deemed appropriate; this included ensuring the first module contained 
some basic information on hypoglycaemia management. The content of the first two 
modules was then reviewed, paying particular attention to readability and use of 
language. The preference for short, clear sentences which avoided the use of too many 
abbreviations was deemed preferential. Attention was also paid to the appropriate use 
of illustrations and videos. This included making sure all images were clear, of the 
appropriate size and easy to understand. Existing videos linked to the MAGIC 
programme, via their websites, were reviewed for their appropriateness to people 
with CFD, sound quality and educational content. These included: ‘what is diabetes 
video?’ produced by Diabetes UK and a series of carbohydrate counting videos 
produced by Norfolk and Norwich University Hospital. All videos made by the 






























Basic skills and 
knowledge that form 
the foundation of CFD 
management
What is CFD?
Insulin and food intake
The need for insulin
BG- how to check
BG- normal ranges




Skills and knowledge to 
improve how CFD is self-
managed in daily life
Carb awareness
Mode of insulin action
Insulin injection techniques 
& sites
BG & HbA1c targets
Relationship CF & CFD on 




Skills and knowledge to 
advance self-
management skills and 
understanding 
Carb counting
Insulin to carb ratios
Nutrition- meeting 
requirements
Insulin safety – driving, 
storage, travel, passport etc.
Relationship CF & CFD – risk 
long-term complications 
(including morbidity and 
mortality)
CFD wizard
High level skills and 
knowledge to become 
proficient at CFR self-
management  
Advanced carb counting 
(e.g. meals out, recipes, 
take aways)
Nutrition- achieving a 
healthy balance (include 
protein and fats)
Insulin dose adjustment
BG- managing steroid 
treatment, illness, activity, 
holidays
 




In the third meeting the group viewed and discussed the prototype of the web-based 
programme for the CFD-beginner module, which had been developed between the 
second and third meeting. This provided greater visual clarity of the MAGIC 
programme. The content of the final two modules were then reviewed. 
The stakeholder development group believed that personal experiences would add to 
the quality of the MAGIC programme. They were believed to be a beneficial part of the 
learning process because people with CF are recommended to not have face-to-face 
contact with each other and hence have limited opportunities to share experiences. 
The stakeholder development group explored how personal experiences of people 
with CFD could be incorporated into the programme. Some example questions for 
exploration were drafted to try out with volunteers who were happy to record videos. 
The decision was made to produce some self-recorded ‘vlog style’ videos and some 
written quotes reflecting personal experiences of living with and managing CFD. 
In the final stakeholder development group meeting the group viewed and discussed 
the web-based programmes developed for the CFD beginner and CFD improver 
modules, this included: overall structure, content, a demo personal experience video, 
personal experience quotes, the formatting of the test your learning sections and the 
interactive components. Feedback from the group then guided the development of the 
web-based format for the final two modules.  
The stakeholder development group also briefly explored the role of the facilitator 
within the MAGIC programme to help identify the frequency and type of support they 
would provide. Time points for facilitation have been highlighted in the programme 
curriculum, see appendix 19 for the example curriculum of CFD beginner. The role of 
the facilitator was clarified in terms of the supporting role they would have with 
patients undergoing the programme. Their role would be in facilitating education and 
acquisition of skills and not the provision of clinical support. It has not been confirmed 
how the support from the facilitator will be best provided and this will be developed in 




5.2.2 The MAGIC programme 
5.2.2.1 Overall design 
The four modules that made up the MAGIC programme are described in more detail 
below, with illustrative examples of content and the application of the theoretical 
underpinnings.  
The MAGIC programme was designed as a patient focussed, staged approach to 
learning; with the aim to develop self-efficacy, knowledge and skills as the participant 
progressed through the modules. All the modules contained a mixture of text, 
educational videos, illustrations, interactive tasks, personal experience quotes/ videos 
and a ‘test your learning’ quiz. Three educational videos were produced by the 
stakeholder development group. These were: what is CFD? how to use a blood glucose 
monitor and how to give an insulin injection (figure 21). These videos were less than 
two minutes long and included both subtitles and narration. The ‘what is diabetes 
video’ by Diabetes UK and series of carbohydrate counting videos by Norfolk and 
Norwich University Hospital were reviewed. The stakeholder development group 
decided these videos were well made and applicable to the educational needs of 
people with CFD. 
   
 





The stakeholder development group have not specified that someone with CFD should 
complete all four modules of the programme; it is dependent upon the individual and 
their needs. It would be the role of the programme facilitator to work with the 
individual and establish their specific requirements. As the programme takes a staged 
approach to learning it is anticipated that most individuals will work through the 
modules from the CFD beginner to the CFD wizard. However, an individual may choose 
not to do this and perhaps dip in and out of modules choosing areas of interest to 











Figure 23 Screenshot CFD beginner 
CFD beginner (figure 23), the first module, was designed for someone new to CFD with 
the assumption being they had very little knowledge or experience of CFD. The 
stakeholder development group considered it as the foundation to CFD management. 
It focussed on basic dietary, insulin and blood glucose management- the minimum 
knowledge someone with CFD was expected to have. The stakeholder development 
group decided to include some basic information about hypoglycaemia in this module, 
as a safety net. Therefore, illustrations of the symptoms of hypoglycaemia (figure 24) 
and the hypoglycaemia flowchart (figure 25), developed for the CFD improver module, 













Figure 24 Illustration of hypoglycaemia symptoms 
 
 





CFD improver (figure 26), the second module, built upon the learning from CFD 
beginner with increasing levels of depth and complexity. This included a focus on 
increasing knowledge about different types of carbohydrates and their effects, insulin 
administration and mode of action.   
 
Figure 26 Screenshot CFD improver 
The third module, CFD advancer (figure 27), aimed to develop more advanced skills in 
CFD management which included carbohydrate counting and calculating insulin to 
carbohydrate ratios. These are more complex skills to learn and develop and therefore 
more practical examples and illustrations were included to help facilitate learning in 







Figure 27 Screenshot CFD advancer 
 
 





The final module- CFD wizard (figure 28) addressed more complex CFD management 
skills which included: insulin dose adjustment and managing insulin in daily life (eating 
out, travelling, alcohol, illness and exercise).  
5.2.2.2 Adult learning styles 
The four adult learning styles: visual, aural, read/write and kinaesthetic (Fleming 2001) 
were carefully considered when designing the MAGIC programme (table 26). Figure 
29-32 are visual representations of how the MAGIC programme applied adult learning 
styles. 
Table 26 Application of adult learning styles to the MAGIC programme 
 






use of colour 
Personal experience videos 
Educational videos 
Aural Personal experience videos 
Educational videos 
Discussion with the facilitator 
Read/write Text- use of short sentences, highlighting key points,  
Personal experience quotes 
Personal logs 
Completing food and blood glucose diaries 
Following instructions 
Kinaesthetic Practical activities 
Completing test your learning quiz 
Carrying out example scenarios/activities  











































5.2.2.3 Self-management framework of chronic illness 
As stated in chapter two the self-management framework of chronic illness  (Corbin & 
Strauss 1988) recognises three important components to self-management of chronic 
illness namely: medical management, role management and emotional management. 
All three of these roles have been addressed within the MAGIC programme (table 27). 
 
Table 27 Mapping of module content and self-management roles 
 
 CFD beginner CFD improver CFD advance CFD wizard 
Self-management 
role 
    
Medical 
management 





 Why does CF 
cause diabetes? 



















Insulin safety Glycaemic index 
 Relationship 
between CF & 
CFD 







 Symptoms of CFD Relationship 
between CF & CFD 
Relationship 
between CF & CFD 
 










   
Emotional 
management 
Beginning to live 
with CFD 
 Living with CFD  
Role 
management 
   Managing 
insulin in daily 
life 
 
5.2.2.4 Self-efficacy theory 
The four main influences on self-efficacy are mastery experience, vicarious 
experiences, verbal encouragement and psychological state (Bandura 1977b); these 
have been addressed within the MAGIC programme. Mastery experience builds upon 




highlight how the complexity of the modules, and hence the associated skills and 
knowledge required, increased from CFD beginner module to the CFD wizard module. 
Mastery experience is also acquired through the direct experience of successfully 
mastering a task. There are many tasks involved in the MAGIC programme to manage 
CFD, including: giving an insulin injection correctly, calculating the carbohydrate 
content of food, managing blood glucose effectively during illness and treating 
hypoglycaemia successfully. The identification and competition of tasks will vary 
according to the individualised requirements of the participant and will be driven by 
their learning, experience and skills requirements.  
 





Vicarious experiences involve learning from others and includes the observations of 
behaviours and actions. Due to cross infection risks the MAGIC programme will be 
delivered on a 1:1 basis via the Internet. The opportunity to learn from others in this 
context is more limited, however the inclusion of personal experience videos gives the 
participants opportunities to listen to others with CFD talk about their experiences and 
provides a vehicle for learning. 
Verbal encouragement influences an individual’s belief in their ability to self-manage 
and acknowledges that many challenges and difficulties may occur. The MAGIC 
programme facilitator will provide support while participants complete the MAGIC 
programme. Some messages of persuasion, encouragement and acknowledgement of 
difficulties are also present in the personal experience videos. The MAGIC programme 
offers messages of normalistaion throughout. These include the acknowledgement 
that carbohydrate counting and insulin to carbohydrate ratios are not always easy 
concepts to understand, but they get easier with time. The living with CFD sections in 
CFD beginner and CFD advancer modules helps to normalise that living with CFD is 
challenging and can impact upon feelings; these sections include personal experiences 
quotes and videos to help deliver these messages (figure 34). 
 





The main focus of the MAGIC programme was on self-management skills and the 
knowledge required to manage abnormal glucose in CF. Therefore, addressing 
psychological challenges such as mood, anxiety or stress were not addressed in detail 
within the MAGIC programme. The sections on living with CFD addressed some 
psychological and emotional challenges and included recommended resources and 
suggestions on how to seek further support and advice. The use of personal experience 
quotes and videos, from people living with CFD, provided insight into some of the 
challenges faced and how these were managed. 
5.2.2.5 NICE criteria 
The MAGIC programme was developed to meet the NICE criteria (NICE 2016). Table 28 
demonstrates how NICE criteria were considered when designing the MAGIC 
programme. A curriculum was developed to support each module of the MAGIC 
programme, it addressed aims, learning outcomes, content and resources. An example 
of a page from the module curriculum for CFD beginner is illustrated in figure 35, the 
full CFD beginner curriculum can be found in appendix 19.  
Table 28 How the MAGIC programme meets NICE criteria 
NICE criteria Examples from the MAGIC programme 






• Have specific aims and 
learning objectives and 
support the development of 
self-management 
 
• Follow a structured written 
curriculum driven by theory  
 
• Be delivered by trained 
facilitators 
• Be quality assured 
• Have its outcomes audited 
regularly 
Qualitative finding from stages 1a and 1b 
Use of expert healthcare professional and people 
with CFD in co-designing the programme 
Use of evidence-based recommendations e.g. FIT, 
UK Gov. 
 
Aims and learning outcomes specified for the 




Curriculum developed for each module. Informed 
by: self-efficacy theory, self-management 
framework and adult learning styles 
 
        






Figure 35 Example of aims and learning outcomes as identified in the curriculum 
 
5.3 Method - Stage 2b review of MAGIC programme  
5.3.1 Research design 
The aim of this stage was to determine the face validity of the MAGIC programme with 
people who had not been previously involved in any part of the study. Cognitive 
interviewing techniques were used to focus on participants’ experiences and 
understanding of the MAGIC programme and its content.  
5.3.2 Research setting  
All participants received their care at a Regional Adult CF centre. All interviews took 
place in a private room, either within the research facility or on the CF ward, at this CF 
centre. 
5.3.3 Participants 
It was originally decided that the MAGIC programme was going to be reviewed with 




and the decision was therefore made to also include people without CFD as the 
reviewers of the first two MAGIC programme modules. Due to time constraints and 
the development phase taking longer than expected there was a limited widow of 
opportunity for recruitment. Participants were initially identified from outpatient clinic 
schedules and ward lists. The participants were purposively sampled to meet the 
inclusion criteria of having CF and/or CFD and being over 16 years of age. Twenty-one 
letters were sent out in stages. The aim was to recruit 8-10 people. Eleven people 
agreed to take part in the study however one withdrew prior to the interview due to ill 
health. Study visits coincided with outpatient clinic appointments or ward admissions. 
This reduced requirement for additional hospital attendance. Interviews took place 
between December 2018 and January 2019. No participant had taken part in any 
previous MAGIC study related activity. Participants received a £20 ‘thankyou’ voucher 
for taking part in the study, and if required travel expenses were reimbursed. 
5.3.4 Ethical considerations 
Prior to commencing the study, approval was received from: London-South East 
Research Ethics committee- 17/LO/0377 (appendix 7), NHS Health Research Authority 
(appendix 8) and Royal Brompton and Harefield NHS Foundation Trust (appendix 9). 
Informed written consent, including agreement for digital audio-recording and note 
taking was obtained prior to starting the interviews. A copy of the participant’s 
consent form was stored in their electronic patient record. The audio recordings were 
stored on a password protected computer. 
5.3.5 Data collection 
Each participant reviewed one module with the researcher. A range of cognitive 
interviewing techniques including: exposure to test material, think aloud, observation, 
probing and task completion were used to verify understanding of content and 
instructions, identify gaps and appraise the visual appeal of the programme 
(D'Ardenne et al. 2015). Table 29 illustrates how cognitive interviewing techniques 
were applied to the MAGIC programme review process. The interviews were digitally 




Table 29 Application of cognitive interviewing techniques in the MAGIC programme 
review 
Cognitive interviewing technique Example  





















Participants were asked to work their way 
through the module, trying tasks, navigating 
around the website, watching videos and 
completing quizzes 
 
Participants were asked to talk through their 
thought processes when completing tasks/ 
activities 
 
Participants were observed navigating around 
the module and its content 
 
Participants were asked questions to review 
their understanding for example from reading 
that section can you tell me what carbohydrates 
are? What do you think that section is trying to 
tell you? Was there anything in that section 
wasn’t clear? Was there anything missing? 
What could be done to make this clearer? 
 
Participants were observed carrying out tasks 
such as the drop and drag activities, calculating 
the carbohydrate content of meal activity, 
working out insulin correct factors and test your 
learning quiz. Questions were used  
to clarify their understanding of instructions and 
processes 
   
5.3.6 Data analysis 
After each review the interview notes were written up; where there was ambiguity the 
interview recordings were listened to for further clarity. The findings were given 





Table 30 Classification of findings 
classification description 
omission Missing information- words/ letters/ punctuation 
error Information/ objects in the wrong place 
Information not correct 
visual Any issues with use of colour, illustrations, diagrams, 
highlighting text 
comprehension Difficulty understanding wording/ illustrations/ graphics/ 
videos 
Use of language 
technical Anything involving sound, videos, moving images or links to 
websites 
other Anything else 
 
5.4 Results 
Ten people participated in the interviews, these lasted between 71 and 134 minutes 
(median 107 minutes). Demographic information for the participants is shown in table 
31. Six of the study participants had CFD, three did not have CFD and one had impaired 
glucose tolerance, for which he was not currently receiving treatment. Each module 
was reviewed by at least two participants. An example of review findings is shown in 






Table 31 Demographics of study participants 
participant gender Age 
(years) 




1 M 36 IGT- not on 
treatment 
N/A CFD beginner 
2 M 42 CF N/A CFD beginner 
3 M 48 CFD > 5 years CFD improver 
4 M 43 CF N/A CFD improver 
5 M 33 CF N/A CFD improver 
6 M 44 CFD >5 years CFD advancer 
7 M 56 CFD >5 years CFD advancer 
8 F 32 CFD >5 years CFD advancer 
9 F 43 CFD >5 years CFD wizard 
10 F 45 CFD >5 years CFD wizard 
 
 





The MAGIC programme was highly regarded by the review participants. Some of the 
participants’ comments on the overall feedback of the MAGIC programme are 
highlighted in table 32. Very little negative criticism, other than that described in tables 
33-37, was received. 
Table 32 Overall feedback on the MAGIC programme 
Participant comments on their overall impression of the MAGIC programme 
(participant number) 
It’s a useful tool all of this, would have made things a little easier if someone had 
said to me ‘look here’s a website, go to this when you get home.’  If you’ve got any 
questions you’re welcome to call us. But you know this is a useful resource for 
people, I do think. Because you know sometimes, you know, we don’t want to call 
and hassle you over one little question. (1). 
It’s good to read their experiences especially because you obviously can bring up 
things that they might bring up, they might be worried about (2) 
I like the way it is broken down into different section. It feels like I could, on one bus 
journey read one section, on the next I’ll read he next. So it’s nice that it’s not just 
one long document. It’s really friendly (4) 
I think it’s a really good website because its got, it’s very comprehensive but it 
doesn’t feel like there’s too much there. Erm, the module doesn’t feel like it’s got too 
much in it, it’s well structured as well and erm I personally learnt a lot. (5) 
The videos are good, you haven’t just got people in white coats, not that there is 
anything wrong with them. You’ve got real people in there, that’s good as well. (7) 
I wasn’t this educated at the beginning and I think this would educate me quicker at 
the beginning, being diagnosed. (8) 
Oh it’s brilliant, I wish I had it sooner, years ago. (9). 
 
Um, well it was easy to, easy on the eye, clear. Not just loads and loads of text that 
you have to read. Also diagrams and little challenges does probably get you thinking 













Table 33 Omissions identified within the MAGIC programme 
Module Example of omissions Example participant quotes (participant number) 
CFD beginner • No explanation that the personal experience quotes are 
from real people 
• Word missing 
• Heading from hypo flowchart missing 
 
 
It might be worth having a heading there. (1) 
CFD improver • Missing capital letter 
• Do not say what FIT is 
• Time missing on mode of insulin action charts 
• Use terms long-acting and background instead of just 
the agreed term long-acting 
• Test your learning quiz does not say only tick one answer 
• Personal experience quotes under carbohydrate section 
are missing a heading 
 
And what’s the one across the bottom? Time? (5) 
 
Can you click more than one? (4) 
CFD advancer • No warning to clarify that not all the information is 
medical advice e.g. personal experience quotes/ videos 
• Word missing 
You could say not all information given in the videos are, 
not necessarily err medical advice that we would give to 
our patients. I’m thinking particularly about the third guy. 
(7) 
CFD wizard • No information on people with CF needing more salt 
• Letter missing from your, says you 
• No instructions for insulin dose adjustment chart 
• Challenging foods video not clarified that for people with 









Table 34 Errors identified within the MAGIC programme 
Module Example of errors Example participant quotes (participant number) 
CFD beginner   
CFD improver • Reference to a carbohydrate table which no longer exists  
• Wrong classification of milk as fast acting 
• Reference to how insulin is absorbed from the arms, 
however the arms are not included in the illustration 
• Comma missing from text 
• Of should be if 
• Use should be used 
• Cause instead of causes 
• Sweets are carbs- drop and drag identifies incorrectly 
 
CFD advancer • Cooked and uncooked rice are labelled as the same 
weight 
• Table and example for calculating carb content of 
weighing foods do not say the same value for potatoes 
• Food and carb content not lined up correctly in food 
diary 
• Example of calculating insulin to carb ratio- values do 
not agree between table and text 
• Use of this instead of it 
• Use instead of used 
• Feedback Q2 and Q3 on calculating meal do not match 




















• Q6 of test your knowledge -discrepancy between text 
and correct answer 
What, err right. Every 30 minutes, well I’m not surprised I 
got that one wrong. I thought it said 2 hours earlier when I 
read that. I thought it said every 2 hours? (6)  
CFD wizard • Calculation in recipe examples are wrong- lasagne and 
scones mixed up 
• Dairy and alternatives and beans, pulses, fish, eggs, meat 




Make sure you’ve got the labels right, cause I was 
confused. (9) 
 
Table 35 Visual issues identified within the MAGIC programme 
Module Example of visual issues Example participants quotes (participant number) 
CFD beginner • Why we need insulin illustration – words too far away 
from illustration 
• Effect of food on insulin- images hazy 
• Text quite small in some sections 
• Use of bullet points helpful 
• Highlight key words in bold to make clearer 
• Not clear graph enlarged when clicked on it 
 
Think it could be mildly confusing in some way, unless you 
can combine them and just have one group. I would be 
wondering why is this one here? (1) 
 
The writing is bolder, so that is better (2) 
CFD improver • Did not notice well done- consider colour scheme used 
• Highlight key words e.g. do not  
• Not clear graph enlarged when clicked on it 










• They all contain the same amount of carbohydrate box not 
clear 
• In drop or drag quiz -need a reminder if answers were 
correct or not for when move up and down the page. 
 
 
I wouldn’t be able to remember which ones should be here 
and which ones should be there. So, if you had a tick or a 
cross over each one. (4) 
 
CFD advancer • Size of print on bread label a bit small 
• Box with answers on which food contains the most 
amount of carbohydrate quiz is not clear 
• To look visually the same should have a box under each 
food label to summarise amount of carbohydrate 
• Would like to see answer after each meal on carbohydrate 
counting activity 
• Didn’t like use of different colour to highlight section in 
another module 
 
I mean that’s small though, isn’t it? [..] I think that’s too 
small to read. (7) 
 
I think keeping it consistent. The way my mind works I’m 
looking for the same thing on each page and actually on this 
one you have to scroll down to see that text. And on this 
particular screen I hadn’t scrolled down so hadn’t seen it. (8) 
CFD wizard • Table of blood glucose confusing, shading would help to 
make the numbers stand out 
I don’t know if doing something with the graph, putting a 
bit of colour, or just that bit, the time bit, cause its just 
numbers. And for somebody who really doesn’t struggle 
with numbers, for me it’s a little bit, I’m struggling a bit. It’s 











Table 36 Comprehension difficulties identified within the MAGIC programme 
Module Example of comprehension difficulties Example participants quotes (participant number) 
CFD beginner • The term respiratory exacerbation was not thought to 
be understandable by all- chest infections considered a 
more appropriate term 
• Expand and collapse not clear throughout- click to 
enlarge considered clearer 
• Images of carbohydrates- bread unclear 
• Need to clarify that should not use hand cream prior to 
checking blood glucose  
• Use of language consider changing some people to 
people to reflect a more common problem 
• Didn’t know what a PEG was 
 
It says more frequent respiratory exacerbations; do 
you know what it means by that?  
No, what does that mean? (2) 
 
I wouldn’t know to click on that, I’ll be trying to squint 
and read it. (1) 
 
CFD improver • Use term sweet not candy 
• Drop and drag- some images not clear (oil, potato) 
• Types of carbs- images not clear (potatoes, yoghurt, 
rice, oats, pancakes) 
• Quick vs slow- some images not clear (breakfast cereal, 
pasta, fizzy drink) 
• DUK video- not clear what this link is, need an 
introductory sentence 
• FIT website- link not clear, need to say further 
information can be found: 
 
I don’t know what the hell that is. (3) 
 








• Use of language- if you do eat, reads better if you eat 
• HbA1c- is the section about NICE targets for type 1 
diabetes necessary, a bit confusing as wan to know 
own targets 
• The section on the concentration of glucose in the 
airways was not clear and easy to understand 
 
CFD advancer • Which foods contain the most amount of 
carbohydrates- not clear need to drag the word to the 
box or what some of the pictures contained 
• How to count – not clear should use the per 100g figure 
• Consider use of cross referencing to the exercise 
section for link with rounding up/down. Ask questions 
about if people will know the effects of exercise 
• Carbohydrate counting activity not clear what have to 
do 
• When reading the underweight section needed 
reminding this was for underweight and not everybody 
• Q9 test your knowledge- the option more activity than 
usual during the previous evening was confusing 
• Living with CFD one participant was having problems 
with the terms try and identify. Which they felt could 
be a more personal reflection of their experience at 
that time. The other two participants did not struggle 
with this 
I also thought that was just a roast chicken rather than a 
whole roast dinner so, because you can’t see any potatoes 






















• Term ‘get help’ – 1 participant again was worried about 
use of language, prefer term ‘receive’ 
• Test your knowledge quiz- not clear can only tick one 
answer 
• To remind again what fast -acting carbohydrates are 




Or is it just the wording? Try and identify which parts. I’m 
wondering if that can be a bit softer- I don’t know. (7) 
CFD wizard • Fish- not understanding why it says to have two 
portions fish per week here, what if didn’t eat fish. Felt 
it was a bit confusing and could be removed as there 
was a link to the Eatwell guide. 
• Wording in the UK Chief Medical Officer guidelines is 
not clear 
• Wording why alcohol causes hypoglycaemia not clear 
• Did not understand why a blank insulin dose 
adjustment diagram was in the text 
• One participant questioned if people would know how 
to increase their salt intake- both participants knew 
how to 
• Steroids- the picture used looked for like pancreatic 
enzymes 
 






Erm I don’t think so cause people would know that 









Table 37 Technical issues identified within the MAGIC programme 
Module Example of technical issues Example participant quotes (participant number) 
CFD beginner • Quality of sound in what is CFD video; one participant 
felt that the voice over was a bit drab and the video was 
formal.  
• Personal experience videos – the voice in one of the 
videos is not in synch 
• Can’t see all the side headings on the screen  
 
This scrolly thing, I assume if you go on it, it should go up 
and down, but it doesn’t. (1) 
CFD improver • Types of carbohydrates- illustrations move too quickly 
• How to use an insulin pen video- the sound quality goes 
up and down 
• Relationship between CF & CFD – the videos in this 
section could not be opened in the programme, videos 
loop together 
• Personal experience quotes in hypo section move too 
fast to read 
• Personal experience videos in hypo section loop 
together 
• Suitability of programme for tablets/ phone highlighted 
 
They move a bit fast. (4) 
CFD advancer • Personal experience videos in carb counting section- the 










• Music on introduction to carbohydrate counting video 
made by Norfolk and Norwich was a bit annoying for 
one participant 
• One mention of considering the use of subtitles on 
videos 
• Quotes in living with CFD section move too fast 
• Format of side panes is grey, could there be a way of 





Didn’t quite get the end of this. Doesn’t want me to read 
that does it? (6) 
CFD wizard • Managing insulin in daily life- personal experience quote 
move too fast to read 
 





One other comment, received from two participants, was to consider the use of a 
glossary for key terms and definitions.  
 
5.5 Discussion  
The findings from this study are discussed in relation to the research question “what 
does a web-based education programme for people with CFD need to contain?” 
Clinical implications of the research findings, methodological issues and ideas for 
further research will then follow.  
The precise content for DSME programmes is not specified in NICE guidelines (NICE 
2016). The content for the MAGIC programme was guided by four key areas of self-
management: insulin, managing nutrition, blood glucose and ‘what is CFD?’ which 
were identified from stages 1a and 1b, and the stakeholder development group. DSME 
programmes, that meet NICE criteria (NICE 2016), including DAFNE (DAFNE Study 
Group 2002) and BERTIE (Everett et al. 2003) also focus on insulin, nutrition and blood 
glucose as key areas, however as they are aimed at people with type 1 diabetes they 
have a greater emphasis on healthier eating principles, exercise and diabetic 
complications including diabetic ketoacidosis (DKA). They both also explore pregnancy 
and contraception which has not been addressed in the MAGIC programme. BERTIE 
(2019) has an extensive ‘streetwise’ section that covers issues not discussed in the 
MAGIC programme such as: drugs, school, leaving home, tattoos and piercing. DAFNE 
(DAFNE Study Group 2002) is delivered in a group setting whereas BERTIE (Everett et 
al. 2003, BERTIE 2019) is the only available type 1 DSME programme available to 
groups and online. There are currently no evidence-based DSME programmes available 
for people with CFD. The MAGIC programme is evidence-based and supports the 
development of the core self-management skills required to successfully manage CFD 
via a web-based learning platform. 
In agreement with the MRC Framework (Craig et al. 2008) and to meet NICE criteria 
(NICE 2016) the MAGIC programme was developed with sound theoretical 




chronic illness and adult learning principles. These theories are commonly used in 
DSME (chapter two) and were identified as being the most relevant to meet the 
learning needs of this population. At a later stage of research to demonstrate 
effectiveness of the MAGIC programme self-efficacy will need to be considered as an 
outcome measure.  
The review of the MAGIC programme was designed to: explore understanding and 
ease of use, identify missing information, establish any visual issues and detect 
problems with the information or instructions provided. Ten people with CF took part 
in these reviews; six of these had CFD. Overall the programme was well received by the 
participants. The reviewers identified omissions, errors, technical issues, visual 
problems and comprehension difficulties within the programme. All errors and 
omissions were discussed with the digital content manager and the necessary 
amendments were made. All visual issues were discussed with the digital content 
manager and all except the format of the carbohydrate counting meal activity were 
changed. One participant did not like the answers to the carbohydrate counting meal 
activity appearing at the end of the activity, they would have liked to see the answer 
appear after each meal instead. The programme that was used to write all the quizzes 
for the MAGIC programme did not have the facility to give answers after each 
individual question. This being the opinion of a single participant, and the overall 
quality of the programme not being significantly affected by this format, the decision 
was made to leave it as it was. Changes could be made after future reviews if deemed 
appropriate. 
The comprehension issues identified were considered very carefully. Where difficulties 
with clarity of images were highlighted, these were changed. Instructions on how to 
enlarge charts and graphs were made clearer with use of ‘click to enlarge labels.’ In the 
alcohol and HbA1c sections, where clarity was needed because the text was complex 
and difficult to understand, modifications were made using the suggestions given by 
the participants. Where comprehension issues were identified in the living with CFD 
section further advice was sought from patient members of the stakeholder 




All technical issues concerning sound, the movement of images/quotes and videos 
were reviewed with the digital content manager. Due to inconsistencies in sound the 
narration for the how to use a blood glucose monitor video and how to give an insulin 
injection video was re-recorded. One participant felt the voice on the what is CFD 
video was a bit drab and considered it to be quite formal although they then 
acknowledged it was meant to be. The video was shown to four other participants 
during the reviews and none of them commented on this. It has also been shown the 
stakeholder development group and PhD project management group during its 
creation, with no further comments received. The decision was therefore to go with 
the consensus and to leave the video as it was. All moving images and quotes were 
either slowed down or stopped from moving so that they could be read more easily 
and did not distract the participant from the content on screen. 
The review generated two comments about the use of a glossary. The idea was 
considered, but has not been included in the MAGIC programme at present, due to 
prioritisation of all the other amendments that needed to be addressed in the 
timeframe. However, opinions from the stakeholder development group will be sought 
to review the need for a glossary as a future addition to the MAGIC programme.  
Using the principles of co-design, the stakeholder development group created an 
evidence-based DSME programme for people with CFD. This has been subject to 
review to identify any issues with face validity in a small group of adults with CF/ CFD. 
The majority of the issues identified were subsequently amended. The MAGIC 
programme is unique as no other programmes for people with CFD of its kind exist. It 
is now at the stage that further research is needed to evaluate its impact on the key 
CFD behaviours of managing blood glucose, insulin and nutrition.  
5.5.1 Strength and limitations 
The MAGIC programme is grounded in evidence generated from a qualitative 
systematic review, qualitative interviews and shared experiences of people with CFD 
and healthcare professionals expert in the management of CFD. The content of the 




service provision was identified in chapter three and four, the MAGIC programme 
could be integrated into service improvements to provide educational and self-
management support to people with CFD. 
The MAGIC programme was developed through the process of co-design. The main 
benefits of using a co-design design approach are: the end product reflects customer 
needs, it generates useful information and it creates a feeling of involvement and 
ownership (Bradwell & Marr 2008). With co-design there is equality in the 
contributions from all involved (Bradwell & Marr 2008). Maintaining equality was an 
additional challenge during the use of videoconferencing for the stakeholder meetings. 
The appointment of a ‘link person’ to monitor links with people at home ensured 
equality. Alternatives methodologies to co-design such as participatory action research 
and experience-based co-design were considered but not deemed appropriate as they 
do not focus on intervention development.  
The MAGIC programme has been designed to meet NICE criteria (NICE 2016) however 
delivery by trained facilitators, quality assurance and audit of outcomes will need to be 
addressed in future research. As recommended the development of the MAGIC 
programme was driven by relevant theory appropriate to the needs of people with 
CFD (NICE 2016). Self-efficacy is a particularly important factor that has been identified  
in influencing diabetes self-management behaviours (Mishali et al. 2011) and was very 
influential on the MAGIC programmes staged approach to learning. 
The participants who reviewed the MAGIC programme were known to me in my 
previous role as a healthcare professional. This may have influenced the findings and 
also challenged the researcher-clinician role (Hay-Smith et al. 2016). Before starting 
the interviews, I explained to the participants that the purpose of the interviews were 
to review the MAGIC programme, and I was there as a ‘researcher’ and would not 
comment on their knowledge or self-management practices. Participants are often 
said to have difficulty in differentiating between a clinical consultation and research 
contact (Hay-Smith et al. 2016). Despite discussing my research role some participants 




example their method of carrying out a task was different to the method the 
programme used. For example, one participant calculated carbohydrates in a different 
method, this was due to their more advanced level of understanding and maths skills. 
In another interview a participant attempted to seek advice for their parent with 
diabetes. I remained non-judgemental throughout the interviews and where possible 
avoided clinical discussions. A clinician-researcher cannot completely discard their 
clinical role, what is important is the acknowledgement of this role and exploration of 
challenges created by it (Haye-Smit 2016). 
Another limitation of being known to the research participants in a clinical role is social 
desirability bias. This is the tendency for participants to respond to questions in a way 
that is thought of more favourable so they present themselves in a more positive way 
(Neeley & Cronley 2004). The participants may therefore have been less critical and 
therefore more likely to only say positive things. I don’t believe this happened, to a 
great extent, as participants gave both criticisms such as the images on the effects on 
food on insulin were hazy, voice over on one of the vides was drab, text is quite small 
in some sections along with positive comments such as the use of bullet points is 
helpful, the videos are good and ‘oh it’s brilliant.’ Many important issues were 
identified within the participants reviews which helped inform necessary modifications 
to improve the MAGIC programme. 
This sample size for the reviews was small compared to some studies using cognitive 
interviewing techniques, where sample size ranged from 19-40 participants (Banna et 
al. 2015, Fernandes Davies et al. 2016, Park et al. 2017, Anderson et al. 2018). One 
study, a pre-pilot usability testing of a web-based programme conducted cognitive 
interviews with 4 participants (Berry et al. 2010). The sample size of this study, to 
review the face validity of the MAGIC programme, was deemed relevant to the study 
design, allowed for two or three participants to review each module and was feasible 
in the timeframe allocated for this stage of the study. The cognitive interviews in this 
study were fairly lengthy (median 107 minutes). In studies that reviewed surveys or 
questionnaires cognitive interviews were shorter, lasting 40-60 minutes (Carbone et al. 




interviewing to evaluate a web-based decision support system, for men with prostate 
cancer, it took 60-90 minutes to complete the programme and cognitive interview 
(Berry et al. 2010). Therefore, more complex interventions/ resources such as web-
based programmes, which are often multidimensional, take longer to review. The 
sample did not contain any young people with CFD, three of the 21 letters of invitation 
to participate were sent to people less than 26 years old but they did not respond. One 
of the patient members of the stakeholder development group was younger than 26 
years, so there was some representation and experiences within the MAGIC 
programme development within this age range. Having younger members of the group 
may have had different influences upon the programme and its content. Particularly 
adolescents as they have specific needs associated with seeking independence such as 
going to university, leaving home or starting work which have not currently been 
addressed.  
CFD is a complex disease to manage, the MAGIC programme was informed by four key 
components which were identified as being significant in the self-management of it. 
This meant that not all areas of CFD management were included within the MAGIC 
programme. Psychosocial and emotional support have not been addressed in detail, 
but their importance in CFD self-management has been acknowledged. The 
stakeholder development group recognised the importance of psychosocial and 
emotional support for people with CFD and therefore incorporated as much guidance, 
support and personal reflections where it could. The MAGIC programme contains two 
sections on living with CFD which includes personal experiences quotes/videos and 
identifies mechanisms for further support. Usability testing of a web-based 
programmed for adolescents who had a solid organ transplant, demonstrated patient 
experience videos were well received due to their trustworthiness and reflectiveness 
of real patient’s experiences although their impact on self-management was not 
reviewed (Korus et al. 2015). The use of personal experiences throughout the MAGIC 
programmes reflects what it is really like to live with and manage CFD and these 
messages will provide some support by learning through shared experiences. Online 




experiences to help support self-management (Kirk & Milnes 2016). Personal 
experience videos and quotes are the MAGIC’s programme first step in this process. 
Through further usability testing other forms of communications such as chat boards 
or discussion groups may be considered. It is also important to consider that National 
guidelines recommend that all people with CF have access to a psychologist as part of 
their routine care (NICE 2017), so their emotional health and well-being is regularly 
assessed. The programme facilitator will also be a means of contact with the 
participants and their role in support whilst undertaking the programme will need 
evaluating. 
Other components not included in the MAGIC programme were pregnancy, 
contraception, transplantation and moving away from home/starting university. This 
does mean there were not considered relevant they were not regarded as key factors, 
by the stakeholder development group, that affected the majority of people with CFD. 
In the future additions to the programme may be considered. 
5.5.2 Implications for practice 
The MAGIC programme is an extensive resource to facilitate the self-management of 
CFD. It is versatile programme designed to enable people with CFD to acquire the 
necessary skills and knowledge to manage their CFD. Its web-based delivery means it 
can be used at home or other convenient times, thus avoiding the need to travel to the 
hospital more than necessary. The MAGIC programme could be integrated into the 
delivery of CFD care as a resource for people newly diagnosed with CFD or for those 
with established CFD who could benefit from further education. The MAGIC 
programme may also be of benefit to healthcare professionals working in CF to try to 
improve the knowledge deficits observed among healthcare professionals about CFD 
(chapters three and four).   
This study demonstrated the face validity of MAGIC programme however to establish 
its effectiveness further research is needed. A feasibility study is required to: 
• Identify how the MAGIC programme is used in the ‘real-world’ situation. This 




blood glucose diaries and secure log ins which were not reviewed within the scope 
of this study 
• Determine which outcome measures are appropriate and subject to change 
• Establish the role of the facilitator in delivering the MAGIC programme 
• Explore recruitment and retention rates 
5.6 Conclusion 
Through the process of co-design this study has developed a unique evidence-based 
self-management education programme for people with CFD. The MAGIC programme 
was highly regarded by people with CFD, involved in this study. Its design as a web-
based programme allows for more timely and appropriate delivery of self-
management education. Further studies are however required, to demonstrate 
effectiveness, before the MAGIC programme can be used in routine clinical practice. 
5.7 Research Outputs 
The development of a self-management education programme for people with CFD. 
Oral presentation at adult and paediatric CF research away day, Royal Brompton & 
Harefield NHS Trust- (12th July 2019). 
Collins, S., Jones, A., Woodward, S. & Sturt, J. (2019) P403 The experience of co-
designing the MAGIC programme for people with CFD. Journal of Cystic Fibrosis18, 
S171. Poster presentation at European CF Conference, 5-8th June 2019 
PhD project management group meeting 3, 4th January 2019- presentation of the 







This study has developed an evidence-based self-management education programme 
for people with CFD. This chapter summarises key findings and discusses these in 
relation to the research questions, relevant literature and theory. This is followed by a 
review of the strengths and limitations of the research conducted, the implications for 
clinical practice and recommendations for further research. Figure 37 summaries how 
the MAGIC programme development was informed by the research questions and the 
key themes identified in stage one. 
 
Figure 37 Key themes and how they informed the MAGIC programme development 
 
6.1 Review of key findings 
This study has demonstrated five keys findings: the response and adaptation to CFD 
included learning about CFD and its management and developing support and 
relationships; trying to balance the relationship between CF and CFD involves many 
complexities; there are deficits in service provision and support for people with CFD; 




lastly the MAGIC programme was developed as a staged approach to learning. These 
will be discussed in more detail. 
6.1.1 The response and adaptation to CFD  
The response to chronic illness has been described as first responding to effects of the 
illness followed by the processes of adaptation and management (Charmaz 1995, 
Paterson et al. 1998). Adaptation to, and management of, chronic illness are 
simultaneous and interdependent; they are the processes occurring as the individual 
tries to come to terms with the long-term impact of their illness and include learning 
about the illness and its management, acquiring support and establishing relationships 
(Paterson et al. 1998). The response to CFD was no different to that of other chronic 
illnesses and these processes of adaptation and management were observed in this 
study. Initially the diagnosis of CFD was associated with many negative emotions such 
as confusion, shock and fear which changed as people began to adjust to life with CFD. 
As people began to learn to incorporate CFD into their lives issues which challenged 
identity, coping mechanism, understanding, control and the constancy of CFD were 
seen. These findings are not unique to adaptation to CFD as they have also been seen 
in people with type 1 diabetes (Schur et al. 1999, Celik et al. 2015, Robinson 2015, King 
et al. 2017). For CFD the focus of management, for participants, was about the 
essential components required for the day-to-day management of CFD; these included 
self-management skills, knowledge and balancing CF and CFD. Throughout the clinical 
course of CF, due to changes in health, management and adaption are simultaneously 
evolving. 
When exploring the experiences of people with CF it is important to consider that 
these individuals have experienced healthcare systems from a very early age. They 
have attended hospitals and clinics on a regular on-going basis for medical treatment 
and care and they are experienced at managing complex daily treatment regimens. 
The development of diabetes, for them, is a second chronic illness. Experiences 
developed while living with one chronic condition and familiarity with healthcare 
systems can help the management of subsequent illness (White et al. 2016). This was 




routines and thus experienced less management difficulties. For those who managed 
the conditions separately there was more disrupted routine and less ability to cope.  
CFD had a variable impact on individual day-to-day life and this was influenced by 
changes in health status, ability to cope and level of understanding. The ‘Shifting 
Perspective Model of Chronic Illness’, has been described (Paterson 2001). This model 
views living with a chronic illness as an ongoing and continually shifting perspective in 
which either wellness or illness is in the foreground. Wellness in the foreground 
perspective suggests the management of the chronic illness itself is paramount in 
order to keep ill health away. Paterson (2001, p 24) states “the illness requires 
attention in order not to have to pay attention to it.” This perspective is not static and 
reflects an individual’s needs and situation. This perspective is applicable to the 
management of CF which requires extensive daily treatment regimens to maintain 
health where the focus is on wellness rather than illness. However, the development 
of CFD further increases this burden of treatment and monitoring. CF was perceived as 
having more impact on physical health than CFD and therefore affected the ability to 
complete daily activities, which would be related to its impact on the respiratory 
system and the associated effects of reduced lung function.  
6.1.2 Trying to balance the relationship between CF and CFD  
Living with CF and CFD was regarded as a complex-multi-dimensional process where 
the two conditions were intertwined. The perception of CFD, was it seen and managed 
as part of CF or as a separate entity, directly influenced management. This study 
proposed an integrated model of management based around the presumption CFD 
was regarded as part of CF. When viewed as one condition CFD will be managed as 
part of routine CF care; all treatments, therapies and self-care strategies such as 
behaviours, beliefs and coping mechanisms, are managed together; what affects CFD 
will directly impact CF and vice versa. In middle and older aged adults with diabetes 
the presence of a discordant conditions such as cancer, arthritis or lung disease were 
associated with lower diabetes prioritisation and lower self-management ability (Kerr 
et al. 2007). Although the age of this diabetes population is different from a typical 




other are managed separately and this influence self-management. CFD and CF should 
be managed together, however further work is needed to establish the best way to 
manage gaps in service provision to support this. 
People with CFD view their CF as the most important illness because of the recognition 
they will die from CF. They therefore prioritised the management of their CF. 
Prioritisation of disease management is not uncommon in people with multi-morbid 
conditions. A study of heart failure self-management practices in people with 
multimorbid conditions demonstrated that individuals also had to prioritise one 
condition over another (Dickson et al. 2011). They based decisions upon their 
experiences with the different conditions, for example it they had experienced a life-
threatening episode due to complications of heart failure they would prioritise this. 
Self-management decisions were informed by both experiential beliefs (the behaviour 
is easy/difficult) and evaluative beliefs (the behaviour is important/unimportant) 
(Dickson et al. 2011). People with CF found the effects of not doing CF treatment were 
more noticeable and thus more important to them than those of CFD. In adults with 
diabetes, the severity of co-morbidities influenced an individual’s ability to focus on 
diabetes and to perform self-management tasks; with diabetes viewed as a lower 
priority and its self-management tasks considered more difficult (Kerr et al. 2007). 
Diabetic renal disease is a co-morbidity associated with diabetes. For many of these 
people, with diabetes, the development of diabetic renal disease was a sign to them 
that they needed to regard their diabetes more seriously, specifically dietary and 
treatment regimens (King et al. 2002). Generally, there was an avoidance of thinking 
about the future progression of their renal disease and/or diabetes as this was 
considered unhelpful. There was a sense that individuals carried on to the best of their 
ability, living from day-to-day, not dwelling on their own mortality. Many were more 
concerned with the development or exacerbation of other complications, particularly 
blindness. Participants with CFD, in this study, were aware that they were at risk of 
diabetes related complications, especially eye damage, but they didn’t ruminate on 
these, they just put their thoughts concerning this in the background. People with 




condition through hospital appointments and dialysis sessions. They may have 
therefore had more exposure to people with significant diabetes related complications 
such as blindness. People with CF are advised against face-to-face contact with other 
CF patients and are therefore less likely to see people with CFD and diabetic related 
complications. They are therefore likely to worry less about the risk of blindness and 
other complications.  
A qualitative study, of adults in Taiwan, explored experiences from the diagnosis of 
diabetes through to haemodialysis (Yu & Tsai 2013). Diabetes to most participants was 
identified as a disease that was chronic and long-term, and upon its onset it was not 
felt to be an immediate risk of death. The perception of diabetes symptoms affected 
attitude towards disease control; with self-management neglected unless symptoms 
were apparent. People with CFD were also not concerned with the risk of death from 
diabetes. They however didn’t appear to neglect their CFD, it was more an issue with 
balance and prioritising what was important to them at that particular moment in 
time. With CF often being prioritised because the effects of not doing CF treatments 
were more noticeable and immediate. Diabetes needs to be considered in context, in 
these Taiwanese adult’s cultural beliefs informed decisions relating to changes to diet 
and lifestyle, with changes not being made as symptoms were not evident.  
Since the late 1990s the term cystic fibrosis related diabetes has been used to describe 
diabetes in people with CF. Prior to this it was referred to as diabetes of cystic fibrosis 
or cystic fibrosis diabetes mellitus. In view of the recognition that CFD is caused by CF 
and to strengthen the relationship between these two conditions a name change from 
cystic fibrosis related diabetes to cystic fibrosis diabetes was proposed. In 2014, 
international consensus guidelines recommended that diabetes diagnosed in post-
transplant patients changed its name from new onset diabetes after transplant 
(NODAT) back to post transplant diabetes mellitus (Sharif et al. 2014). This was as a 
recognition that not all cases of diabetes diagnosed post-transplant are new; the 
diagnosis may have been missed pre-transplant due to ineffective screening 
programmes. Therefore, the name post-transplant diabetes mellitus avoids any 




Diabetes has historically gone through many name changes including juvenile or adult 
onset diabetes, insulin dependent diabetes or non-insulin dependent diabetes and the 
current terminology, of type 1 and type 2 diabetes. The diabetes community are not 
happy with current terminology and have petitioned for changing the name to reflect 
the nature of diabetes (Hoskins 2018). Diabetes associated stigma is another driving 
force for changing the names used (Browne et al. 2014). In people with type 1 diabetes 
stigma has been seen as type 1 diabetes specific e.g. discrimination, exclusion and also 
stigma-by-association with type 2 diabetes e.g. blame, stereotyping (Browne et al. 
2014). Similarities have been seen in managing schizophrenia, where the impact of its 
name is seen to be stigmatising and harmful (Lasalvia et al. 2015). Japan was the first 
country to change its name for schizophrenia from ‘split mind’ to ‘integration 
dysregulation syndrome’ (George & Klijn 2013). This resulted in better acceptance of 
diagnosis and a reduction in stigma. This has however not been internationally 
adopted (Lasalvia et al. 2015). Although people with CFD did have concerns around 
stigma experience particularly around giving insulin injections in public, strengthening 
the causal relationship and establishing the therapeutic and treatment links between 
CF and CFD is more important and was the driving force behind name change. 
One of the challenges seen in the management of CFD was associated with the 
unpredictable nature of both CF and CFD. There are lots of uncertainties living with an 
unpredictable long-term condition like CF where the experience has been described as 
being like a ‘rollercoaster’ of fluctuations in health (Knudsen et al. 2018). This can 
result in day-to-day variability in clinical symptoms that in turn impact upon blood 
glucose levels and the management of CFD. The management of CFD is complex due to 
multiple factors, pertinent to CF, that affect glucose metabolism. These include: 
malabsorption, chronic/acute respiratory infections, glucagon deficiency, abnormal 
intestinal transit time, liver dysfunction and increased energy expenditure (Dyce et al. 
2015). People with CFD had to continually make treatment and management decisions 
which changed frequently; this added to the overall complexity in CFD management. 
Taking corticosteroids as a treatment of CF further added to the complexity of CFD 




appearance and blood glucose levels and for some the psychological effects such as 
mood swings. There was a sense of disbelief that a treatment which was meant to be 
benefiting their CF has such negative effects upon them. One participant had an 
extremely negative relationship with corticosteroids as he blamed them for causing his 
CFD; this led to him boxing off diabetes and not fully accepting it. These findings are 
unique to the IPA study as no qualitative work looking at experiences of taking 
corticosteroids in people with CF exists. The impact of corticosteroids on blood glucose 
levels has been reported in CF; approximately one-third of adults and children with 
CFD found controlling their blood glucose challenging whilst taking corticosteroids 
(Millington et al. 2014). Limited qualitative research exploring the experience of taking 
corticosteroids in other illnesses also exists. Haematology patients have reported 
physical symptoms of corticosteroid use to include: weight gain, extreme hunger, 
swollen face, fluid retention, visual disturbances, bruising and flaky skin. They 
described these physical symptoms as distressing and challenging and they 
exacerbated the psychological difficulties experienced with corticosteroid use 
(McGrath & Holewa 2010).  
6.1.3 Deficits in service provision and support for people with 
CFD 
Healthcare professionals were the first point of contact for the participants, however 
there was a requirement for them to be knowledgeable about CFD. There are currently 
only 2026 adults in the UK on treatment for CFD (Cystic Fibrosis Trust 2018a), CFD is 
therefore a rare condition and many healthcare professionals would have had limited 
exposure to people with CFD throughout their training and work.  
A general lack of support for people with CFD was observed. People with CFD wanted 
to feel they had been listened to and there was some awareness from the healthcare 
professional of how they managed CFD in the context of their life. In people with type 
1 diabetes communication with healthcare professionals also showed a lack of insight 
into the recognition of the person rather than the disease (Spencer et al. 2010, 
Robinson 2015), with focus on blood glucose control or HbA1c rather than the 




professionals can hinder type 1 diabetes self-management (Spencer et al. 2013, 
Robinson 2015), impact upon attendance at appointments (Celik et al. 2015) and affect 
psychological well-being (Robinson 2015). Support and advice from healthcare 
professionals to people with all types of diabetes needs to be meaningful, consider the 
wider context of the disease process and be delivered in a caring and considerate 
manner incorporating the individual in care planning.   
Healthcare professionals and people with diabetes may not share the same 
management goals; with clinicians focusing on achieving control in terms of blood 
glucose levels. Where a goal of a healthy balance may be a considered as a more 
appropriate representation of individuals’ willingness to engage in diabetes self-
management (Paterson et al. 1998). This focus on balance rather than control takes 
the emphasis away from issues surrounding concordance. The focus is on the 
individual and valuing their insight into their diabetes management; how they 
understand and achieve balance in their lives whilst appreciating that diabetes is a 
dynamic disease and control can change with life events and changes in health status.  
The CFD clinic was a major drawback in the provision of CFD care within this CF centre. 
The major limiting factors was time. The CFD clinic was held on a different day to the 
CF clinic and only addressed CFD management with very limited CF respiratory 
associated care provided. This meant patients had to attend an additional clinic for 
their CFD care. Separating out the clinics this way was delivering a message that they 
are two separate condition whereas the findings from this study demonstrated the 
need to treat harmoniously. People living with multiple co-morbid conditions struggle 
to integrate the fragmented information they get from different clinicians into their 
disease management, which leads to inadequate self-management and the increased 
risk of poor outcomes (Dickson et al. 2011). 
6.1.4 The MAGIC programme focuses upon the physical needs of 
people with CFD 
Essential key components to the self-management of CFD were identified as the CFD 




regarding insulin were problematic and reflected deficits in knowledge and 
understanding and were further exacerbated by the unpredictability of CF and CFD.  
Blood glucose monitoring was considered the most intrusive element of CFD 
management and hence had a significant impact upon daily life. There was variability 
in the experiences as to what was achievable for individuals in terms of blood glucose 
management. Difficulties in balancing diet and controlling blood glucose were seen, 
with a need to improve knowledge of the role carbohydrates in CFD and how to better 
manage nutrition.  
Another essential component to self-management which was identified was the lack of 
understanding about what CFD is, what causes it and how it interacts with CF. What is 
key in order to improve the self-management of CFD is the need to develop a greater 
understanding of CFD along with the provision of realistic, practical and helpful 
education and support on how to balance the CFD self-management triad. Being 
informed with knowledge to facilitate decision making, along with the provision of 
reliable information and the option to participate in decision making were deemed 
essential to help adults manage their type 1 diabetes (Jull et al. 2016).  
The stakeholder development group considered these keys findings and supporting 
evidence, along with their personal knowledge and experiences of managing CFD, to 
inform the MAGIC programme development. The CFD self-management triad 
addressed the physical needs of someone with CFD; these are the fundamental 
requirements that are needed to effectively manage CFD. Ultimately this influences 
survival because the major driver for treating dysglycaemia early in CF is to improve or 
optimise nutritional and respiratory status which influences morbidity and mortality 
(Bridges et al. 2018). To address the identified deficits in knowledge and self-
management skills, the stakeholder development group agreed with the evidence and 
supported the focus of the programme around the CFD self-management triad and the 
understanding of what CFD is. The stakeholder development group remained mindful 
of the emotional needs of people with CFD throughout the MAGIC programme 
development and incorporated guidance, support and personal reflections through the 




remained true to the focus of the programme on managing abnormal glucose in CF. 
Primarily the MAGIC programme is an educational resource designed to facilitate self-
management and its key focus was to address these identified deficits, so people can 
develop skills to effectively self-manage their CFD. 
NICE (2015) do not specify what core topics should be included as part of a DSME 
programme. The American Diabetes Association’s National Standards for DSME 
identify core topics for DSME, these include: nutritional management, physical activity, 
diabetes disease process, medical treatments, blood glucose monitoring and how it is 
used to inform self-management decisions, developing personal strategies to promote 
health and address psychosocial concerns, and preventing, identifying and treating 
complications (Beck et al. 2017). They however suggest content should be adapted to 
individual requirements according to type of diabetes, age, culture, health literacy, 
numeracy and co-morbidities. Thus, the MAGIC programme was developed to address 
the specific needs of people with CFD. 
6.1.5 The MAGIC programme was developed as a staged approach 
to learning 
The MAGIC programme is a unique self-management education programme for people 
with CFD. No similar programmes for people with CFD exist. It has been designed 
around a staged-approach to learning, which develops skills, knowledge and 
experiences in CFD management, to improve self-efficacy. The MAGIC programme 
consists of four modules: CFD beginner, CFD improver, CFD advance and CFD wizard. 
The stakeholder development group decided the CFD beginner module would be 
regarded as the basic level of knowledge and skills that someone with CFD would 
require. The modules would then increase in complexity with the final module, CFD 
wizard, being regarded as most advanced level of knowledge and skills that someone 
with CFD would require. The stakeholder development group did not make 
recommendations that everyone with CFD should complete all four modules; this 
would be decided between the programme facilitator and the person with CFD and 




In a recent systematic, review eight key components of effective chronic condition self-
management education interventions for children with asthma, cystic fibrosis, and 
diabetes were identified. Having a structured and sequential programme was 
considered one of these (Saxby et al. 2019). The structured and sequential 
programme, as in the stage approach to learning adopted by the MAGIC programme, 
facilitates learning by building upon the skills and knowledge previously learnt and 
developed. Another systematic review identified five main issues influencing the ability 
to self-care in people with type1 and type 2 diabetes: communication, education, 
personal factors, support and provider issues (Wilkinson et al. 2014). They also 
identified sequential learning as key part of education. For knowledge to be sustained 
the scaffolding of education was deemed important, this is learning by building upon 
previous knowledge or education, incrementally. Structured and sequential learning 
are thus identified as key to self-management.   
6.2 Strengths and limitations 
 
CF and CFD research are very medically focussed with limited qualitative research 
within this field as to how these co-morbidities are experienced. However, the 
experiences seen in managing other co-morbid conditions has demonstrated some 
similarities with the experiences of managing CF and CFD (King et al. 2002, Kerr et al. 
2007, Dickson et al. 2011, Yu & Tsai 2013). This included: prioritisation, where one 
disease was considered more important than the other (Kerr et al. 2007); the severity 
of the illnesses informing treatment and self-management, with priority given to the 
most severe illness (Kerr et al. 2007, Yu & Tsai 2013) and the influence of previous 
experiences and personal values on self-management decisions (Dickson et al. 2011). 
People with other multi-morbid conditions have also been shown not to be concerned 
with the risk of death from diabetes (Yu & Tsai 2013) or think about future progression 
of it (King et al. 2002).  
Although the experiences of living with CF and CFD share similarities with other multi-
morbid conditions there is a deficit in CF research concerning the emotional 




greater understanding of emotions to help inform the development of appropriate 
psychosocial support and resources for people with CFD. 
Interpretation is a key feature of meta-ethnography and IPA. A criticism received from 
journal reviewers for both the meta-ethnography and IPA study concerned not going 
beyond description in some of the data analysis. Data analysis, for both the meta-
ethnography and empirical study, were re-worked on many occasions to, where 
possible, achieve a greater sense of meaning. More descriptive methods of analysis 
could have been used instead such as qualitative thematic synthesis or thematic 
analysis but the aim was to go beyond purely describing and summarising findings. It 
was important to demonstrate meaning in experiences, particularly with regards to 
context of trying to live with and manage both CF and CFD; this would have been lost 
with more descriptive methods.  
IPA recognises the role of the researcher in making sense of participants’ experiences 
(Shinebourne 2011). Heidegger’s work acknowledged that researchers’ fore-
conceptions (assumptions and ideas) contribute to the interpretative process but 
suggests priority should be given to new things instead of the researchers’ 
preconceptions (Smith et al. 2009). Thus, throughout the research process there was a 
need to remain mindful to any assumptions emerging while trying to engage with the 
new. I have been working in CFD for a significant amount of time and had an establish 
professional relationship with some of the participants. I had to put my thoughts, 
feelings and knowledge about them aside and engage with them, at that moment, in 
that context. A limitation of this was that I knew some of the patients well, and had my 
own understanding of them, their life and disease management. I approached the 
interviews trying to put these assumptions aside and sought clarity of their 
experiences by asking prompts during the interviews rather than being guided by my 
assumptions or prior knowledge. When participants made comments about colleagues 
or the service I knew I had to depersonalise these and not use my knowledge or 
experience to inform my interpretations. This process of challenging my pre-




Challenging personal interpretations are vital to ensure rigor in qualitative research 
(Toye et al. 2014). Therefore, the use of more than one researcher in the meta-
ethnography and IPA study contributed to increasing rigor. The different professional 
backgrounds, knowledge and experiences of the research team offered different 
perspectives and challenges to the interpretative process. The key findings from each 
stage were also discussed with the PhD project management group, which further 
contributed to enhancing the credibility of the findings. 
Hay-Smith et al. (2016), in a systematic review of clinician-researcher dual- role 
experiences, advocates “once a clinician, always a clinician,” suggesting the clinician-
researcher cannot completely discard their clinical role and the dual role created 
requires acknowledgement (Hay-Smith et al. 2016). I was known to the study 
participants as a CF specialist dietitian and for some this relationship had existed for a 
significant number of years. Indeed, one of the reasons I became a researcher was 
through my clinical experience. Consciously and subconsciously the association 
between the researcher and participant reflects that of the clinician-patient 
relationship (Hay-Smith et al. 2016). I always remained mindful to the possibility of the 
existence of dual roles within the generation of research data in this study. Dual roles 
of clinicians and researcher can pose many challenges throughout research; these are 
classified into two major themes: 1) research role can involve patterns of behaviour 
typical of a clinical role and 2) developing connections that start to resemble a 
clinician-patient relationship (Hay-Smith et al. 2016). Hay-Smiths’ framework is very 
comprehensive and provides guidance for when struggling with the ethical and 
methodological challenges of dual roles. Pertinent to my research was the sub-theme 
from theme one that concerned clinical queries. The IPA interviews did not pose any 
challenges to my clinical relationship with the participants as none of them sought 
clinical advice or clarification and I was mindful to be non-judgemental of their 
experiences and management strategies. In the cognitive interviews, reviewing the 
MAGIC programme, more participants sought clinical opinions from me. This tended to 
be reassurance if what they were doing was correct. For example, one participant used 




through experiential learning. They had merged the three steps taught in the MAGIC 
programme into one step, I made the informed decision to reassure them what they 
were doing was correct and explained how it related to the more ‘simplified’ method 
taught in the MAGIC programme. One participant in the MAGIC reviews asked me a 
clinical question that was related to other health issues they were experiencing, 
because they were post-transplant they were not seeing a not seeing a dietitian 
regularly. I therefore made the clinical decision to address their questions, once the 
interview was over. I had the knowledge and experience to decide if answering clinical 
questions that occurred during the research process were applicable and made 
decisions appropriately so they did not impede the research process. Hay-Smith (2016) 
acknowledges that some researchers are happy to answer, ‘simple and reasonable’ 
questions, however what this means depends upon personal interpretation. I would 
not be prepared to engage in what I interpret as more clinical management decisions 
such as changing insulin doses, reviewing blood glucose levels or making dietary 
changes during research interviews. I would, if required, arrange appropriate clinical 
follow up, for the participants, to address these issues. The clinician- researcher 
boundaries are not clear cut and I believe I have a moral obligation to ensure duty of 
care, this could be referring onto other clinicians or where appropriate providing 
assistance. What is important is the awareness that dual roles can exist but that they 
do not necessarily result in negative effects on the research process and outcomes 
(Hay-Smith et al. 2016).   
Another limitation of being known to the research participants in a clinical role 
included social desirability bias. This is the tendency for participants to respond to 
questions in a way that is thought of more favourable so they present themselves in a 
more positive way (Neeley & Cronley 2004). This is comparable to the sub-theme in 
Hay-Smith’s framework of suspicion and holding back; participants may be limiting 
what they share (Hay-Smith et al. 2016). Criticising care, people or services is a 
reflection of participants not-holding back. I have considered that participants may not 
have been fully open to me due to my dual roles of a researcher and a clinician. They 




their experiences may be judged or criticised. Even though this was discussed as part 
of the consenting process prior the interviews. However, many criticisms were 
revealed in the study particularly concerning deficits in service provision and support 
but also about the face validity of the MAGIC programme. Overall a diverse variety of 
responses were obtained in all parts of the study, which have been used to strengthen 
the understanding of the experiences of managing CFD and establish face validity of 
the MAGIC programme. 
The findings from this study are from one adult CF centre. They may not be completely 
transferable to other CF centres where different practices in the management of 
people with CFD exist. There is also the need to be mindful that the participants were 
self-selecting. Those who came forward for interviews in the IPA study are more likely 
to be having positive experiences although in the case of one participant anger and 
dissatisfaction appeared a motivator to participate. Those who participated in the 
MAGIC reviews were more diverse as they demonstrated variability in knowledge and 
skill mix. In both stages, with the exceptions of those who didn’t have CFD, the 
participants had lived with CFD for many years. The processes of adaptation, 
management and self-management experiences of someone with newly diagnosed 
may differ from those who has had CFD for many years. A meta-synthesis of qualitative 
studies, exploring the diagnosis and early processes of adaptation in adults with newly 
diagnosed type 1 diabetes, identified five key influencing themes: disruption, 
constructing a personal view of diabetes, reconstructing a view of self, learning to live 
with diabetes, and behavioural adaptations (Due-Christensen et al. 2018). The process 
of adapting to the diagnosis of type 1 diabetes was significantly influenced by previous 
life experiences including physical, social and psychological aspects of life. These 
findings share many similarities to those seen in people with CFD within this study. This 
is particularly with regards to: the dynamic nature of diabetes necessitating constant 
change and adaptation, how diabetes impacts upon life is influenced by individual 
perception of it and the multidimensional process of learning involved in managing it. 
What’s missing are those findings only pertinent to CFD such as the complexities in 




Throughout this study it was difficult to recruit younger adults. This is a well-known 
challenge in research (Cain & McGuinness 2005, Gokee-Larose et al. 2009, Kenten et 
al. 2017, Peake et al. 2018). In this study, to avoid coercion, I did not actively follow up 
invitation to participate letters with phone calls. On reflection another member of the 
research team, who was not known to the patients, could have made these follow up 
calls to facilitate recruitment. Letters were the primary method of recruitment in this 
study. For future research it would be useful to consider how to target this more 
difficult to reach population. Consideration should have been given to adopting a more 
applicable method of recruitment to this age group. Social media, such as Facebook 
has been shown as a useful tool to recruitment in health research (Whitaker et al. 
2017) and may therefore be a more applicable recruitment channel for younger adults. 
Convenience, incentives, accentuating benefits and advertisement have been 
proposed as methods to recruit young adults to studies (Corsino et al. 2013). Other 
suggestions to improve recruitment of young adults into research include involving 
them early in the research process from the study design stage (Kenten et al. 2017, 
Peake et al. 2018). The MAGIC study has one younger adult representative on the 
stakeholder development group; in hindsight and for future planning this number 
needs to be increased. The inclusion of younger adults may have influenced some of 
the topics covered in the MAGIC programme, and specific management issues relevant 
to adolescents and younger adults such as body image, drug use (alcohol, tobacco and 
other drugs), puberty and reproductive health issues may require additional attention 
(Withers 2012). Becoming independent is important for adolescents with CF (Withers 
2012) and type 1 diabetes (Spencer et al. 2010, Castensoe-Seidenfaden et al. 2017, 
Strand et al. 2019) and self-management programmes will need to facilitate this. As 
part of seeking independence young adults may move out of home, go to university or 
start work, these experiences would need attention in a self-management education 
programme. BERTIE has a separate ‘streetwise’ section of their website specifically 
aimed at adolescents and young adults (BERTIE 2019). Consideration for additional 




This study had a strong patient and public representation throughout, this started in 
the planning of the proposal, continued through to the development of the MAGIC 
programme and will be incorporated into dissemination of findings. Patient and public 
representation was imperative to this study which has designed an education 
programme for people with CFD which has been heavily influence by the intended 
audience it was designed for. 
The MAGIC programme is a self-management education programme for people with 
CFD. It was designed to address the skills and knowledge required to manage 
abnormal glucose in CF. This was informed by the evidence from stage one and 
expertise from the stakeholder development group. The MAGIC programme does this 
well in a very clear, informative and accessible way, which includes many interactive 
and visual components to facilitate learning. Due to the focus on the education and 
skills required to self-manage CFD and time constraints it was unable to address every 
aspect of CFD care. However, that was not the aim it set out to achieve. The MAGIC 
programme was not designed to address all the psychosocial component or 
management issues of living with CFD. It normalised that emotional challenges exist 
for people with CFD and made suggestions for further channels of support. There is 
limited research looking specifically at the emotional needs of people with CFD. 
Diabetes distress, the emotional distress and behavioural challenges associated with 
living with diabetes (Fisher et al. 2015), has been shown to affect 20-30% of people 
with type 1 diabetes (Sturt et al. 2015). Diabetes distress influences glycaemic control 
and self-management behaviours such as insulin administration/omission and blood 
glucose monitoring (Sturt et al. 2015). Diabetes distress has not been explored in 
people with CFD. People with CF experienced very similar responses and processes of 
adaptation to diabetes as those with type 1 or type 2 diabetes, therefore there are no 
reasons to believe that they will not experience some level of diabetes distress. People 
are generally diagnosed with CF in infancy or early childhood so for many by the time 
they develop CFD, in early adulthood, they will have had many years to develop their 
understanding of their illness experience. They will therefore be familiar with 




themselves as a ‘normal’ person with CF and, despite variable health and daily 
treatments, try to lead a ‘normal’ life (Higham et al. 2013). This illness experience 
could result in lower levels of diabetes distress than that seen in people with type 1 or 
type 2 diabetes. Or for some the experience of a higher burden of treatment 
associated with CFD may result in higher levels of diabetes distress. The MAGIC 
programme facilitator will help facilitate the participants’ learning. They will provide 
support to participants, by telephone or video-conferencing, at individually agreed 
time points throughout the programme. This will include exploring, with the 
participants, any challenges or difficulties they are experiencing with the MAGIC 
programme or any emotional challenges they have encountered whist participating in 
the programme. If any significant difficulties are encountered participants can be 
referred back to their clinical teams. CF teams should have psychosocial support as an 
integral part of their service (UK Cystic Fibrosis Trust Standards of Care Working Group 
2011); this includes access to clinical psychologists and an annual general mental 
health and wellbeing assessment (NICE 2017). 
6.3 Implications for clinical practice 
As highlighted in chapters two and three, the meta-ethnography was the driving force 
to reconsider the name cystic fibrosis related diabetes. The language and 
terminologies used had a vital role in making sense of experiences. Removing ‘related’ 
strengthens the link between CF and diabetes. This is important because a deficit in 
understanding the relationship between CF and diabetes was seen. CFD should be 
regarded as part of CF; it is a complication that occurs due to CF pathophysiology. The 
challenge now is in conveying this message to the wider CF community, at a national 
and international level. The first and significant step in this was the adoption of the 
term CFD by the CF Trusts’ CFD guideline steering group. These guidelines will be 
available via the CF Trust website and can therefore be widely accessed. Any 
communications with the CF community, via the CF Trust, promoting this document 
will be using the name CFD. This will help people to start to become more familiar with 




process taking every opportunity available to continual promote it as widely as 
possible within the CF community.  
CFD management needs to be comprehensive, integrated into routine care, and 
adaptable to consider changes in health status and life events, therefore normalising 
CFD management as part of routine CF care. Healthcare professionals should be 
conveying this message from diagnosis to facilitate understanding and to inform 
management strategies. Guidelines recommend all people with CF are screened for 
CFD from the age of 10 years (Moran et al. 2010b, NICE 2017), this is a time where 
people with CF are informed about the risks of developing CFD. At this point early 
education could be initiated to increase the understanding of the relationship between 
CF and CFD and the importance of effective management as part of routine care. 
The provision of CFD care, particularly clinics, within this study was problematic. By 
holding a specialist CFD clinic which had very little overlap with routine CF care (CF 
clinics) the centre further contributed to separating the two conditions. This service 
does not support managing CF and CFD harmoniously and does not help patients 
develop the correct understanding about the relationship between CF and CFD. It also 
conveys the message that only CFD specialists can manage CFD. This study 
demonstrated that the knowledge of healthcare professionals about CFD was often 
deficient therefore the educational needs of healthcare professionals requires 
attention. All healthcare professionals working in CFD should be educated so that they 
are able to provide some level of care and support to people with CFD. This way, more 
people within the team will be talking about CFD and taking an interest in its 
management which will highlight to patients the importance of the relationship 
between CF and CFD and incorporate CFD management into routine CF care.  
The quality improvement aspects of gaps in service for people with CF and CFD 
therefore need addressing to improve the delivery of support, education and care. This 
needs to consider: time commitments, use of technology, type of support provided 
and educational needs. People with CFD should have an integral part in the planning of 




context beyond the illness itself. Attention should therefore be paid to developing care 
delivery pathways, including digital, to provide continuity of care, education and 
support with known healthcare professionals. This will help support the integration of 
people with CFD in treatment and care planning. 
Many knowledge deficits essential to self-managing CFD were identified. These were 
concerning the self-management triad- insulin, nutrition and blood glucose and an 
understanding of what CFD is. The education of people with CFD therefore needs 
addressing. The MAGIC programme has been developed to address these deficits so 
individuals can develop skills and knowledge to effectively self-manage their CFD. The 
MAGIC programme should be integrated into the delivery of CFD care as a resource for 
people newly diagnosed with CFD and for those with established CFD who would 
benefit from further education. Due to its secure web-based format people with CFD 
can use it in a timely and convent manner to them, thus avoiding the need for 
additional hospital visits. The MAGIC programme could also be used as an educational 
resource for healthcare professionals. 
The MAGIC programme could currently be used by people with CFD however there is 
the conundrum of weighing up the balance between providing patient education and 
providing evidence-based patient education. As a healthcare professional I have a duty 
of care, an element of this is being able to provide disease-specific patient education 
to help patients self-manage their long-term conditions. However, evidence-based 
healthcare requires verification that such programmes or interventions are effective. 
This study is currently being planned, but realistically it will be at least three years 
before evidence of effectiveness is available. Does the MAGIC programme sit unused 
for that time or should it be used? In clinical practice, time for patient education is 
limited and often a more reactive approach to disease management is adopted. The 
MAGIC programme does not necessitate hospital visits and can be used by people with 
CFD in a more timely and convenient manner. I believe that I should start using the 
MAGIC programme with patients in my CF centre. The decision for this will be made on 
an individualised patient basis and take into consideration clinical status, glycaemic 




resources and money has been invested in developing this unique programme with 
established face validity. Using the programme will help generate some user evidence, 
this will include: understanding what is useful or unhelpful, identify areas where more 
support is needed so the role of the facilitator can be more clearly established, identify 
problems with the programme and establish how people use the programme- do they 
just dip in and out or do they work through the programme from start to finish? 
Attendance, either previous or planned for the future, at a DSME programme is part of 
NHS England’s criteria for the funding of flash glucose monitoring, which people with 
CF and diabetes are now eligible for (NHS England 2019). Flash glucose monitoring is 
an innovative technology that minimise the need for finger-prick blood glucose 
monitoring (Abbott 2019). As no DSME programmes exist for CFD our CF centre will 
also need to consider how we are going to address this. Could the MAGIC programme 
be used? It may be, for example, that we recommend all people with CFD who start on 
flash glucose monitoring complete the CFD beginner module. The argument for not 
using the MAGIC programme is that we do not know if it will be effective and upon 
which outcomes it may have an effect.  
6.4 Recommendations for future research 
In the twenty years I have been working in CF the characteristic of the CF population is 
now more clinically diverse. Survival has improved in people with CF (Keogh et al. 
2019) and people are living for longer with more severe disease (George et al. 2011).  
Along with improvements in health and survival comes a high burden of treatment 
(Sawicki et al. 2009). It now not uncommon to also treat people with CF who are 
overweight or obese (Panagopoulou et al. 2014, Hanna & Weiner 2015), who have 
different management requirements. Little research is specifically aimed at this 
population. It would be beneficial to identify what is the role of dietary modification in 
the management of overweight and obese adults with CFD, this could be through a 
national survey looking at practices in different CF centres. It would also be helpful to 
understand the personal experiences of making dietary changes from people with CFD 
to help inform more effective management strategies. The use of CFTR modulator 




would be helpful to establish what are the effects of CFTR modulator therapy on 
glycaemia in people with CFD. 
CFD is the most common co-morbidity affecting people with CF, however despite 
earlier screening and treatment aged-adjusted mortality remains 3.5 times greater in 
people with CFD compared to those without (Lewis et al. 2015). Establishing the cause 
of mortality in people with CFD would be valuable to inform future management 
strategies. There is also need for further research to inform national guidelines of 
when should treatment for dysglycaemia in people with CF be commenced? 
This study identified a deficit in qualitative studies exploring the experiences of living 
with and managing CFD indicating a need for further studies exploring these 
experiences to be undertaken. These could be further qualitative studies, or case 
reports which highlight CFD self-management strategies and processes to reflect what 
can be learnt from those with CFD who are managing or not managing CFD well. It 
would be particularly beneficial to explore the experiences of those newly diagnosed 
with CFD and the more difficult to recruit groups, such as adolescents and young 
adults, to identify similarities and differences in experiences.  
The MAGIC programme is a self-management education programme for people with 
CFD, it therefore focussed on the physical needs of people with CFD. Further research 
should be considered looking at the emotional needs of people with CFD to inform the 
development of a healthcare pathway to meet these needs. 
Oral antidiabetic drugs are not widely used in the treatment of CFD, because its 
primary pathophysiology is insulin deficiency, and studies on their use are limited 
(Ballmann et al. 2014, Onady & Stolfi 2016). DPP-4 inhibitors (gliptins) may be 
beneficial for those with CF who have a good nutritional status, early stages of 
dysglycaemia and demonstrate barriers to insulin therapy (Sunsoa et al. 2017, Farrell 
et al. 2018). Further studies are needed to identify the effectiveness of DPP-4 
inhibitors on clinical and patient reported outcomes in overweight and obese adults 




We do not know what the most appropriate clinical and patient reported outcomes 
are for people with CFD, and a CFD core outcome set does not currently exist. A 
programme of research for developing a core outcome set for clinical studies in CF has 
been registered with the COMET Initiative (COMET 2019). The scope of which includes 
respiratory, gastrointestinal, nutritional, mental health and quality of life. What is not 
clear is if CFD is included in this scope. The development of a core outcome data set 
and the development of patient reported outcome measures arising from the priorities 
established in the core outcome set research is an essential next step. Only once a core 
outcome set for CFD is established then can the MAGIC programme be assessed, 
against relevant outcomes, in the entire CF community. 
This study demonstrated face validity of the MAGIC programme however to establish 
its effectiveness further research is needed. The next stage of the work is a feasibility 
study which will run in conjunction with the development of a CFD specific core 
outcome set, the logic model (figure 38) gives an overview of this.  
The feasibility study is required to: 
• Identify how the MAGIC programme is used in the ‘real-world’ situation. This 
includes: delivery of the programme, the use of the personal log function, food and 
blood glucose diaries and secure logins which were not reviewed within the scope 
of this study 
• Determine which clinical and patient reported outcome measures are appropriate 
and subject to change 
• Establish the role of the facilitator in delivering the MAGIC programme 
• Explore recruitment and retention rates 
• Develop a protocol to determine the effectiveness and cost effectiveness of the 













7  Conclusions 
This study aimed to answer the research question “how can we best meet the self-
management education requirements of people with CFD?” This was achieved through 
two stages of work informed by the MRC Framework for developing and evaluating 
complex interventions. 
In the first stage a meta-ethnography and an empirical IPA study provided insight into 
the experiences of living with, and self-managing, CFD. The response and adaptation to 
CFD is not completely unique and shares many similarities with that experienced by 
people with type 1 or type 2 diabetes and other chronic illnesses. The differences 
experienced related to the complexities trying to balance the relationship between CF 
and CFD. How CFD was perceived influenced its management. The relationship 
between CF and CFD is entwined, this study proposed an integrated model of 
management to reflect this and to promote the management of CFD as part of CF. To 
strengthen the causal relationship between CF and CFD, and to promote patients and 
healthcare professionals managing them as one condition, a name change from cystic 
fibrosis related diabetes to cystic fibrosis diabetes was proposed. The challenge now is 
to promote this within the wider CF community.  
Deficits in service provision and lack of support for people with CFD were identified as 
limiting factors in the care of people with CFD. To provide continuity of care, education 
and support for people with CFD a more timely, digital and harmonious service which 
is integrated into routine CF care is needed. 
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facilitate self-management and its primary focus was to address these identified 
deficits, to enable people with CFD to develop self-management skills to effectively 
manage their CFD. The MAGIC programme was developed as a staged approach, this 
facilitates learning by building upon skills and knowledge previously learnt and 




efficacy in managing their CFD. The focus of the MAGIC programme was therefore on 
the physical needs of people with CFD. Further research on the emotional needs of 
people with CFD is required to inform appropriate healthcare pathways. 
The MAGIC programme is a unique web-based resource, highly regarded by the people 
with CFD involved in the study. Its major benefits include: its strong-evidence base, 
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Appendix 6: Meta-ethnography reporting guidelines 
Application of the reporting criteria to this study 
 
No. Criteria Headings Reporting Criteria Comments- in relation 
to this study 
Phase 1—Selecting meta-ethnography and getting started  
Introduction  
1 Rationale and 
context for the 
meta-ethnography 
Describe the gap in research or 
knowledge to be filled by the 
meta-ethnography, and the wider 






2 Aim(s) of the meta-
ethnography 




3 Focus of the meta-
ethnography 
Describe the meta-ethnography 
review question(s) (or objectives) 
In methodology 
chapter 
4 Rationale for using 
meta-ethnography 
Explain why meta-ethnography 
was considered the most 




Phase 2—Deciding what is relevant  
Methods  
5 Search strategy Describe the rationale for the 
literature search strategy 
completed 
6 Search processes Describe how the literature 
searching was carried out and by 
whom 
completed 
7 Selecting primary 
studies 
Describe the process of study 




8 Outcome of study 
selection 
Describe the results of study 
searches and screening 
Presented as 
flowchart 
Phase 3—Reading included studies  
Methods  
9 Reading and data 
extraction approach 
Describe the reading and data 






Describe characteristics of the 
included studies 
Characteristics 
presented as a table 
Phase 4—Determining how studies are related  
Methods  
11 Process for 
determining how 
studies are related 
Describe the methods and 
processes for determining how the 
included studies are related: 





- Which aspects of studies were 
compared 
AND 
- How the studies were compared 
Findings  
12 Outcome of relating 
studies 
Describe how studies relate to 
each other 
Brief 
Phase 5—Translating studies into one another  
Methods  
13 Process of 
translating studies 
Describe the methods of 
translation: 
- Describe steps taken to preserve 
the context and meaning of the 
relationships between concepts 
within and across studies- Describe 
how the reciprocal and 
refutational translations were 
conducted- Describe how potential 
alternative interpretations or 
explanations were considered in 
the translations 
 
Discussed. Use of 




14 Outcome of 
translation 
Describe the interpretive findings 
of the translation. 
Presented as table of 
occurrence of themes 
Phase 6—Synthesizing translations  
Methods  
15 Synthesis process Describe the methods used to 
develop overarching concepts 
(“synthesised translations”). 
Describe how potential alternative 
interpretations or explanations 
were considered in the synthesis 
Discussed 
Findings  
16 Outcome of 
synthesis process 
Describe the new theory, 
conceptual framework, model, 
configuration, or interpretation of 
data developed from the synthesis 
Conceptual model 
developed 
Phase 7—Expressing the synthesis  
Discussion  
17 Summary of 
findings 
Summarise the main interpretive 
findings of the translation and 






Reflect on and describe the 






- Methodological aspects—for 
example, describe how the 
synthesis findings were influenced 
by the nature of the included 
studies and how the meta-
ethnography was conducted. - 
Reflexivity—for example, the 
impact of the research team on 
the synthesis findings 
19 Recommendations 
and conclusions 



































































Appendix 9: Royal Brompton and Harefield NHS 

















Appendix 11: Interview schedule 
 
1. Can you describe what it is like for you to live with CF? 
Possible prompts; typical day/ treatments/ feelings 
2. Can you tell me about when you were diagnosed with CFD? 
Possible prompts: thoughts/ feelings/ meanings/ treatments/coping/ awareness 
 
3. Can you describe the actual experience of living with CFD on a day-to-day basis? 
Possible prompts- thoughts/ feelings/ attitudes/ activities/ barriers/ difficulties/ what 
helps/ how fits in with CF/ impact on health/ what difficult or easy 
 
4. Can you describe how you learnt to manage your CFD? 
Possible prompts; support/ feelings/ resources 
 
5. Can you describe what it means to you having CFD? 
Prompt words/ images/ metaphors/ associations/ identity 
 
6. Please discuss how you feel you manage your CFD 
Possible prompts; barriers/ facilitators/ comparisons to CF/coping 
 
7. Can you discuss what it is like for you managing your CF and CFD? 
Possible prompts: conflicts/ challenges/ feelings/ identity 
 
8. Can you discuss how you see your future living with CFD? 
Possible prompts: compare and contrast with CF/ is one more important than the 
other 
 
9. Can you discuss any ideas that you have that will help people with CF manage 
their CFD? 
Possible prompts; types resources/ education/ support/what you think will help/ what 
doesn’t help 
 
10.Is there anything else today that you would like to discuss about what it is like for 
you to 



































































Appendix 14: Illustrations of emergent themes 
 
cluster label - 
MAGIC 02 
theme Page & number quote/keyword 
  managing the diabetes 
diagnosis 
3,17 So, there was so much going on in the space of about six months that erm it just kind of was 
another thing that came  
    3,28 it was just constant erm finger pricks I found that actually harder than the insulin injections 
[laughs]  
    4,5 Yeah cos it was my GCSE’s as well which erm yeah it was all a bit crazy I lost a lot of my 
vision so I had to have large print paper at school erm again I just I never I just literally got 
on with it 
    4,11 I don’t know if I ever really processed it, it was just one of those things and you just kind of 
role with the punches erm yeah 
        
learning to live 
with diabetes 
managing the impact of CF 
and its treatments 
3,4 with all of the yoyoing of the steroids then my glucose levels went all over the place so I got 
diabetes 
    3,5 huge doses of steroids for at least a year erm when I was 14 to 15 
    3,10 I think because I’d been having to watch my glucose levels for several weeks because of the 
steroids I think it was at the back of my mind  
    6,17 I’ve always had up until my mid to late 20’s a brilliant appetite erm and then about four 
years ago it just went pretty much overnight erm I’ve never known why it went I also 
started vomiting a lot 
    6,20 that would get worse if my chest was worse so erm so it’s been very difficult  








    8,18 I don’t feel comfortable doing it in front of strangers erm you know it’s the same with 
insulin if you’re out and about some people will just do it in front of people I’m much less 
comfortable doing that 
    8,27 So, if I’m out and about that can be, that causes issues  
    18,3 I’m having to have such high sugar supplements I think it was so much better before I had 
to rely on those 
    22,10 steroids you know you’re doing that’s actually something beneficial for your CF but it then 
throws you, all your diabetes into yeah it goes haywire totally 
    22,13 always difficult to then especially with a constantly changing dose of steroids to keep on 
top of that yeah as well as all the other things 
        
  influence of family 
members with diabetes 
3,19 also my older sister has it so I knew about it 
    3,20 I knew what she had to do erm in terms of blood sugars and things so it wasn’t a whole new 
learning curve for me 
    3,21 so erm so it wasn’t maybe as scary to me 
    7,4 Erm mmm partly probably through watching my sister actually learning what not to do cos  
    7,9 I couldn’t understand why you would put yourself in that position to be that vulnerable and 
so I think that’s seeing that made me realise what not to do  
    20,10 I definitely wasn’t as scared of it because I’d been watching her do it for the you know for 
the previous 10 years  
        
  who provided CFD support 7,14 I didn’t really have much input at the time when I was diagnosed 
    7,16 So, it was mostly erm my family, my mum was brilliant 
    7,25 Mmm erm……the level of support erm it was okay, it wasn’t I think if I hadn’t had the 
support of my family and particularly my mum and things I would have found it poor erm 








    7,29 And my consultant wasn’t someone I felt that I could talk to particularly openly and the 
other staff again it was a bit rubbish 
    8,4 then I think because it was CF related diabetes the ***** felt that it would be better if I 
came here, started coming here 
    10,14 I don’t think I’ve ever been given anything 
    10,16 [laughs] Erm is there additional help? Like yeah, it’s never been erm offered to me I 
wouldn’t have thought there was other ways of doing things  
    10,18 I didn’t know there erm if there is additional help I definitely don’t know about it so. 
    13,3 I don’t, I tend not to like the CF forum cos I actually find it quite depressing 
    13,27 there’s a lot of people, you get some people who are really into it but they might be further 
along in their condition than you and they talk about things that are potentially in your 
future  
    14,1 I’ll deal it with it when I get there,  
    14,20 I make sure I stay out of everyone’s way. So, there’s definitely not a way for me to meet 
people unless it would be online and as I avoid all of that anyway I kind of no I don’t have 
any peer 
    14,25 I think a lot of people would get a lot out of that  
    14,28 So, I think yes that would be good, may, not necessarily for me but I don’t, things could 
change if things get more difficult maybe I would rely on those things more peer support 
    15,12 erm myself again blogs, yes erm I will see blogs I don’t necessarily follow medical blogs 
    15,14 I just go, dip in and out if and when I want to know something or find out something 
    15,15 So yes, I would rely on them blogs and what other people say when I’m trying to get more 
information 
    18,18 I do find the appointments quite difficult because I feel like I live here these days and the 
diabetes appointments tend to be very short 
    18,22 so it often feels like I’ve come in for nothing because a lot of the time nothing changes  
    18,24 So, it does feel like it’s a lot of effort to have to, to do the diabetes appointments as well 








    9,19 Erm that would be nice if the two could be combined 
        
        
  diabetes treatment draws 
attention from others 
9,3 Erm I don’t like it just because I think other people get scared 
    9,4 ‘Oh what’s wrong?’ as if something’s happening and then they start to panic so I’m trying 
not to panic other people  
        
  words to describe CFD 6,28 mostly it’s just annoying 
    20,20 Mmm it’s a pain [laughs]. 
    21,1 it’s a pain it gets in the way  
    21,1 its nuisance having to check or erm go off to do insulin or you’re not always in a or you’re at 
work and you start to feel like you’re going low but you’re in a meeting and it’s just a 
nuisance it’s you know 
        
An unpredictable 
world 
managing changes in health 1,9 Okay erm at the moment it’s getting harder erm that’s just within the last couple of years it 
kind of has got a lot harder very quickly  
    2,12 its limiting me quite a lot.  
    23,25 because I’m on steroids and supplements which effect my diabetes a lot more the diabetes 
has got a bigger role now so 
        
  looking for an 
understanding of the 
relationship between CF 
and CFD 
4,18 the diabetes has a greater impact I think on my CF wellbeing 








    5,6 the worse my chest is the worse my diabetes is and the worse my diabetes is the worse my 
chest is so there is, there is that relationship 
    5,15 if my chest is good doesn’t mean my diabetes will be good though if that makes sense? And 
if my diabetes is good it doesn’t mean my CF will be good it might just be easier to manage 
but I can have one bad and one good. 
    5,29 if I eat the same things, do the same things, have very similar days, my insulin requirements 
can be quite different and I’ve always put that down to maybe something different is 
happening with my chest  
    6,26 I do think that my CF would probably be going a little bit more straight forward if I didn’t 
have it  
    23,1 , I think I’ve always seen them as separate and that’s possibly because my sisters got 
diabetes so I see it as a separate condition but I think it probably should be seen as one and 
treating both together 
    23,9 even in clinic the two are separated very much 
        
  unpredictability managing 
CF and CFD 
4,15 Erm it can be quite erm up and down at the moment with the lack of appetite and a lot of 
the supplements which are really sugary it can mean that the blood sugars yoyo  
    5,9 there’s always the ambition to keep it all under control but that’s a lot easier said than 
done so I can have one day 
    5,25 and it just that can be exhausting and to keep on top of that, that every time you eat it 
seems to go sky high but insulin it yeah it’s difficult to some days one dose of insulin will be 
enough and another day the insulin dose will be completely different so yeah 
    5,29 That’s what I find quite difficult is that it can be quite erratic 
    24,19 you do feel out of control a lot of the time with diabetes cos you think you’re doing the 
right thing and you can be checking and it’s still the wrong thing and that can be frustrating 
        
  differences to other types 
of diabetes 








    11,22 Erm so again I don’t know why or how that’s not really been erm if it was explained to me 
        
        
  impact of CFD control 4,17 I have to keep a much closer eye on them now than I did a few years ago 
    4,19 it’s if the more out of control they are the worse my CF symptoms will be I think so 
    4,23 , if they do go out of control it seems to go it I might start coughing erm blood  
    5,8 but trying to keep them both under control is incredibly difficult 
    8,13 I think I manage it okay I know I could do better erm  
    12,2 I’ve only worked out through myself that if my chest is bad that my blood sugars will be 
more erratic  
        
  influence of the individual 3,18 you just deal with  
    3,29 but I got over that relatively quickly erm  
    8,27 I were more comfortable doing all of these things in front of people that would also help 
but I don’t know that that’s gonna change any time soon yeah 
    9,10 it was a need to know basis 
    9,15 it’s definitely not something I’m erm loud, loud and proud about but yeah. 
    10,21 Erm I kind of tend to be just get on with it I tend not to fuss or ask questions so I don’t know 
how much I would take up additional help erm 
    11,1 definitely just because of my personality erm I tend to have to be pushed if I’m feeling 
unwell just to call the CF nurses  
    11,9 I’ll be determined that I can do it myself  
    13,14 I think because I’m just far too private maybe that I don’t like putting things out there,  
    14,5 I’d rather try and keep in higher spirits if I can you know  
    14,11 some people who dwell on it and its and moan and I just no, I don’t have time for that 
    24,21 my personality I need to be in control [laughs] erm so I, that is erm difficult and so then 








    25,24 Me and then my condition [yeah] is always very much just a part of it but not who I was  
    25,27 whereas for me it was just I have to do these things but there’s oth, a load of other things I 
want, I enjoy getting on with so 
        
  The future with CF and CFD 6,9 I did just have a libre on I thought that was brilliant [laughs] I loved it and just through the 
ease of it and also seeing my patterns what was going on  
    9,20 I think I get nervous about my eye sight erm I would hate for that to go 
    9,22 I think that is definitely a worry of mine particularly if they yoyo and I’m on a drug at the 
moment for my vasculitis 
    10,1 when I think of my conditions CF is definitely the main one I don’t think CF and diabetes,  
    10,3 So, I do see them separately so when I think about my future it def, it is more of a CF 
dominated future than a diabetes one 
    10,6 the CF future which is now more prominent in my head  
        




8,6 Erm what helps? Checking more frequently, blood sugars erm which isn’t always easy 
    6,13 checking more and erm trying to eat, obviously eating regularly helps but that can be quite 
difficult with erm poor appetite so yeah. 
    8,11 I do check my blood probably about four times a day but I know I would do better if I was 
doing it more particularly after meals 
    8,14 Erm and that’s probably, possibly why I do yoyo because I don’t know what’s happening 
after I’ve eaten  
    8,18 testing my blood more erm……mmm…I think that’s mostly, mostly it is the te, is having 
more readings to go by erm yeah but it’s very inconvenient to be checking all the time you 
know when you’re out and about  









    17,1 cos I don’t know what I’m doing wrong for it to go so high and to stop the yoyoing. 
    17,8 it’s not just going up a little bit and coming down a little bit it goes really high and then 
comes down 
        
        
  understanding insulin  6,3 it isn’t just as straight forward as have the same doses all the time so yeah 
    8,21 I don’t feel comfortable doing it in front of strangers erm you know it’s the same with 
insulin  
    16,12 so I seem to be having the right amount of insulin to bring me back down but how do you 
stop going so high in the first place? 
    17,14 Erm oh dear it’s probably largely guess work …. 
        
  managing food 4,15 Erm it can be quite erm up and down at the moment with the lack of appetite and a lot of 
the supplements which are really sugary it can mean that the blood sugars yoyo  
    12,10 how to calculate how much insulin to have with erm a meal in terms of carbohydrates in 
grams. Erm so that actually was helpful 
    12,14 didn’t realise that there was a link between how much insulin you have with the 
carbohydrate 
    17,7 its mostly that it’s the because I would have great levels if I didn’t eat [laughs] and it’s the 
eating and things that seem to throw them into chaos 
        
  self-directed learning 7,14 Mmm…oh god, I could say myself,  
    17,18 I’ve got there eventually to the right levels a 













    16,14 after 17 years I still don’t know which is actually probably pretty terrible erm I should know 
these things and I don’t. 
    17,11 how, I don’t know how to stop, how to stop it going so high yeah. 
        
  format of support 13,7 I would use an online, online is a way that I would try and find things out yeah 
    13,10 I’ll just Google the question a lot of the time and then see what comes up. 
    13,15 I’ll see if someone else is going through it and if they’re not then I’m not going to fuss about 
starting it  
    13,17 I think that’s probably also why I like online because it means that I don’t have to do group 
activities necessarily 
    13,20 I went to it but I had to go to a group session and I never went back cos it was so depressing  
    13,24 you get a lot of people who are very open but can be quite erm down and down about 
things and I’m just not interested in that 
    15,24 It kind of depends what the leaflets are about I guess  
    16,3 but again it has to be something maybe that would change my care in some way or 
revolutionise it, 
        
  what information is needed 11,17 Erm yeah there’s very little CF diabetes information if I have looked its more just diabetes  
    11,27 , I would quite like to know why it’s different actually erm cos I don’t know if that would 
help me manage my diabetes better if I know what to expect or why there are certain 
triggers or what potential, what the potential triggers are I mean I have no idea 
    16,10 Erm mmm how to manage meal times cos I still don’t think I have that down because I still 
when I eat seem to go up really high 
    17,23 I think all information helps 
    17, 23 I never do ketone checks. I don’t know if I’m supposed to 
    17,24 I think all information is good I don’t think there’s anything that I wouldn’t not want to 
know  








  demands on time 12,18 so if there are going to be things like that to help you manage better I think a week off work 
is way too much  
    12,21 when you’re having to take so much time off for appointments, so much time off for 
admissions or for IV’s then you’ve got your holidays on top  
    12,24 you really want the holiday leave  
    12,26 yeah it needs to be short manageable things or maybe online 
    19,16 but it definitely feels like its once every couple of weeks. 
    19,23 when it just for 20 minutes you think oh god I’ve travelled for three hours just for 20 
minutes so yeah 






Appendix 15: Emergent themes- searching for 
connections 
Similar emergent themes were merged together (participant 2) 
similarities merging similar themes 
impact of health changes managing changes in health 
changes in health   
    
influence of family members with diabetes influence of family members with diabetes 
    
education regarding food and insulin understanding insulin 
judging insulin doses   
    
influence of food   
role of food managing food 
managing food   
    
instability of blood glucose levels   
role of blood glucose monitoring understanding blood glucose monitoring 
role of blood glucose testing   
trying to make sense of blood glucose 
levels 
  
variability/unpredictability of blood glucose 
levels 
  
    
lack of professional support   
support from family who provided CFD support 
role of specialist team   
uncertainty re support   
role of peer support   
peer support via blog   
use of CF forums   
dislikes of groups   
negatives of forums   
value of CFD clinic   
    
coping in adversity   
getting on with life   
disclosure   
attitude/ personal attributes Influence of the individual 
personal attributes   
personality   




positive attitudes   
CF and CFD just something to manage   
    
words to describe CFD words to describe CFD 
an additional problem   
CFD is annoying   
CFD is a pain   
    
demands on time demands on time 
limited demands on time   
    
separate conditions   
relationships between diabetes and CF looking for an understanding of the 
relationship between CF and CFD 
looking for an understanding of the 
relationship between CF and CFD 
  
increase knowledge of link between CF and 
CFD 
  
    
unpredictability in management unpredictability managing CF and CFD 
unpredictability of CFD   
    
impact of CF treatments managing the impact of CF and its treatments 
impact of CF   
impact of treatments and monitoring   
impact of steroids   
managing consequences of CF   
treatment impacting on diabetes   
    
impact of control   
impact of CFD control impact of CFD control 
    
complications of diabetes The future with CF and CFD 
impact of CF on future   
benefits of new technology   
    
use of leaflets role of leaflets 
role of leaflets   
    
self-directed learning self-directed learning 
learning through doing   
    
lack of CFD information   




Appendix 16: Clustering themes 
 
cluster label - MAGIC 02 theme 
  managing the diabetes diagnosis 
learning to live with diabetes managing the impact of CF and its treatments 
  influence of family members with diabetes 
  who provided CFD support 
    
  diabetes treatment draws attention from others 
  words to describe CFD 
An unpredictable world managing changes in health 
  looking for an understanding of the relationship 
between CF and CFD 
  unpredictability managing CF and CFD 
  differences to other types of diabetes 
  impact of CFD control 
  influence of the individual 
  The future with CF and CFD 
skills needed to self-manage 
CFD 
understanding blood glucose monitoring 
  understanding insulin   
managing food 
  self-directed learning 
what information and support 
is needed 
lack of knowledge 
  format of support 
  what information is needed 

















































Appendix 19: MAGIC curriculum CFD beginner 
 
 










• CFD BEGINNER •  •  
Learning goals Content Resources/ notes 
 
 
• Be able to describe what CFD is 
 
What is CFD? 
• Brief explanation diabetes caused by lack of 
insulin and resultant increase in blood 
glucose 
• Discussion of delay and reduction in insulin-  
• Who affects 
 
 
• video – brief overview CFD 




• Know where insulin is produced 
• Know why cells need glucose 
• Understand how insulin lowers 
blood glucose levels 
• Understand that normally insulin is 
produced automatically 
 
Why do we need insulin? 
• Explanation of journey from carbohydrates 
in food we eat to energy for use by our 
bodies. 
• Discussion what happens in someone 
without diabetes  
 
 
• Module text 
• Diagram food to energy 
• Chart normal insulin production 
 
• Discuss what happens when the 
body does not produce enough 
insulin 
 
What happens without insulin? 
• Discussion of consequences of not having 
enough insulin- increase glucose production 
by liver, breakdown of body’s protein and 
fat stores and consequent weight loss, 
muscle weakness, tiredness. Spill over of 




• Module text 













• Identify why having CF causes CFD 
• Be aware that CFD is not 
preventable 
Why does CF cause diabetes? 
• Discussion of link between pancreatic 




• Module text 
 
 
• Be aware of the effects of CFD on CF 
Relationship between CF and CFD 
• Brief discussion of consequences of 
uncontrolled CFD on lungs and nutrition  
 
• Module text 
 
• Be able to identify the symptoms of 
CFD 
Symptoms of CFD 
• Discussion of symptoms some people who 
develop CFD experienced 
 
• Module text 
• Personal log- my symptoms of CFD 
 
 
• Know why insulin needs to be 
injected 
• Know the difference between long-
acting and quick-acting insulin 
• Be able to identify own insulin 
regimen 
• Know what foods affect blood 
glucose levels 
• Give examples of carbohydrate 
containing foods 
How is CFD treated? 
 
• Insulin 
o How given 
o Types of insulin- long-acting and 
quick-acting 
• Diet  
o Food broken down into three main 
nutrients- protein, fats and 
carbohydrates 
o What are carbohydrate containing 
foods 
o Limit sugary drinks, sweets and fruit 




• Module text 
• Personal experience quotes 












• Know how to test blood glucose 
levels 
• Understand why to test blood 
glucose levels 
• Understand when to test blood 
glucose levels 
• Know what normal blood glucose 
levels are for people without 
diabetes 
• Demonstrate what ideal blood 
glucose levels are 
Blood glucose 
 
• Why test 
o Will not know what blood glucose 
are by the way feel 
o Include testing to inform treatment 
and dietary decisions, high and low 
blood glucose levels, lifestyle 
choices 
 
• How to test 
o Give stepwise instructions how to 
check blood glucose levels in video 
o Highlight use of side of fingertip 
rather than pad 
 
• When to test 
o Discussion of when to test if on 
long-acting insulin and meaning of 
results 
o Discussion when to test if on quick-
acting insulin and meaning of 
results 
 
• What do they mean? 
 
 
























o What are normal blood glucose 
levels for people without diabetes 
o Discussion of initial blood glucose 
targets in the early days of 
managing CFD- 4.5-7.5 on waking 
and between meals, <10mmol 1½-2 
hours after meals 
o Discussion that normal to take a 




• Appreciate how other people 
manage with CFD  
Managing your diagnosis 
• Explanation that normal to feel 
overwhelmed, experiencing managing CFD 
is challenging 
• Team there to offer support  
 
 
• Module text 
• Videos and quotes – experiences of 
managing CFD diagnosis 
 
 
• To review knowledge and skills 
acquired through module 
Review of module  
• Test your learning quiz 
• Course moderator to contact participant 7 
days after being given module, then at 
followed agreed timepoint to review 
questions, understanding and readiness 
for next module/ or more follow up 
sessions if required 
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